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Abstract 
Background: The 11th revision to the WHO International Classification of Diseases (ICD-
11) identified Complex Posttraumatic Stress Disorder (CPTSD) as a new condition. There is 
a pressing need to identify effective CPTSD interventions.  Methods: We conducted a 
systematic review and meta-analysis of Randomised Controlled Trials (RCTs) of 
psychological interventions for Posttraumatic Stress Disorder (PTSD), where participants 
were likely to have clinically significant baseline levels of one or more CPTSD symptom 
clusters (affect dysregulation, negative self-concept and/or disturbed relationships). We 
searched MEDLINE, PsycINFO, EMBASE and PILOTS databases (January 2018), and 
examined study and outcome quality. Results: Fifty-one RCTs met inclusion criteria. 
Cognitive Behavioural Therapy (CBT), Exposure alone (EA), and Eye Movement 
Desensitization and Reprocessing (EMDR) were superior to usual care for PTSD symptoms, 
with effects ranging from g = -0.90 (CBT; k=27, 95% CI -1.11, -0.68; moderate quality) to g 
= -1.26 (EMDR; k=4, 95% CI -2.01, -0.51; low quality). CBT and EA each had moderate-
large or large effects on negative self-concept, but only 1 trial of EMDR reported this 
outcome. CBT, EA and EMDR each had moderate or moderate-large effects on disturbed 
relationships. Few RCTs reported affect dysregulation data. The benefits of all interventions 
were smaller when compared to non-specific interventions (e.g., befriending). Multivariate 
meta-regression suggested childhood-onset trauma was associated with a poorer outcome.  
Conclusions: The development of effective interventions for CPTSD can build upon the 
success of PTSD interventions. Further research should assess the benefits of flexibility in 
intervention selection, sequencing and delivery, based on clinical need and patient 
preferences.   
Keywords: CPTSD, psychological therapies, childhood trauma, systematic review, meta-
analysis, randomised controlled trials 
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Introduction 
 
The 11th revision to the World Health Organization’s International Classification of 
Diseases (ICD-11) (WHO, 2018) includes two distinct sibling conditions, Posttraumatic Stress 
Disorder (PTSD) (code 6B40) and Complex PTSD (CPTSD) (code 6B41), under a general 
parent category of ‘Disorders specifically associated with stress’. PTSD is comprised of three 
symptom clusters including (1) re-experiencing of the trauma in the here and now, (2) 
avoidance of traumatic reminders, and (3) a persistent sense of current threat that is manifested 
by exaggerated startle and hypervigilance. ICD-11 CPTSD includes the three PTSD clusters 
and three additional clusters that reflect ‘disturbances in self-organization’ (DSO); (1) affect 
dysregulation, (2) negative self-concept, and (3) disturbances in relationships (Maercker et al., 
2013). These disturbances are proposed to be typically associated with sustained, repeated, or 
multiple forms of traumatic exposure (e.g., genocide campaigns, childhood sexual abuse, child 
soldiering, severe domestic violence, torture, or slavery) (Karatzias et al., 2017), reflecting loss 
of emotional, psychological, and social resources under conditions of prolonged adversity 
(Cloitre et al., 2013).  
The qualitative distinction between PTSD and CPTSD symptomatology has been 
supported in different trauma samples (see Brewin et al., 2017) including those experiencing 
interpersonal violence (Cloitre et al., 2013), rape, domestic violence, traumatic bereavement 
(Elklit, Hyland, & Shevlin, 2014), survivors of institutional abuse such as that occurring within 
foster care and religious organizations (Knefel et al., 2015) and refugees (Hyland et al., 2018). 
The distinction between PTSD and CPTSD has also been confirmed in samples of young adults 
(Perkonigg et al., 2014) and children (Sachser, Keller, & Goldbeck, 2016). The second-order 
factorial structure of CPTSD in which the disorder is comprised of both PTSD and DSO has 
also been supported in previous research (e.g. Karatzias et al., 2016; Hyland et al., 2017a; 
Hyland et al., 2017b; Shevlin et al., 2017). 
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To date a number of meta-analyses and systematic reviews have investigated the 
effectiveness of PTSD treatments in general (Barrera et al, 2013; Bisson & Andrews, 2005, 
2007; Bisson et al., 2007; Bisson et al., 2013; Callahan et al 2004; DeJong & Gorey, 1996; 
Ehring et al, 2014; Pelekis & Dahl, 2005; Roberts et al, 2015; Sloan et al, 2013; Taylor & 
Harvey, 2009; Taylor & Harvey 2010; Watts et al, 2013). Overall, previous meta-analyses have 
supported the efficacy of trauma-focused psychological treatments, such as Cognitive 
Behavioural Therapy (CBT) and Eye Movement Desensitization and Reprocessing (EMDR), 
for the treatment of DSM-IV PTSD, a condition of three clusters of symptoms including re-
experience, avoidance of the traumatic reminders and hyperarousal. CBT and EMDR target 
patients’ memories of their traumatic events and the personal meanings of the trauma and 
typically include repeated in vivo and/or imaginal exposure to the trauma, reappraisal of the 
meaning of the trauma and its consequences, or some combination of these techniques (e.g. 
Bisson et al., 2013). These approaches have been identified as efficacious for a range of PTSD 
survivors, including rape victims, survivors of childhood abuse, refugees, combat veterans, and 
victims of motor vehicle accidents (Foa et al.  2009), although most existing evidence on these 
interventions concerns single adult traumas (e.g. Bisson et al., 2013). There is disagreement 
whether trauma focused treatments are optimal for more complex traumatic presentations such 
as CPTSD. For complex traumatic presentations, a phase-based model, originally proposed by 
Herman (1992), has been suggested as the preferred treatment option (Cloitre et al., 2012).  
Phased interventions address disturbances in self-organization and related problems in 
day to day functioning (e.g., improving safety, emotion regulation and social skills) first, while 
explicit exploration of the trauma (e.g., exposure) is subsequently introduced (Cloitre et al., 
2012b). The rationale for this sequencing is two-fold; firstly to increase emotional, 
psychological and social resources to improve functioning in daily life and secondly, to use 
these resources to enhance the effectiveness of trauma-focused work. Whilst there is some 
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support for this approach (e.g., Cloitre et al., 2010), it is uncertain if a stabilisation phase is 
necessary and it might lead to unhelpful delays in using more trauma-focused interventions 
(De Jongh et al., 2016). Another approach to managing complex traumatisation focuses on 
treating symptoms that are co-morbid with PTSD. Empirical investigations have generally 
demonstrated the feasibility and effectiveness of these approaches. Examples include PTSD 
with Substance Use Disorder (SUD) (Mills et al., 2012) where SUD and PTSD interventions 
are integrated and implemented relatively simultaneously and PTSD with Borderline 
Personality Disorder (BPD) (Harned, Korslund and Linehan, 2014) where ideally the BPD and 
PTSD interventions occur concurrently (but only once the patient has developed the emotional 
and behavioural control to tolerate the PTSD intervention). However, it is important to 
emphasise that CPTSD is not identical to PTSD and its co-morbidity but is rather a distinct 
disorder with a specific symptom profile.   
Considering that ICD-11 CPTSD is a new condition, it will take a substantial amount 
of time before an evidence base accumulates regarding its treatment. However, there is 
evidence on interventions that addressed at least partially the symptoms of CPTSD, including 
those of DSO.  The aim of this systematic review and meta-analysis was to synthesise the 
evidence on effectiveness of treatments for the symptoms of CPTSD and identify therapies that 
look most promising for treating the symptoms of CPTSD. To achieve this goal, we examined 
evidence from trials for PTSD where participants were also likely to have clinically significant 
levels of one or more CPTSD DSO symptom clusters at baseline, and where usable data on the 
effect of interventions on these symptoms were reported. We also aimed to explore the 
moderating effect of RCT quality, the developmental timing of traumatic exposure (childhood 
vs. adulthood), phased vs. non-phased interventions, and individual vs. group interventions on 
treatment outcome. Our ultimate goal was to create a list of research priorities to inspire future 
research in the treatment of ICD-11 CPTSD. 
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Method 
Protocol registration 
A protocol for this systematic review and meta-analysis was pre-registered 
(CRD42017055305) on February 2017. Changes to the protocol are listed in the supplement.  
 
Search strategy and study selection 
The search process was conducted in three main phases. First, MEDLINE, PsycINFO, 
EMBASE and PILOTS databases were searched for studies published from database inception 
to October 2017 using the following search terms: (“PTSD” or “posttrauma*” or 
“psychological stress*” or “combat” or “post-trauma*” or “gross stress reaction” or “stress 
disorder*” or “trauma*” or “psychological trauma”) AND (“randomised” or “randomized” or 
“randomised controlled trial” or “randomized controlled trial” or “RCT”) AND (“therapy” or 
“psychological therapy” or “psychological intervention” or “intervention” or “treatment”). The 
only limiter applied in this search was language (English only). Second, to update the search, 
the same databases were searched for studies published from database inception to January 
2018 using similar search terms: (“PTSD” or “posttrauma*” or “psychological stress*” or 
“combat” or “post-trauma*” or “gross stress reaction” or “stress disorder*” or “trauma*” or 
“psychological trauma”) AND (“randomised” or “randomized” or “RCT”) AND (“therapy” or 
“intervention” or “treatment”) . Limiters applied in this search were language (English only), 
humans, age group (adolescence, defined as between 13 and 17 years old, and adulthood, 
defined as 18 years and older), treatment and prevention, and randomised controlled trials. 
Third, the reference lists of earlier systematic reviews and meta-analyses of clinical trials for 
PTSD were screened for additional studies (Bisson et al., 2013; Bradley et al., 2005; Cusack et 
al., 2016; Ehring et al., 2014; Imel et al., 2013; Kline et al., 2018). Three independent 
investigators (AB, SR, PM) carried out the search. Any discrepancies between search results 
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were discussed and resolved with members of the research team (PHU, TK). As a final step, 
unpublished data were identified through contacting investigators and searching clinical trial 
registries (ClinicalTrials.gov and the UK Clinical Trials Gateway).  
Studies were eligible for inclusion if they were randomised controlled trials (RCTs) 
reporting the effects of an individual or group-based psychological intervention for adults 
(mean age ≥16 years) with PTSD (ICD-10 and/or DSM-III-IV criteria), if participants 
experienced at least one of the additional CPTSD criteria at baseline (affect dysregulation, 
negative self-concept and disturbances in relationships, as defined in ICD-11), and if 
participants were free from developmental or intellectual disability, neurodegenerative 
disorders and acquired and/or traumatic brain injury. Studies where participants had comorbid 
substance misuse difficulties or other mental health conditions were included, but studies where 
participants had a primary diagnosis of substance misuse disorder were excluded. Case studies, 
uncontrolled trials and crossover trials were not included. 
To establish whether participants had clinically significant levels of one or more of the 
additional CPTSD symptom clusters at baseline, any published clinical cut-offs relating to the 
CPTSD syndrome or individual CPTSD DSO symptoms were referred to in the first instance. 
If these were not available, any original validation study of the CPTSD index was referred to 
in order to try to identify relevant healthy norms; if the mean of the participants was more than 
one standard deviation (SD) away from the mean of these norms (in the direction of 
impairment), participants were considered to have clinically significant levels of the relevant 
CPTSD index. If there was no original validation study or if studies did not contain relevant 
healthy norms, studies that contained such norms was then searched for; if there were multiple 
studies, those with the largest sample sizes were prioritised. If the above clinical cut-offs or 
relevant norms could not be obtained, a decision about clinical significance was made on a 
case-by-case basis (e.g., if the participants’ mean on a CPTSD DSO symptom indicated that 
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they were closer to being intact than impaired, they were not considered to have clinically 
significant levels of the relevant CPTSD symptom).    
We defined a ‘psychological intervention’ as a talk-based intervention delivered by a 
trained therapist who adapted the treatment to patients on the basis of a therapeutic relationship 
(i.e., no delivery of a non-modifiable standard protocol, e.g., progressive muscle relaxation) 
(Benish, Imel and Wampold, 2008), and met at least two of the following four criteria: (a) a 
citation to an established school or approach to psychotherapy; (b) a description of the therapy 
that contained a reference to a psychological process (e.g., operant conditioning); (c) a 
reference to a treatment manual that was used to guide the delivery of the treatment; (d) the 
identification of active ingredients of the treatment and citations for these ingredients. Some of 
the face-to-face interventions we included did not meet these criteria (e.g., mindfulness, yoga), 
however we decided to report their effects in the interests of completeness. Online or other 
non-face-to-face interventions, even though they may meet these criteria, were excluded 
because of their different method of delivery and in an effort to reduce heterogeneity. 
We further categorized psychological interventions into four different groups; (a) CBT 
(see definition below); (b) exposure therapy alone (i.e., psychological interventions, which 
were not better defined as CBT, emphasizing exposure to the trauma memory as the principal 
active treatment component, such as PE and imaginal exposure); (c) EMDR (i.e., psychological 
interventions consistent with the manual by Shapiro, 1995); (d) other psychological 
interventions (e.g., mindfulness). As per NICE guidelines, CBT was defined as a discrete 
psychological intervention where service users: (i) establish links between thoughts, feelings 
or actions with respect to the current or past symptoms, and/or functioning; (ii) re-evaluate 
their perceptions, beliefs or reasoning in relation to the target symptoms (National 
Collaborating Centre for Mental Health, 2014). To be categorized as CBT, the intervention 
also had to focus on at least one of the following: (iii) service users monitoring their own 
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thoughts, feelings or behaviours with respect to the symptom or recurrence of symptoms; (iv) 
promotion of alternative ways of coping with the target symptom (National Collaborating 
Centre for Mental Health, 2014). Given this broad definition of CBT, psychological 
interventions which involved cognitive/imagery modification with or without exposure therapy 
were considered to be CBT in nature.   
We compared psychological intervention(s) to each other or to a control condition, 
which could be treatment as usual (TAU; also included 'waiting list control'), or TAU plus a 
non-specific therapeutic intervention (i.e. befriending, counselling).  
 
Outcomes and data extraction 
Our primary outcome was the standardised difference between groups at end of 
treatment in severity of (a) PTSD symptoms (as per ICD-11, DSM III-IV criteria) and (b)  affect 
dysregulation, negative self-concept and disturbances in relationships. These were also used to 
calculate the associated number needed to treat (NNT) for clinically significant response, based 
on different estimates of response rates in the control condition.  
Two reviewers (PHU, AB) extracted data relating to study characteristics, including 
details on participants, interventions received and outcomes assessed. Three reviewers (PM, 
AB, SR) also completed independent assessments of whether participants’ mean baseline 
scores on measures of CPTSD symptoms were within the clinical range, which were then 
discussed and approved by two other reviewers (TK, PHU). Study authors were contacted in 
every case where CPTSD-relevant outcomes appeared to have been assessed but not reported. 
To assess outcomes, we extracted means and standard deviations (SD) where possible. If SDs 
were not reported, then these were derived from standard errors, confidence intervals, p-values 
or t-values where possible, following Cochrane Handbook procedures (Higgins and Green, 
2011).  
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Analysis 
We used Comprehensive Meta-Analysis software (version 3) for the meta-analyses. We 
first calculated the post-intervention standardised mean difference (Hedges’ g) and standard 
error (SE) for each individual study on each outcome (PTSD, affect dysregulation, negative 
self-concept, disturbances in relationships). Hedges’ g was selected as the effect size measure 
because it accounts for variation in sample size and sample variance (Deeks, Altman and  
Bradburn, 2001). A composite effect was also computed for each study by combining PTSD 
and any available CPTSD DSO outcome data. To do this, we computed the average Hedges’ g 
and associated SE across the outcomes. The range of measures used to assess these meant it 
was not feasible to adjust the composite estimate for the between-outcome correlation, and had 
to instead assume this was zero. When the number of participants (N) contributing data to each 
domain differed, we used the smallest N for the composite estimate. When there was sufficient 
data (at least two studies), we calculated the differences between interventions and controls on 
PTSD, affect dysregulation, negative self-concept, and disturbances in relationships 
individually, using DerSimonian and Laird (1986) random-effects meta-analyses. We then 
pooled data from studies reporting PTSD plus (a) 1, 2 or 3 CPTSD DSO outcomes, (b) 2 or 3 
CPTSD DSO outcomes, and (c) all 3 CPTSD DSO outcomes. The estimates were expressed in 
units of Hedges’ g with associated 95% confidence intervals. Between group differences in 
clinically significant change were derived from the Hedges’ g estimate and an assumed control 
event response rate (CER) using the Furukawa method (Furukawa, 1999; Furukawa and 
Leucht, 2011; http://rpsychologist.com/d3/cohend/) and presented as NNT for benefit or harm. 
Morina et al., (2014) report a CER of 44% for PTSD however because CPTSD is assumed to 
have a poorer prognosis we estimated what the NNT to benefit or harm would be if we halved 
this value to 22%. We also estimated what the NNT would be if the natural remission rate in 
the control conditions was either very high (50%) or very low (10%). Using the relative group 
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difference and a range of assumed CERs to compute NNT is the method recommended by the 
Cochrane Handbook, since this “helps users to understand the important impact that typical 
baseline risks have on the absolute benefit that they can expect” (Higgins and Green., 2011).     
The potential impact of publication bias was assessed using funnel plots, Egger’s test 
and Duval and Tweedie’s Trim-and-Fill procedure (random-effects) (Duval and Tweedie, 
2000; Egger et al., 1997), but only for analyses derived from at least 10 studies (Higgins and  
Green, 2011). Cohen’s (1988) established conventions (small = 0.2, moderate = 0.5, large = 
0.8) were used to interpret individual and meta-analytical estimates of Hedges’ g. Statistical 
significance was inferred when p-values were below 0.05, although values between 0.01 and 
0.09 were downgraded for imprecision. Heterogeneity was assessed using the I2 statistic, and 
compared with thresholds specified in the Cochrane Handbook (<40% low; 30-60% moderate; 
50-90% substantial; 75-100% considerable) (Higgins and  Green, 2011).  
 
Assessment of study and outcome quality 
Individual study quality was assessed using the Cochrane Collaboration Risk of Bias 
tool (Higgins et al., 2011) and meta-analytical estimates were assessed using the GRADE 
approach (Guyatt et al., 2008) (see supplement). The GRADE approach considers the quality 
of studies contributing to each analysis, the consistency, directness and precision of the pooled 
estimate, and the risk of publication bias. 
Cochrane risk of bias ratings were completed by two reviewers independently (PM, 
AB), and checked by a third (PHU). An overall individual study quality rating was also 
produced (see supplement for criteria). GRADE ratings were performed by one reviewer 
(PHU) and checked by two others (PM, TK). An overall GRADE assessment is provided 
alongside each outcome to inform the interpretation of these findings.  
 
Psychological therapies for CPTSD symptoms 
12 
 
Moderator analyses 
We combined all studies into a single dataset to conduct a series of pre-specified 
univariate moderator analyses, and one multivariate analysis, again using Comprehensive 
Meta-Analysis software (version 3). The outcome for each meta-regression analysis was the 
post-treatment group difference in CPTSD symptom severity. For this we used, in order of 
preference, the composite estimates of differences in (1) PTSD plus the three CPTSD DSO 
symptom clusters; (2) PTSD plus two CPTSD DSO symptom clusters (3) PTSD plus one 
CPTSD DSO symptom cluster or (4) PTSD alone. 
Pre-specified univariate analyses included the relevant Cochrane Risk of Bias 
parameters (sequence generation, allocation concealment, detection bias, reporting bias, 
attrition bias), onset of trauma (childhood vs adulthood), degree to which sample met CPTSD 
criteria (i.e., whether data on PTSD plus three, two, one or no CPTSD DSO symptom clusters 
were used) and therapy format (individual vs group). There was insufficient data to support 
pre-specified analysis of phased vs non-phased interventions. We also examined the effect of 
therapy type (individual CBT, group CBT, EMDR, exposure alone, group IPT), and the effect 
of using a non-specific control condition (i.e., versus a usual care / waiting list control group). 
To ensure that all studies with 3 or more arms could be included without double-counting of 
participants, we split the sample size of any shared treatment or control arms in half for these 
comparisons, as recommended in the Cochrane Handbook (Higgins and Green, 2011), and 
revised the individual study effect sizes accordingly. To ensure power for the multivariate 
analyses, we limited this to 5 variables; study quality, therapy type, degree to which sample 
met CPTSD criteria, trauma onset, and use of a non-specific control condition.  
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Results 
Study selection 
The search returned 28,521 results, of which 28,310 were excluded on the basis of title 
or abstract (see Figure 1). Following title and abstract screening, the full texts of the remaining 
211 articles were examined. One hundred and forty one full text articles were excluded. A 
further 19 full text articles were excluded because they described studies that did not include 
clinically significant levels of one or more CPTSD DSO symptom clusters at baseline. Fifty-
one studies met full inclusion criteria and were included in the current study. Of these, 35 
studies had a CBT arm, 11 had an exposure only arm, 9 had an EMDR arm, and 9 assessed the 
effect of other interventions, including interpersonal psychotherapy (IPT), mindfulness, trauma 
management training (TMT), dialogical exposure therapy (DET), dialectical behaviour 
therapy, CBT plus emotion regulation training, and stabilisation therapy. Figure 2 provides an 
overview of studies contributing to each analysis. A table of included study characteristics and 
a table of excluded studies, with reasons for exclusion, are provided in the supplement. 
 
Insert Figure 1 
 
Insert Figure 2 
 
Quality assessment 
The results of the Cochrane risk of bias assessment are shown in the supplement and 
GRADE ratings for each meta-analytical outcome are shown below and in the far right column 
of Tables 1-4 and Table J.1 (supplement). Just over half of the included studies used appropriate 
methods to generate a random sequence to allocate participants to groups, but poor reporting 
limited our assessment of this domain. A slightly smaller proportion had a low risk of bias for 
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allocation sequence concealment, but again poor reporting prevented a clear assessment of this 
domain. The majority of studies had a low risk of detection bias because assessors were 
unaware of the group that participants had been allocated to. Most also had a low risk of 
attrition bias with acceptable rates of missing post-intervention data (<25%). However, most 
had a high risk of reporting bias primarily due to a lack of a preregistered protocol. The risk of 
performance bias was unavoidably high across all studies due to the nature of the interventions, 
which precluded blinding of participants. Overall, we rated the majority of studies as high in 
methodological quality. 
 
Meta-analytical outcomes  
Cognitive behavioural therapy (CBT) (Table 1, and supplement) 
As shown in Table 1, compared to usual care, CBT had a moderate-large effect on 
disturbances in relationships (k=16, g = -0.66; 95% CI = -0.84, -0.48) and large effects on affect 
dysregulation (k=3, g = -1.42; 95% CI = -2.20, -0.65), negative self-concept (k=9, g = -0.82; 
95% CI = -1.19, -0.44) and PTSD symptoms (k=27, g = -0.90; 95% CI = -1.11, -0.68) (all 
moderate quality evidence), with the NNT varying from 2 (affect dysregulation assuming CER 
of 22%) to 6 (disturbances in relationships assuming CER of 10%). Moderate to large effects 
were also observed on the composite estimates of PTSD and CPTSD DSO symptoms (low to 
high quality evidence), with NNTs of between 3 (PTSD + 1, 2, or 3 CPTSD DSO outcomes 
assuming CER of 50%) and 8 (PTSD + 3 CPTSD DSO outcomes assuming CER of 10%). 
However few studies measured more than one type of CPTSD DSO symptom. Significant 
publication bias was detected whenever there were sufficient studies to assess this, however 
only the estimate for disturbances in relationships was reduced when trim-and-fill analysis was 
applied. Compared to non-specific control interventions, CBT had a small effect on 
disturbances in relationships (k=3, g = -0.32; 95% CI = -0.60, -0.03) and a small-moderate 
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effect on PTSD symptoms (k=9, g = -0.37; 95% CI = -0.66, -0.09) (moderate quality evidence), 
with NNTs varying between 7 (PTSD assuming 50% CER) and 15 (disturbances in 
relationships assuming 10% CER). Although there was no evidence it had significant effects 
on affect dysregulation and negative self-concept, few studies reported usable data. When we 
pooled effects from all 9 studies reporting data on PTSD and at least one CPTSD DSO domain, 
a small effect was observed (k=9, g = -0.34; 95% CI = -0.62, -0.06; low quality evidence), with 
NNTs of between 8 (50% CER) and 14 (10% CER), but no studies measured more than one 
domain.  
 
Exposure therapy alone (Table 2, and supplement) 
As shown in Table 2, compared to usual care, exposure therapy alone had a moderate 
effect on disturbances in relationships (k=4, g = -0.59; 95% CI = -1.12, -0.07; moderate quality 
evidence), a moderate-large effect on negative self-concept (k=3, g = -0.73; 95% CI = -1.03, -
0.43; moderate quality evidence), and a large effect on PTSD symptoms (k=6, g = -1.05; 95% 
CI = -1.52, -0.58; low quality evidence), with NNTs of between 3 (PTSD - all assumed CERs) 
and 7 (disturbances in relationships, assuming 10% CER). No studies examined whether 
exposure was superior to usual care in relation to affect dysregulation. Moderate to large effects 
on the composite outcomes of PTSD and CPTSD DSO symptoms were observed (low to high 
quality evidence), with NNTs ranging from 3 (PTSD + 1, 2 or 3 CPTSD DSO outcomes, CERs 
of 22% and 50%) to 7 (PTSD + 2 or 3 CPTSD DSO outcomes, assuming 10% CER), however 
only one study provided usable data on more than one type of CPTSD DSO symptom. There 
was no evidence that exposure alone was superior to non-specific therapies in relation to 
disturbances in relationships, but only one study provided usable data. No studies reported 
whether exposure alone was superior to non-specific therapies in relation to either affect 
dysregulation or negative self-concept. Two studies found no effect of exposure alone on either 
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PTSD data, or the composite outcome of PTSD plus CPTSD DSO symptoms (low quality 
evidence). No studies provided data on more than one CPTSD DSO symptom.  
 
Eye-Movement and Desensitisation and Reprocessing therapy (EMDR) (Table 3, and 
supplement) 
As shown in Table 3, compared to usual care, the few available studies suggested 
EMDR had a moderate effect on negative self-concept (k=1, g = -0.61; 95% CI = -1.04, -0.17; 
low quality evidence), a moderate-large effect on disturbances in relationships (k=4, g = -0.76; 
95% CI = -1.35, -0.16; moderate quality evidence), and large effects on  affect dysregulation 
(k=1, g = -1.64; 95% CI = -2.56, -0.72; very low quality evidence) and PTSD symptoms (k=4, 
g = -1.26; 95% CI = -2.01, -0.51; low quality evidence), with NNTs ranging from 2 (affect 
dysregulation, all CERs) to 7 (disturbances in relationships, assuming CER of 10%). EMDR 
also had a large effect on the composite outcome of PTSD and at least one CPTSD DSO 
symptom (k=4, g = -1.15; 95% CI = -1.92, -0.37; low quality evidence), with NNTs of 2 (CER 
of 22%) or 3 (CER of 10% or 50%), but it did not have an effect on the composite outcome of 
PTSD and more than one CPTSD DSO symptom (very low quality evidence). There was no 
evidence that EMDR was superior to non-specific interventions in relation to disturbances in 
relationships or affect dysregulation (very low quality evidence). Although moderate-large 
effects on negative self-concept (k=2, g = -0.78; 95% CI = -1.56, -0.01) and PTSD symptoms 
(k=3, g = -0.69; 95% CI = -1.35, -0.03) (very low quality evidence) were observed, with NNTs 
of between 4 (negative self-concept, all CERs) and 6 (PTSD; CER of 10%), these analyses 
were based on only 2-3 studies. A moderate effect on the composite outcome of PTSD and at 
least one CPTSD DSO symptom was observed (k=3, g = -0.52; 95% CI = -0.97, -0.08; low 
quality evidence), with NNTs of between 5 (CER 50%) and 8 (CER 10%), but no effect was 
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found on the composite outcome of PTSD and more than one CPTSD DSO symptom (very 
low quality evidence). 
 
Comparison of CBT, Exposure and EMDR (Table 4, and supplement) 
As shown in Table 4, there was very limited evidence that EMDR had a small-moderate 
advantage over CBT in relation to PTSD symptoms (k=2, g = 0.37; 95% CI = 0.03, 0.71; low 
quality evidence), with an NNT of 7-12, but no differences between CBT, exposure alone or 
EMDR were observed for any other outcomes 
 
Other comparisons (supplement) 
As shown in Table J.1 (supplement), one small study (Krupnick 2008) found IPT had 
an advantage over usual care in reducing PTSD plus disturbances in relationships (k=1, g = -
1.02; 95% CI = -1.65, -0.39; very low quality evidence), with an NNT of  3-4, and another 
small study (Azad marzabadi 2014) found mindfulness was more effective than usual care in 
relation to disturbances in relationships (k=1, g = -1.60; 95% CI = -2.43, -0.77; very low quality 
evidence), with an NNT of 2-3. Several other small studies compared various 
psychotherapeutic interventions to other interventions, or to CBT, exposure or EMDR. We 
found no evidence to favour any particular intervention in relation to the composite outcome 
of PTSD plus CPTSD DSO symptoms (very low to low quality evidence). 
 
Moderator analyses (Figure 3, and supplement) 
As shown in Table L.1 (supplement), use of a non-specific control condition rather than 
usual care or waiting list was associated with a smaller benefit of psychological therapy in 
univariate meta-regression, with a reduction in Hedges’ g of 0.48, (95% CI = 0.18, 0.77). No 
other moderators were significant when examined individually. As shown in Table M.1 
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(supplement), the effect of using a non-specific control condition was larger in multivariate 
meta-regression, with a reduction in Hedges’ g of 0.69 (95% CI = 0.39, 1.00) in this analysis. 
Study quality and age of trauma onset also emerged as significant moderators of therapy effects 
in this analysis. Low quality studies were associated with a significantly lower effect size, with 
a reduction in Hedges’ g of 0.30 (95% CI = 0.00, 0.61). Studies where participants had 
predominantly childhood-onset trauma were associated with a reduction in Hedges’ g of 0.35 
(95% CI = 0.02, 0.69), when compared to trials where most participants had adult-onset trauma 
(Figure 3).  
 
Discussion 
We examined evidence from RCTs of psychological treatments for PTSD where 
participants were also likely to have clinically significant levels of one or more CPTSD DSO 
symptoms at baseline, and where usable data on the effect of interventions on these symptoms 
were reported. A total of 51 studies met inclusion criteria. Overall, results indicate that when 
compared to usual care, CBT, Exposure alone and EMDR perform relatively equally for 
symptoms of PTSD and the DSO symptoms of negative self-concept and disturbances in 
relationships. While the quality of this evidence was moderate for CBT, it ranged from low to 
moderate for Exposure alone and EMDR. Few trials reported the effectiveness of psychological 
therapies for symptoms of affect dysregulation. Low quality evidence suggests that EMDR has 
a small-moderate advantage over CBT in relation to PTSD symptoms, but there was no 
evidence of any differences between CBT, Exposure alone or EMDR for the other outcomes 
including DSO symptoms. Univariate and multivariate meta-regression confirmed that the 
effectiveness of psychological therapies was considerably lower when compared to non-
specific therapies, which suggests that non-specific effects may account for a large proportion 
of therapeutic change in symptoms of CPTSD in these trials. The multivariate meta-regression 
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also found that treatment outcome may be moderated by the developmental time of the onset 
of psychological trauma, with childhood trauma being associated with smaller effects of 
psychological therapies on CPTSD symptoms.  
The data are encouraging in that the accumulation of evidence suggests that there are 
specific interventions that work for several of the CPTSD symptom clusters. The data also 
suggest that no particular type of intervention (exposure, cognitive re-appraisal, bilateral 
stimulation) is necessary to resolve any one symptom cluster. A critical question is whether 
current treatments devised for PTSD are equally effective for those who will be diagnosed with 
CPTSD. Our results replicate earlier findings that individual trauma-focused treatments show 
large effect sizes. Although the evidence is at a very early stage, we found that some non-
trauma-focused therapies, such as mindfulness and IPT, may also reduce PTSD and 
interpersonal disturbance, suggesting alternative options. Importantly, childhood abuse was 
found to moderate all outcomes across all types of treatments, suggesting those with a history 
of childhood trauma may experience less improvement, and that current treatments for this 
patient population can be improved. These results have implications for the treatment of 
CPTSD as those with childhood abuse are at risk for CPTSD and in this meta-analysis may 
represent those more likely to have the full symptom profile.  
Research is needed to determine how to optimize treatment outcomes for those with 
childhood abuse and other populations at risk for CPTSD. This includes identifying which 
treatment interventions are most effective for specific symptom clusters, which are most 
acceptable to patients, in what order to present interventions and the optimal duration of 
different types of interventions. Considering current debates in the literature, it would have 
been useful to explore the usefulness of phased vs. non-phased interventions and individual vs. 
group interventions for CPTSD. Unfortunately, we did not find adequate evidence to enable 
further analysis of these treatment outcome moderators. There is substantial evidence 
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indicating that CPTSD and PTSD represent distinct patient populations with different 
symptoms profiles (Brewin et al., 2017), suggesting the value of developing treatments that 
more precisely and effectively resolve the differing effects of trauma exposure by 
systematically testing type, order and duration of interventions specific to each disorder and 
taking into account patient preferences across both disorders (Cloitre, 2015).  
Our meta-analysis has a number of strengths. We minimised the risk of bias by pre-
registering the review, and we minimised errors and omissions by having two or more 
reviewers conduct comprehensive searches, assess study quality and extract descriptive data. 
We considered a range of treatments from different countries and included participants with a 
range of backgrounds and types of psychological trauma including military, civilian and 
childhood trauma. Many studies have used qualified therapists and considered assessments of 
adherence to the protocol. However, most of the research was conducted in western countries, 
thus limiting the extent to which the findings may generalise to non-western countries. 
Furthermore, the evidence we have reviewed as part of this meta-analysis was predominantly 
on DSM-IV PTSD. Most studies did not present data on multiple traumatisation which 
typically results in CPTSD (Karatzias et al., 2016). Even when the index trauma that was 
targeted occurred in adulthood in included studies, it would be useful to assess lifetime 
traumatic history and consider the accumulative effect of multiple traumatisation. In relation 
to outcomes, we have only considered therapeutic gains at post-treatment. Future research 
should explore long-term outcomes of these interventions. Furthermore, for this meta-analysis 
we have used proxy measures for the CPTSD constructs. It might well be the case that a number 
of studies that included people with CPTSD have not been included in the study as they have 
not reported outcomes on relevant constructs or reported outcomes have not met clinical 
thresholds or our definition of ‘clinical significance’. It might also be the case that the measures 
employed in included studies do not accurately reflect the corresponding DSO clusters, thus 
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introducing some measurement bias. Moreover, while the quality of the meta-analytical 
evidence was high or moderate for some of the outcomes (e.g., when CBT was compared with 
usual care or non-specific control interventions), it was low or very low for most of the 
outcomes. Related to this, there was substantial heterogeneity for just over half of the outcomes. 
Thus, there is some uncertainty in the conclusions that can be drawn. It is also worth noting 
that we did not downgrade the meta-analytical outcomes for indirectness, as indirect evidence 
of psychological interventions for CPTSD was the focus of this review. If, on the other hand, 
we had been interested in direct evidence of psychological interventions for CPTSD, most if 
not all the outcomes would have been downgraded for indirectness.  
There is clearly a need for further well-designed trials of psychological therapies that 
incorporate appropriate methods of randomisation, blinding of assessors, long-term follow up 
and appropriate training of therapists and monitoring of treatment adherence. We have 
identified a set of research priorities to benefit people with CPTSD in the future that might 
directly or indirectly result from the findings of this review: 
• Effectiveness of phased vs. non-phased interventions for CPTSD: Very few included 
studies in this meta-analysis have incorporated a phased approach to treatment and it 
was not possible to address this question. 
• Effectiveness of trauma focused treatments vs. non – trauma focused treatments. 
Existing evidence is predominantly focused on trauma-focused treatments.  
• Head-to-head comparisons between trauma focused treatments for CPTSD. Most 
studies explored the effectiveness of interventions against standard care or no treatment.  
• Exploring safety of trauma focused therapies for CPTSD. It is essential that future 
research in this area provides information on adverse effects.  
• Investigation of whether diagnosis of CPTSD moderates outcomes when compared 
against those who do not meet diagnosis in standard treatments. Clinical reality suggests 
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that many people do not meet full diagnostic criteria but still suffer from a number of 
debilitating symptoms that relate to that condition. 
• Appropriateness and effectiveness of trauma focused treatments for CPTSD following 
childhood trauma. In this meta-analysis, childhood trauma was found to negatively 
moderate the effect of trauma focused interventions.  
• Comparing pharmacotherapy vs. psychotherapy for CPTSD. In this meta-analysis we 
did not address the effectiveness of pharmacotherapies alone or in combination with 
psychotherapy. 
• Considering the nature of the three DSO factors, it is worth exploring the effectiveness 
of attachment based interventions and relational therapies as limited evidence is 
currently present for these interventions. 
• Exploring the effectiveness of individual vs. group interventions for CPTSD. We found 
no evidence addressing this question for people with CPTSD. 
• Exploring the effectiveness of interventions that tackle all CPTSD symptom clusters in 
a single study using as a primary outcome of CPTSD based on a dedicated measure. 
The present review extracted proxy data from existing trials that measure the CPTSD 
constructs. 
In conclusion, this meta-analysis is the first step in identifying effective treatments for 
CPTSD. Findings regarding the usefulness of trauma-focused interventions look promising 
but less so for CPTSD symptoms following childhood trauma. Further research is needed to 
explore and develop existing and new treatments for CPTSD.  
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A.        Protocol 
 
Title: Psychological interventions for Complex PTSD: systematic review and meta-analysis.  
 
Reviewers: Thanos Karatzias, Mick Fleming, Susan Roberts, Aoife Bradley, Claire Fyvie, 
Jonathan Bisson, Neil Roberts, Philip Hyland, Marylene Cloitre, Tobias Hecker, Andreas 
Maercker, Paul Hutton 
 
Review question(s) 
What psychological interventions are effective for complex post traumatic stress disorder, and 
how effective are they? What is the safety and acceptability of psychological interventions for 
complex post traumatic stress disorder? 
  
Searches 
Searches of MEDLINE, PsycINFO, EMBASE and PILOTS will be conducted using the search 
terms listed below. Unpublished trials will be identified through contacting investigators and 
through searching clinical trial registries such as Clinicaltrials.gov. Language will be restricted 
to English. There will be no time period restrictions. #1. PTSD or posttrauma* or psychological 
stress* or combat or post-trauma* or gross stress reaction or stress disorder* or trauma* or 
psychological trauma. #2. randomised or randomized or randomised controlled trial or RCT or 
randomized controlled trial. #3.therapy or psychological therapy or psychological intervention 
or intervention or treatment).mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, 
mf, dv, kw, fs]. 
  
Types of study to be included 
Randomised controlled trials with or without rater masking will be included. Uncontrolled, 
non-randomised and crossover trials, qualitative studies and case studies will be excluded. 
  
Condition or domain being studied  
Complex post traumatic stress disorder (CPTSD) as described in ICD-11 proposals. According 
to ICD-11 individuals meet diagnostic criteria for complex PTSD if they meet existing criteria 
for post traumatic stress disorder (PTSD) (re-experiencing of the trauma, avoidance of 
reminders of the trauma, enhanced sense of threat indicated by hypervigilance and 
hyperarousal) and have clinically significant difficulties in affect dysregulation, a pervasive 
negative self-concept and experience interpersonal disturbances (Cloitre et al. 2013). 
Individuals meet diagnostic criteria for complex PTSD if they meet existing criteria for post 
traumatic stress disorder (PTSD) (re-experiencing of the trauma, avoidance of reminders of the 
trauma, enhanced sense of threat indicated by hypervigilance and hyperarousal) and have 
clinically significant difficulties in affect dysregulation, a negative self-concept and experience 
interpersonal disturbances (Cloitre et al. 2013). 
  
Participants/population  
We are interested in the effect of psychological interventions on adults who meet criteria for 
CPTSD. However, since CPTSD is a new diagnostic category, we anticipate that few studies 
have explicitly included this group. For this reason we will only include trials of interventions 
where participants meet ICD and DSM – III and IV criteria for PTSD and present with 
clinically significant symptoms of re-experience, avoidance hyperarousal and score within the 
clinically significant range on at least one of the additional CPTSD criteria, namely emotion 
dysregulation, negative self-concept and interpersonal disturbance. We will only include trials 
where the mean or median age of participants is at least 16, and we will only include trials 
where participants with developmental or intellectual disability, neurodegenerative disorders 
and acquired or traumatic brain injury are excluded. We will include studies where participants 
have comorbid substance misuse difficulties, but we will exclude trials where participants have 
a primary diagnosis of substance misuse disorder. 
 
Intervention(s), exposure(s)  
We will include trials where participants in at least one arm receive 'bona fide' psychological 
interventions (defined according to criteria developed by Benish et al (2008),* delivered in 
group or individual format, including but not limited to CBT, interpersonal therapy, 
psychodynamic therapy, EMDR or psychoeducation. *The bona fide definition (Benish, Imel 
and Wampold, 2008) requires that treatments had to be delivered by a trained therapist who 
adapted the treatment to patients on the basis of a therapeutic relationship (i.e., no delivery of 
a non-modifiable standard protocol, e.g., progressive muscle relaxation); treatments also 
needed to be conducted personally and face-to-face (i.e., no online treatments or treatments 
conducted with, e.g., audio material). Moreover, at least two of the following four criteria had 
to be fulfilled with regards to their descriptions in the studies: (a) a citation to an established 
school or approach to psychotherapy; (b) a description of the therapy that contained a reference 
to a psychological process (e.g., operant conditioning); (c) a reference to a treatment manual 
that was used to guide the delivery of the treatment; (d) the identification of active ingredients 
of the treatment and citations for these ingredients.  
*Benish SG, Imel ZE, Wampold BE. The relative efficacy of bona fide psychotherapies for 
treating posttraumatic stress disorder: A meta-analysis of direct comparisons. Clin Psychol 
Rev. 2008;28:746–58. doi:10.1016/j.cpr.2007.10.005. 
  
Comparator(s)/control 
Psychological interventions will be compared against one another and also against no 
additional treatment (i.e., 'treatment as usual' and 'waiting list control') and non-active 
interventions, such as befriending. 
  
Context  
All settings to be included. 
  
Primary outcome(s)  
The primary outcome will be twofold: 1. The between group difference, at end of treatment 
and 12-months post-randomisation, in severity of (a) PTSD symptoms as per ICD-11 and DSM 
III and IV and (b) emotion dysregulation, negative self-concept and/or interpersonal 
disturbance. To compute this composite outcome, we will calculate the average standardised 
mean difference across these outcomes taking into account the correlation between these 
variables where / if possible. 2. The between group difference at end of treatment and at 12-
months post randomisation, in the relative and absolute risk of not achieving a clinically 
significant response in PTSD symptoms, defined using Jacobson criteria. 
  
Timing and effect measures  
End of treatment and 12-months post randomisation (or nearest time-point within a 3-month 
range). 
  
Secondary outcome(s) 
1. Safety, as measured by the between group difference, at end of treatment and at 12-months 
postrandomisation, in the relative risk of serious adverse events (death, suicide, attempted 
suicide, significant deterioration in symptoms, admission to hospital). 2. The acceptability of 
the interventions, as measured by the between group difference in the relative risk of dropping 
out early from either the treatment or the trial (where the comparator is treatment as usual). 
  
Timing and effect measures  
End of treatment and 12-months post randomisation (or nearest time-point within a 3-month 
range) for safety, and end of treatment for acceptability. 
 
Data extraction (selection and coding) 
We will extract group means and associated standard deviations (and N contributing to those 
means) for continuous outcomes, and number of events (denominator = number randomised to 
arm) for dichotomous outcomes, using a spreadsheet. We will use the total number randomised 
if reported. For all outcomes except acceptability, we will assume those not including in the 
reported analyses are either missing completely at random (for continuous outcomes) or had 
no change from randomisation (dichotomous outcomes). Two researchers will double-extract 
data for all outcomes, and a third rater will be consulted in relation to any discrepancies and / 
or disagreements. If means and standard deviations are not reported, then we will estimate the 
between group difference from other statistical parameters, such as confidence intervals, 
standard errors, p-values, t-values or F-values, following procedures in the Cochrane 
Handbook, and using the Campbell Effect Size Calculator, if possible. If we need to combine 
data from 2 groups before entry into the meta-analysis, we will do so following the formulae 
specified in the Cochrane Handbook. 
  
Risk of bias (quality) assessment  
At the study level the risk of bias will be assessed using the Cochrane collection Risk of Bias 
Tool (Higgins et al 2011). This involves categorising studies as having a low, high or unclear 
risk of bias in the areas of selection and allocation of participants, intervention concealment, 
attrition and reporting. The results of this assessment will be used to inform interpretation of 
reported effect sizes and overall conclusions. The quality of overall outcomes will be assessed 
using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) 
(Guyatt et al 2011). 
  
Strategy for data synthesis  
For continuous outcomes, we will perform random-effects meta-analyses to compute an overall 
standardised mean difference and associated 95% confidence intervals, with Hedges's g 
adjustment. For dichotomous outcomes, we will also perform random-effects meta-analyses to 
compute an overall relative risk, an overall difference in absolute risk, and the number needed 
to treat for one to experience benefit / harm (computed as the inverse of the absolute risk). 
  
Analysis of subgroups or subsets  
We will examine whether the results are moderated by the degree to which the sample 
population meet CPTSD criteria (whether the sample score within the clinical range on 1, 2 or 
3 CPTD criteria at baseline). We will also examine the potential moderating role of quality 
parameters including rater blinding, attrition, random sequence generation description. We will 
also examine whether the effectiveness of psychological treatment for CPTSD is moderated by 
the following: - individual vs. group format - adult onset trauma vs.. childhood onset trauma 
vs. both - phased / staged interventions vs. non-phased / non-staged interventions. 
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B.        Changes from Protocol 
 
A subsequent change was our inclusion of some psychological interventions (e.g., mindfulness, 
yoga) which were not strictly ‘bona fide’ psychological interventions (Benish, Imel, & 
Wampold, 2008). We made this decision in the interests of completeness.  
 
While we had planned to take into account the correlation between variables when computing 
the composite outcome, this was not possible due the range of measures used to assess the 
variables; instead we had to assume the correlation was zero.   
 
Additional changes included abandoning our pre-specified moderator analysis of phased vs 
non-phased interventions due to insufficient data.  
 
We were also unable to determine rates of clinically significant response according to our pre-
specified method (Jacobsen’s criteria). We instead converted the SMDs to NNTs using the 
Furukawa approach, under 3 assumptions of the control event rate (10%, 50% and 22%, which 
is half the control event rate observed for PTSD). Secondary outcomes (safety, drop-out) and 
follow-up data will be reported separately. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C.        Excluded Studies 
 
The following table (Table C.1) details studies or reports excluded after inspection of the full-
text report, or via correspondence with authors. Studies or reports excluded on basis of title or 
abstract alone are not detailed as these are too numerous and the vast majority were of different 
conditions or were otherwise unrelated to the review question.  
 
Study reference Reason for exclusion 
Acarturk 2016 No useable CPTSD index 
Acierno 2017 No relevant comparator 
Akbarian 2015 No useable CPTSD index 
Alghamdi 2015 Sample not suitable 
Arntz 2007 Baseline CPTSD index/indices not clinically significant 
Asukai 2010 No useable CPTSD index 
Badura-Brack 2018 No relevant psychological intervention 
Bass 2016 Sample not suitable 
Beidel 2017 Not RCT 
Belleau 2017 No useable CPTSD index 
Betancourt 2014 Sample not suitable 
Bichescu 2007 No useable CPTSD index 
Blanchard 2003 Baseline CPTSD index/indices not clinically significant 
Boden 2012 No useable CPTSD index 
Bohus 2013 No useable CPTSD index 
Bormann 2013 No useable CPTSD index 
Bormann 2014 No useable CPTSD index 
Bradley 2003 Sample not suitable 
Bremner 2017 Baseline CPTSD index/indices not clinically significant 
Brom 1989 Baseline CPTSD index/indices not clinically significant 
Brunet 2013 Sample not suitable 
Bryan 2016 No useable CPTSD index 
Bryant 2003 No useable CPTSD index 
Bryant 2008 No useable CPTSD index 
Buhmann 2016 Baseline CPTSD index/indices not clinically significant 
Carlson 1998 No useable CPTSD index 
Castillo 2016 No useable CPTSD index 
Catani 2009 Sample not suitable 
Chard 2005 No useable CPTSD index 
Classen 2001 Sample not suitable 
Cloitre 2010 Baseline CPTSD index/indices not clinically significant 
Cloitre 2012 Study has overlapping sample with another study 
Coffey 2016 No useable CPTSD index 
Cook 2010 No useable CPTSD index 
Cooper 1989 No useable CPTSD index 
Cooper 2017 No relevant comparator 
Cottraux 2008 No useable CPTSD index 
de Bont 2016 No useable CPTSD index 
Devilly 1998 No useable CPTSD index 
Study reference Reason for exclusion 
Devilly 1999 No useable CPTSD index 
Echeburua 1997 No useable CPTSD index 
Edmond 1999 Sample not suitable 
Edmond 2004 Study has overlapping sample with another study 
Ertl 2011 Baseline CPTSD index/indices not clinically significant 
Fecteau 1999 No useable CPTSD index 
Feeny 2002 Study has overlapping sample with another study 
Feske 2008 Unable to obtain relevant norms 
Foa 1991 No useable CPTSD index 
Foa 2004 Study has overlapping sample with another study 
Foa 2013 No useable CPTSD index 
Foa 2017 No useable CPTSD index 
Fredman 2016 No relevant psychological intervention 
Gamito 2010 No useable CPTSD index 
Gersons 2000 No useable CPTSD index 
Gilboa-Schechtman 
2010 
Sample not suitable 
Glynn 1999 No useable CPTSD index 
Goldstein 2018 No relevant psychological intervention 
Gutner 2016 Study has overlapping sample with another study 
Hien 2004 No useable CPTSD index 
Hien 2009 No useable CPTSD index 
Hien 2017 Baseline CPTSD index/indices not clinically significant 
Hien 2017 (b) Study has overlapping sample with another study 
Hinton 2005 No useable CPTSD index 
Holliday 2014 Study has overlapping sample with another study 
Holliday 2015 Study has overlapping sample with another study 
Ironson 2002 No useable CPTSD index 
Jacob 2014 No useable CPTSD index 
Jensen 1994 No useable CPTSD index 
Jindani 2015 Baseline CPTSD index/indices not clinically significant 
Johnson 2011 No useable CPTSD index 
Johnson 2016 Not RCT 
Kearney 2013 Baseline CPTSD index/indices not clinically significant 
Kearney 2016 Baseline CPTSD index/indices not clinically significant 
Kip 2014 Study has overlapping sample with another study 
Konig 2016 Study has overlapping sample with another study 
Kruse 2009 Not RCT 
Lange 2003 No relevant psychological intervention 
Lee 2002 No useable CPTSD index 
Levi 2016 Not RCT 
Liedl 2011 Retracted 
Litz 2007 No relevant psychological intervention 
Lovell 2011 Study has overlapping sample with another study 
Macdonald 2016 No relevant psychological intervention 
Study reference Reason for exclusion 
Marcus 1997 No useable CPTSD index 
Markowitz 2015 Baseline CPTSD index/indices not clinically significant 
Markowitz 2017 Study has overlapping sample with another study 
Maxwell 2016 No useable CPTSD index 
McGovern 2015 No useable CPTSD index 
McLay 2017 No useable CPTSD index 
McLean 2014 No useable CPTSD index 
Meier 2015 No useable CPTSD index 
Mills 2012 No useable CPTSD index 
Monson 2012 No relevant psychological intervention 
Moradi 2014 No useable CPTSD index 
Morath 2014 No useable CPTSD index 
Morland 2014 No relevant psychological intervention 
Moser 2010 Study has overlapping sample with another study 
Nacasch 2011 No useable CPTSD index 
Nacasch 2015 No relevant comparator 
Neuner 2004 No useable CPTSD index 
Neuner 2008 No useable CPTSD index 
Neuner 2010 No useable CPTSD index 
Nijdam 2018 No useable CPTSD index 
Nosen 2014 No useable CPTSD index 
Oktedalen 2015 Baseline CPTSD index/indices not clinically significant 
Pabst 2014 No useable CPTSD index 
Paivio 2010 No relevant comparator 
Paunovic 2001 No useable CPTSD index 
Peniston 1991 No useable CPTSD index 
Polusny 2015 Baseline CPTSD index/indices not clinically significant 
Possemato 2016 Sample not suitable 
Pruiksma 2016 Study has overlapping sample with another study 
Reger 2016 No useable CPTSD index 
Resick 2003 Study has overlapping sample with another study 
Resick 2008 No relevant comparator 
Resick 2015 No useable CPTSD index 
Resick 2017 No relevant comparator 
Roberts 2016 Not RCT 
Rothbaum 1997 No useable CPTSD index 
Rothbaum 2005 No useable CPTSD index 
Rothbaum 2006 No useable CPTSD index 
Rothbaum 2014 No relevant psychological intervention 
Ruglass 2017 No useable CPTSD index 
Sack 2016 No relevant comparator 
Sannibale 2013 No useable CPTSD index 
Sautter 2015 No relevant psychological intervention 
Schaal 2009 Baseline CPTSD index/indices not clinically significant 
Schneier 2012 No relevant psychological intervention 
Study reference Reason for exclusion 
Schnurr 2003 No useable CPTSD index 
Schnurr 2007 No useable CPTSD index 
Schnyder 2011 No useable CPTSD index 
Scott 2017 Study has overlapping sample with another study 
Shea 2013 Sample not suitable 
Shnaider 2017 No relevant psychological intervention 
Sikkema 2007 No useable CPTSD index 
Sin 2017 Not RCT 
Slade 2017 Study has overlapping sample with another study 
Sloan 2012 No useable CPTSD index 
Spence 2011 No relevant psychological intervention 
Steinert 2017 No useable CPTSD index 
Study Ref Reason for Exclusion 
Tarrier 1999 (a) No useable CPTSD index 
Tarrier 1999 (b) No useable CPTSD index 
Taylor 2003 Baseline CPTSD index/indices not clinically significant 
van den Berg 2016 Study has overlapping sample with another study 
van der Kolk 2007 No relevant comparator 
van der Kolk 2016 No relevant psychological intervention 
van Emmerik 2008 No useable CPTSD index 
Vaughan 1994 No useable CPTSD index 
Wahbeh 2016 Baseline CPTSD index/indices not clinically significant 
Wells 2015 No useable CPTSD index 
Wilson 1995 No useable CPTSD index 
Wilson 1997 Study has overlapping sample with another study 
Wolf 2015 Not RCT 
Zang 2013 No useable CPTSD index 
Zang 2014 No useable CPTSD index 
Zang 2017 No useable CPTSD index 
Zlotnick 1997 No useable CPTSD index 
Zlotnick 2009 No useable CPTSD index 
Zoellner 1999 Study has overlapping sample with another study 
Zoellner 2017 No relevant psychological intervention 
 
 
 
 
 
 
 
 
 
 
 
 
 
D.        Table D.1. Summary of Characteristics of the 51 Included Studies 
 
Study Ref Groups 
included 
 
N  Country 
 
Participants Age, 
mean 
(SD) 
 
% female Duration & N 
sessions 
available 
Drops 
outs N 
(%) 
Trauma 
exposure 
 
Type of 
Trauma 
 
Trauma 
onset 
 
Treatment 
setting 
 
             
 
Ahmadi 2015  
 
EMDR 
 
16 
 
Iran 
 
Military 
servicemen 
 
29.9 
(7.8) 
 
0 
 
Unclear 
 
5 (31.3) 
 
Single 
 
 
Non- sexual 
 
 
Adulthood 
 
 
Community 
 REM 16     Unclear 6 (37.5)     
 Control 16      4 (25.0)     
             
 
Azad 
marzabadi 
2014 
 
Mindfulness 
 
14 
 
Iran 
 
War victims 
with PTSD 
 
Not 
reported 
 
0 
 
90mins, 8 
 
2 (14.3) 
 
Single 
 
 
Non- sexual 
 
 
Adulthood 
 
 
Community  
 Control 14      2 (14.3)     
             
 
Basoglu 2007 
 
SSBT 
 
16 
 
Turkey 
 
Earthquake 
survivors  
 
34.0 (11) 
 
87 
 
60 mins, 1 
 
1 (6.3) 
 
Single 
 
 
Non- sexual 
 
 
Adulthood 
 
 
Community  
 RA 15      0(0)     
             
 
Beidel 2011 
 
TMT 
 
18 
 
USA 
 
Combat 
Veterans 
 
58.93(N
R) 
 
0 
 
90 mins, 29 
 
4 (22.2) 
 
Single 
 
 
Non- sexual 
 
 
Adulthood 
 
 
Community  
 EXP 17   59.76(N
R)  
 90 mins, 29 1 (5.9)     
             
Beidel 2019 TMT 49 USA Military 
veterans 
37.67 
(8.51) 
7 90 mins, 29 14 (28) Single 
 
Non- sexual 
 
Adulthood 
 
Community  
 EXP 43   33.26 
(11.31) 
 90 mins, 29 22 (50)     
             
Study Ref Groups 
included 
 
N  Country 
 
Participants Age, 
mean 
(SD) 
 
% female Duration & N 
sessions 
available 
Drops 
outs N 
(%) 
Trauma 
exposure 
 
Type of 
Trauma 
 
Trauma 
onset 
 
Treatment 
setting 
 
Bryant 2013 Support/CB
T 
34 Australia Adult civilian 
patients  
41.15 
(12.92) 
54 90 mins, 12 13 (38.2) Single Non- sexual Adulthood Community  
 Skills/CBT 36   37.86 
(12.70) 
 90 mins, 12 3 (8.3)     
             
Butollo 2016 DET 74 German
y 
Trauma 
survivors  
37.99  
(12.1) 
66 90 mins,max.24 9 (12.2) Multiple Sexual and 
non-sexual 
Adulthood Community  
 CPT 67   33.67  
(10.3) 
 90 mins, max.24 11(14.9)     
             
 
 
Cloitre 2002 
 
 
STAIR+MP
E 
 
 
31 
 
 
USA 
 
 
 
CSA 
survivors 
 
 
 
34 (7.22) 
 
 
100 
 
 
60 -90 mins, 16 
 
 
9 (29) 
 
 
Single & 
Multiple 
 
 
Sexual & 
Non-sexual 
 
 
 
Childhood 
 
 
 
Community  
 
 MA WL 27     15 mins,12 3 (11)     
             
Difede 2007 CBT 15 USA Disaster 
workers 
45.77 
(7.72)  
NR 75mins ,12  8 (53.3) Single Non- sexual Adulthood Community 
 TAU 16       2(12.5)     
             
Dorrepaal 
2012 
EXP 38 Netherla
nds 
CSA 
survivors 
40.3 
(10.7) 
NR 120mins, 20 7(18.4) Multiple Sexual and 
non-sexual 
Childhood 
& 
Adulthood 
Community 
 TAU 33   37.1 
(10.3) 
  5 (15.1)     
             
Duffy 2007 CT 29 Ireland Trauma 
survivors  
NR NR NR ,12 9 (31.0) Multiple  Non- sexual Adulthood  Community  
 WL 29      3 (10.3)     
             
Dunn 2007 SMT 51 USA Veterans 54.7 
(6.9) 
0 90 mins, 14 17(33.3) Single  Non-sexual Adulthood Community 
Study Ref Groups 
included 
 
N  Country 
 
Participants Age, 
mean 
(SD) 
 
% female Duration & N 
sessions 
available 
Drops 
outs N 
(%) 
Trauma 
exposure 
 
Type of 
Trauma 
 
Trauma 
onset 
 
Treatment 
setting 
 
 PGT 50   55.0 
(7.6) 
 90 mins, 14   6(12.0)     
             
Dunne 2012 TF-CBT 13 Australia MVA 
survivors  
32.54 
(7.09) 
50 60mins,10 1 (7.7) Single  Non-sexual Adulthood Community 
 WL 13      2(15.4)     
             
Ehlers 2003 CT 28 UK MVA 
survivors 
NR NR 60-90mins, 12 0 (0) Single  Non- sexual Adulthood Community 
 SHB 28     40mins,1 3 (10.7)     
 RA 29     20mins, 1 2 (6.9)     
             
Ehlers 2005 CT 14 UK PTSD 
patients 
35.4 
(10.9) 
53.6 60-90mins, 4-20 0 (0) Single  Non-sexual Adulthood Community 
 WL 14   37.8 
(11.2) 
  0 (0)     
             
Ehlers 2014 Intensive 
CT 
30 UK Chronic 
PTSD 
39.7 
(12.4) 
58.7 18hrs over 5-7 
days 
1(3.3) Multiple Sexual and 
/or non-
sexual 
Childhood 
& 
Adulthood 
Community 
 Weekly CT 31   41.5 
(11.7) 
 100mins,12 1(3.2)     
 Weekly ST 30   37.8 
(9.9) 
 100mins ,12 3 (10)     
 WL 30   36.8 
(10.5) 
  0 (0)     
             
Foa 1999 PE 25 USA Chronic 
PTSD  
34.9 
(10.6) 
100 90-120mins , 9 2 (8) Single Sexual or  
non-sexual 
Childhood 
or 
Adulthood  
Community 
 SIT 26     90-120mins , 9 7(27)     
 PE-SIT 30     90-120mins , 9 8 (27)     
 WL 15      0 (0)     
Study Ref Groups 
included 
 
N  Country 
 
Participants Age, 
mean 
(SD) 
 
% female Duration & N 
sessions 
available 
Drops 
outs N 
(%) 
Trauma 
exposure 
 
Type of 
Trauma 
 
Trauma 
onset 
 
Treatment 
setting 
 
             
Foa 2005 PE 79 USA 
 
Assault 
survivors  
31.3 
(9.8) 
100 90-120mins, 9-12 27 (34.1) Single Sexual or  
non-sexual 
Childhood 
or 
Adulthood  
Community or 
University -
based 
 PE-CR 74     90-120mins, 9-12 30(40.5)     
 WL 26        1 (3.8)     
             
Forbes 2012 CPT 30 Australia Military 
veteran 
53.13 
(13.97) 
3.4 60-90 mins, 12 9(30.0) Single  Non-sexual Adulthood Community 
 TAU 29   53.62 
(13.33) 
  9 (31.1)     
             
Ford 2011 TARGET 48 USA 
 
Mothers with 
PTSD 
 
30.7(6.9) 100 50mins, 12 12(25) Unclear Unclear Adulthood  Community  
 
 PCT 53      NR, 12 14 (26)     
 WL 45           
             
Galovski 
2012 
MCPT 53 USA Trauma 
survivors 
39.80 
(11.74) 
69 NR, 12 14 (26.4) Single Sexual or 
non-sexual 
Childhood 
or 
Adulthood 
Community 
 SMDT 47     NR12, 7 (14.9)     
             
Ghafoori 
2017 
PE 24 USA Trauma 
survivors 
35.2 
(12.0) 
83.1 60-90 mins, 12 34 (72) Multiple Sexual and 
/or non-
sexual 
Adulthood  Community 
 PCT 47     60-90 mins,12 16 (66)     
             
Harned 2014 DBT 9 USA Women with 
BPS & PTSD 
32.6 
(12.0) 
100 1 year of 
treatment 
4(44.4) Single Sexual or 
non-sexual 
Childhood 
or 
Adulthood 
Community 
 DBT -PE 17     1 year of 
treatment 
7(41.2)     
Study Ref Groups 
included 
 
N  Country 
 
Participants Age, 
mean 
(SD) 
 
% female Duration & N 
sessions 
available 
Drops 
outs N 
(%) 
Trauma 
exposure 
 
Type of 
Trauma 
 
Trauma 
onset 
 
Treatment 
setting 
 
             
Hinton 2009 IT-CBT 12 USA Refugees 49.92 
(9.23) 
60 NR, 12 0 (0) Single Non sexual  Adulthood Community 
 DT- CBT 12   49.08 
(7.56) 
 NR,12 0 (0)     
             
Hinton 2011 CA-CBT 12 USA 
 
Female 
Latino 
patients 
 
47.6 
(8.2) 
100 60 mins, 14 0 Unclear Unclear 
 
Unclear Community 
 AMR 12   51.4 
(5.9) 
 60 mins, 14 0     
             
Hogberg 2007 EMDR 13 Sweden Public 
transportation 
workers 
43 (8) 20.8 90mins, 5 0(0) Single  Non sexual  Adulthood Community 
 WL 11   43 (11)   2(18.2)     
             
Hollified 
2007 
CBT 28 USA Adults with 
PTSD 
40.9 
(13.4) 
 120mins,12 7 (25) Multiple Unclear Childhood 
or  
Adulthood 
Community 
 WL 27   43.4 
(13.5) 
  6 (22.2)     
             
Jung 2013 CRIM 17 German
y 
CSA 
survivors 
37.18 
(10.85) 
100 50 & 90mins,  2 0 (0) Multiple Sexual Childhood Community  
 WL 17      0 (0)     
             
Keane 1989 Implosive 
(flooding) 
11 USA Veterans  34.7 
(4.3) 
0 90 minutes,14-16 1 (9.1) Single Non-sexual Adulthood Community 
 WL 13   34.5 
(2.1) 
  1(7.7)     
             
Study Ref Groups 
included 
 
N  Country 
 
Participants Age, 
mean 
(SD) 
 
% female Duration & N 
sessions 
available 
Drops 
outs N 
(%) 
Trauma 
exposure 
 
Type of 
Trauma 
 
Trauma 
onset 
 
Treatment 
setting 
 
Kip 2013 ART US
A 
29 Veterans  41.0 
(12.4) 
20 60-75mins, 2-5 3 (10.3) Single  Sexual  or 
non-sexual 
Adulthood Community 
 AC  28    60mins, 2 4 (14.3)     
             
Krakow 2001 CIT 88 USA Sexual 
Assault 
survivors  
40 (11.2) 
C 
37 (12.7) 
NC 
100 60-180mins , 3 22(25) Multiple Sexual Childhood 
& 
Adulthood 
Community 
 WL 80   36 (9.3) 
C 
31 (10.5) 
NC 
   2
0 (25) 
    
             
Krupnick 
2008 
IPT 32 USA Trauma 
survivors 
32 (10.2) 100 120 mins, 16 NR* Multiple Sexual & or 
non-sexual 
Childhood 
& 
Adulthood 
Community  
 WL 
 
16      NR*     
  
 
           
Kubany 2003 Immediate 
CTT-BW 
19 USA Battered 
women 
36.4 
(9.1) 
100 90 mins,8-11 1 (5.3) Multiple Non-sexual Adulthood Community 
 Delayed 
CTT-BW 
18     90 mins, 8-11 4 (22.2)     
             
Kubany 2004 Immediate 
CTT-BW 
63 USA Battered 
women 
42.2 
(10.1) 
100 90 mins,8-11 18 (28.6) Multiple Non-sexual Adulthood Community 
 Delayed 
CTT-BW 
62     90 mins, 8-11 22 (35.5)     
             
Lindauer 
2005 
BEP 12 Netherla
nds 
Trauma 
survivors 
 
37.6 
(10.2) 
54 45-60 mins, 16 3(25) Multiple 
 
Non-sexual Adulthood 
 
Community 
Study Ref Groups 
included 
 
N  Country 
 
Participants Age, 
mean 
(SD) 
 
% female Duration & N 
sessions 
available 
Drops 
outs N 
(%) 
Trauma 
exposure 
 
Type of 
Trauma 
 
Trauma 
onset 
 
Treatment 
setting 
 
 WL 12   40.3 
(8.9) 
       
             
Marks 1998 Exposure 23 UK Outpatients 
with PTSD 
39 (11) 36 90 mins,10 3(13) Single Sexual or 
non-sexual 
Adulthood Community 
 Cognitive 19   39 (9)  90 mins,10 1(5.3)     
 E+C 24   38 (9)  105 mins,10 5(20.8)     
 Relaxation 21   36 (10)  90 mins,10 1(4.8)     
             
McDonagh 
2005 
CBT 29 USA 
 
CSA 
survivors 
 
39.8 
(9.9) 
100 90-120mins, 14 12(41) Multiple 
 
Sexual Childhood  Community 
 PCT 22   39.6 
(9.6) 
 90-120mins, 14 2(9)     
 WL 23   42.0 
(9.8) 
  3(13)     
             
Monson 2006 CPT 30 USA 
 
Veterans 
 
54.0 
(6.3) 
10 2p/w, 12 6(20) Single  
 
Sexual or  
Non-sexual 
Adulthood 
 
Community 
 
 WL 30      4(13)     
             
Mueser 2008 CBT 54 USA 
 
Severe 
Mental Illness 
patients 
44.21 
(10.64) 
79 NR,12-16 19 Single 
 
Sexual or 
non-sexual 
 
Childhood 
& 
Adulthood 
Community  
 TAU 54           
             
Mueser 2015 CBT 104 USA Severe 
Mental Illness 
patients 
42.96 
(10.46) 
72.3 NR,12- 16 37 (35.6) Single 
 
Sexual or 
non-sexual 
 
Childhood 
& 
Adulthood 
Community 
 BT 97   44.52 
(11.60) 
 NR, 3 14 (14.3)     
             
Study Ref Groups 
included 
 
N  Country 
 
Participants Age, 
mean 
(SD) 
 
% female Duration & N 
sessions 
available 
Drops 
outs N 
(%) 
Trauma 
exposure 
 
Type of 
Trauma 
 
Trauma 
onset 
 
Treatment 
setting 
 
Nijdam 2012 BEP 70 Netherla
nds 
Trauma 
survivors 
37.3 
(10.6) 
56.4 45-60 mins,15 25 (36) Single  Sexual or 
non-sexual 
  
Adulthood 
Community 
 EMDR 70   38.3 
(12.2) 
 90 mins, NR  20 (29)     
             
Pacella 2012 PE 40 USA Adults with 
HIV 
46.37 
(6.30) 
36.9 90-120 mins, 10 17 (42.5) Multiple   Sexual or 
non-sexual 
Childhood
& 
Adulthood 
Community 
 WL 24      0 (0)     
             
Power 2002 EMDR 39 UK Adults with 
PTSD 
38.6 
(11.8) 
41.7 90 mins,10 12 (31) Single  Sexual or 
non-sexual 
Adulthood  Community 
 E+CR 37   43.2 
(11.0) 
 90 mins ,10 16 (43)     
 WL 29   36.5 
(11.6) 
  5 (17)     
             
 
Resick 2002 
 
CPT 
 
41 
 
USA 
 
 
Female Rape 
Victims 
 
32 (9.9) 
 
100 
 
2 p/w 13hrs,12 
 
11(26.8) 
 
Multiple 
 
 
Sexual & 
/or Non-
sexual 
 
Adulthood 
 
Community 
 PE 40     2 p/w 13hrs, 9 (27.3)     
 MA 40      (14.9)     
             
Scheck 1998 EMDR 30 USA Traumatised 
Young 
Women 
20.93(no 
SD 
reported) 
100 90mins, 2 0 (0) Single  Sexual  Childhood 
& 
Adulthood 
Community 
 AL 30     90mins, 2 1 (3.3)     
             
Steel 2017 CBT 30 UK Adults with 
schizophrenia 
42.3 
(10.2) 
37.7 NR ,12-16 4(13.0) Single or 
Multiple 
Sexual or 
non-sexual 
Childhood 
& 
Adulthood 
Community 
 TAU 31      5 (16.1)     
Study Ref Groups 
included 
 
N  Country 
 
Participants Age, 
mean 
(SD) 
 
% female Duration & N 
sessions 
available 
Drops 
outs N 
(%) 
Trauma 
exposure 
 
Type of 
Trauma 
 
Trauma 
onset 
 
Treatment 
setting 
 
             
Suris 2013 CPT 72 USA Veterans  46.1 
(9.8) 
84.9 Unclear , 12 25(35) Single  Sexual Adulthood Community 
 PCT 57     Unclear, 10-12 10(18)     
             
Talbot 2014 CBT-I 29 USA Adults with 
PTSD  
37.1 
(10.4) 
68.9 Unclear 2 (6.9) Unclear Unclear Unclear Community  
 WL 16   37.3(11.
0) 
  1 (6.3)     
             
ter Heide 
2011 
EMDR 10 Netherla
nds 
Asylum 
seekers and 
refugees 
40.00 
(9.31) 
40 90 mins , 11 5 (50) Multiple Non-sexual Adulthood Community 
 Stabilisation 10   43.00 
(7.93) 
 60 mins, 11 5(50)     
              
ter Heide 
2016 
EMDR 37 Netherla
nds 
Refugees 43.1(10.
7) 
27.8 60-90mins,  9  6 (16.7) Multiple Non-sexual Adulthood Community 
 Stabilisation 37   39.8(11.
9) 
 60 mins , 12  8  (22.2)     
             
van den Berg 
2015 
PE 53  Netherla
nds 
Severe 
Mental Illness 
patients 
41.2 
(10.5) 
54.2 90 mins, 8 13(24.5) Single or 
Multiple 
Sexual &/or 
Non-sexual 
Childhood 
& 
Adulthood 
Community 
 EMDR 55     90 mins, 8 11(20.0)     
 WL 47           
             
Abbreviations: AC, Attention Control; AL, Active Listening Control; AMR, Applied Muscle Relaxation; ART, Accelerated Resolution Therapy; BEP, Brief Eclectic 
Psychotherapy; BPS, Borderline Personality disorder; BT, Brief Treatment; CA-CBT, Culturally Adapted Cognitive Behaviour Therapy; CBT, Cognitive Behaviour Therapy; 
CBT-I, Cognitive Behavioral Therapy for Insomnia; CIT, Cognitive Imagery Treatment; CPT, Cognitive Processing Therapy; CRIM, Cognitive Restructuring and Imagery 
Modification; CSA, Childhood Sexual Abuse; CT, Cognitive Therapy; CTT-BW, Cognitive Trauma Therapy for Battered Women; DBT, Dialectical Behavior Therapy; DBT 
PE, Dialectical Behavior Therapy Prolonged Exposure; DET, Dialogical Exposure Therapy; DT –CBT, Delayed Treatment Cognitive Behaviour Therapy;E+C, Exposure and 
Cognitive; E+CR, Exposure plus Cognitive Restructuring; EMDR, Eye Movement Desensitization and Reprocessing Therapy; EXP, Experimental Treatment; EXP, Exposure 
Therapy Only; Intensive CT, Intensive Cognitive Therapy; IPT, Interpersonal Psychotherapy; MA, Minimal Attention; MA WL, Minimal Attention Wait List; MCPT, Modified 
Cognitive Processing Therapy Intervention; MVA, Motor Vehicle Accident; PCT, Present Centred Therapy; PE, Prolonged exposure; PE-CR, Prolonged Exposure plus 
Cognitive Restructuring; PE-SIT, Prolonged Exposure + Stress Inoculation Training; PGT, Psychoeducational Group Therapy; PTSD, Post-traumatic Stress Disorder; RA, 
Repeated Assessments; REM, Rapid Eye Movement; SHB, Self-help booklet; SIT, Stress inoculation training; SMDT, Symptom –Monitoring Delayed Treatment; SMT, Self- 
Management Therapy; SSBT, Single Session of Behavioural Treatment; STAIRS + MPE, Skills Training in Affective and Interpersonal Regulation with modified Prolonged 
Exposure; TARGET, Trauma Affect Regulation: Guide for Education and Therapy; TAU, Treatment as usual; TFCBT, Trauma-Focused Cognitive-Behavioural Therapy; TMT, 
Trauma Management Therapy; Weekly CT, Weekly Cognitive Therapy; Weekly ST, Weekly Supportive Therapy ;WL, Waitlist.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
E.        Table E.1. Participants’ baseline scores on the CPTSD symptom clusters and corresponding norms 
 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
          
 
Ahmadi 2015  
 
EMDR 
 
Emotional 
control subscale 
of the 
Mississippi 
Scale for 
PTSD, -5.3 
(4.4) [these are 
the mean (SD) 
change scores] 
 
- 
 
- 
 
- 
 
Interpersonal 
relation subscale 
of the Mississippi 
Scale for PTSD, -
4.7 (5.2) 
 
- 
 
Only change 
scores were 
reported (no 
baseline 
scores). 
 
Include – 
although 
exclude in 
sensitivity 
analysis. 
REM -6.4 (3.9) [these 
are the mean 
(SD) change 
scores] 
- -1.3 (2.7) 
Control 0.7 (2.5) [these 
are the mean 
(SD) change 
scores] 
- -0.08 (2.3) 
          
 
Azad 
marzabadi 2014 
 
Mindfulness 
 
- 
 
- 
 
- 
 
- 
 
Social life 
subscale of the 
WHOQOL-26, 
5.5 (1.65) 
 
- 
 
Baseline scores 
indicate that the 
participants 
were on 
average at least 
dissatisfied in 
their social life. 
 
Include 
Control - - 5.21 (0.97) 
          
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
 
Basoglu 2007 
 
SSBT 
 
- 
 
- 
 
- 
 
- 
 
WSAS, 4.1 (0.8) 
 
- 
 
Baseline scores 
above 4 on the 
WSAS suggest 
moderately 
severe or worse 
psychopatholo-
gy (Mundt et 
al., 2002). 
 
Include 
RA - - 4.1 (0.9) 
          
 
Beidel 2011 
 
TMT 
 
CAPS social 
and emotional 
subscale, 22.6 
(5.3) 
 
- 
 
- 
 
- 
 
CAPS social and 
emotional 
subscale, 22.6 
(5.3) 
 
- 
 
Using the "1, 2" 
rule (i.e., a 
frequency score 
of 1 and an 
intensity score 
of 2) to 
determine 
symptom 
severity, scores 
above 12 on 
this subscale 
meet the 
clinical 
threshold 
(Weathers, 
Ruscio, & 
Keane, 1999). 
 
Include 
EXP 22.4 (3.8) - 22.4 (3.8) 
          
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
Beidel 2019 TMT - - - - Duration of Daily 
Social Interaction 
(outside of family 
interactions at 
home) (mins per 
day), 49.7 (54.3) 
- On average, a 
non-clinical 
group aged 16–
36 years engage 
in 63.49 h of 
structured 
activity per 
week, and 
activity levels 
below 30 h are 
indicative of 
poor social 
functioning 
(Hodgekins et 
al., 2015). 
Include 
EXP - - 52.7 (61.9) 
          
Bryant 2013 Support/CBT - - 
 
- 
PTCI-self, 4.08 
(1.29)  
Median (SD) 
among people 
with no trauma: 
1.08 (0.76) 
(Foa et al., 
1999) 
- - - Include 
Skills/CBT - 4.41 (1.18) - 
          
Butollo 2016 
 
 
 
 
DET - - PTCI-self, 3.71 
(1.2) [these are 
the mean (SD) 
across both 
groups] 
Median (SD) 
among people 
with no trauma: 
1.08 (0.76) 
(Foa et al., 
1999)  
IIP-C, 1.34 (0.59) 1.28 (0.52) (non-
clinical) (Brahler 
et al., 1999) 
- Include NSC 
data but not 
DR data. 
CPT - 1.38 (0.57) 
          
Cloitre 2002 STAIR+MPE NMR, 85 (15.6) - - IIP, 1.88 (0.57)  - 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
MA WL 84 (17.9) 101.6 (15.43) 
(non-clinical) 
(Cantanzaro & 
Mearns, 1990) 
- 1.70 (0.46)  
(the weighted 
mean across 
these groups is 
1.79) 
1.28 (0.52) (non-
clinical) (Brahler 
et al., 1999) 
Include AD 
data but not 
DR data. 
          
Difede 2007 CBT - - - - SAS-SR, 2 (0.4)  1.59 (0.33) (non-
clinical) 
(Weissman et al., 
1978)  
- Include 
TAU - - 2.28 (0.44) 
          
Dorrepaal 2012 EXP - - - - - - As all 
participants in 
this study had 
to meet 
diagnostic 
criteria for 
complex PTSD 
as assessed by 
the SIDES, this 
study is 
relevant. 
Include 
TAU - - - 
          
Duffy 2007 CT - - - - - Include 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
WL - - SDS-social 
subscale, 7.7 
(2.4) [these are 
the mean (SD) 
across both 
groups] 
A score of 7 or 
above on this 
subscale 
indicates a 
marked 
impairment. 
Moreover, it 
has been 
suggested that 
clinicians 
should pay 
special 
attention to 
patients who 
score 5 or 
greater on this 
subscale (Rush 
et al., 2000). 
          
Dunn 2007 SMT SCQD, 86.14 
(12.95) 
101.2 (15.46) 
(non-clinical) 
(Mezo & 
Heiby, 2004) 
- - - - - Include 
PGT 79.74 (17.77) - - 
          
Dunne 2012 TF-CBT - - - - SF-36 social 
functioning 
subscale, 43.46 
(18.12) 
85.66 (19.83) 
(among male 
norms aged 25-
44); 88.54 
- Include 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
WL - - 45.42 (13.97) (18.09) (among 
male norms aged 
35-55); numerous 
other norms are 
available as well 
(Ware et al., 
1993). 
          
Ehlers 2003 CT - - - - SDS, 5.9 (2.4) - A score of 4 to 
6 on this scale 
indicates a 
moderate 
impairment. 
Moreover, it 
has been 
suggested that 
clinicians 
should pay 
special 
attention to 
patients who 
score 5 or 
greater on this 
subscale (Rush 
et al., 2000).  
Include 
SHB - - 6.3 (2) 
RA - - 6.1 (1.9) 
          
Ehlers 2005 CT - - - - SDS, 7.6 (1.9) - Include 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
 WL - - 6.7 (1.9) A score of 7 or 
above on this 
scale indicates 
a marked 
impairment. 
Moreover, it 
has been 
suggested that 
clinicians 
should pay 
special 
attention to 
patients who 
score 5 or 
greater on this 
subscale (Rush 
et al., 2000).  
          
Ehlers 2014 Intensive CT - - - - SDS, 20.48 
(5.55) 
- Each of the 
baseline mean 
SDS scores 
need to be 
divided by 3 so 
they are 
comparable to 
those of Ehlers, 
2003 and 2005 
above (e.g., 
21.39/3 = 7.13).   
Include 
Weekly CT - - 21.39 (5.11) 
Weekly ST - - 19.65 (6.97) 
WL - - 17.28 (7.74) 
          
Foa 1999 PE - - - - SAS (interview 
version), 3.73 
(0.83) 
- Normative data 
for the 
interview 
Include 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
SIT - - 3.79 (1.23) version of the 
SAS were not 
available. This 
version of the 
SAS is a 7-
point scale. 
Assuming a 0-6 
scoring method, 
scores of 3 or 
greater indicate 
that participants 
are closer to 
being impaired 
than intact. 
PE-SIT - - 4 (1.11) 
WL - - 3.93 (1.16) 
          
Foa 2005 PE - - - - SAS social 
subscale 
(interview 
version), 4 (0.9) 
- Normative data 
for the 
interview 
version of the 
SAS social 
Include 
PE-CR - - 3.9 (1) 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
WL - - 3.9 (1.2) subscale were 
not available. 
This version of 
the SAS social 
subscale is a 7-
point scale. 
Assuming a 0-6 
scoring method, 
scores of 3 or 
greater indicate 
that participants 
are closer to 
being impaired 
than intact. 
          
Forbes 2012 CPT - - - - - Include 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
TAU - - Social subscale 
of the WHO-
QOL Bref, 8.1 
(2.8) [this is the 
mean (SD) across 
both groups] 
Normative data 
for this 
subscale were 
not available. If 
a participant 
were to answer 
"neither 
satisfied or 
dissatisfied" on 
2 of the items 
and 
"dissatisfied" 
on the other 
item they 
would receive a 
score of 8. 
Therefore, a 
score of 8.1 
indicates that 
participants are 
closer to being 
impaired than 
intact.  
          
Ford 2011 WL NMR, 96.9 (20) 101.6 (15.43) 
(non-clinical) 
(Cantanzaro & 
Mearns, 1990) 
PTCI-self, 67.1 
(28.3) [A mean 
of 67.1 is 
equivalent to a 
mean of 3.2 when 
scored the same 
way as the 
normative data] 
Median (SD) 
among people 
with no trauma: 
1.08 (0.76) 
(Foa et al., 
1999) 
RSQ secure 
attachment 
subscale, 13.5 
(3.3) 
15.57 (SD = 
3.01) (non-
clinical) 
(Bäackström & 
Holmes, 2001) 
- Include NSC 
data but not 
AD or DR 
data. 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
TARGET 106.1 (18.1) 51.3 (23.5) [A 
mean of 51.3 is 
equivalent to a 
mean of 2.44 
when scored the 
same way as the 
normative data] 
13.7 (3.8) 
PCT 103.1 (20.2) 53.7 (25.4) [A 
mean of 53.7 is 
equivalent to a 
mean of 2.56 
when scored the 
same way as the 
normative data] 
14 (3.5) 
          
Galovski 2012 MCPT - - TRGI guilt 
cognitions 
subscale, 1.57 
(0.11) [this is the 
least square mean 
(SE)] 
1 (0.5) (among 
participants 
with a history 
of potentially 
traumatic 
CSA/CPA 
without any 
axis-I disorder; 
these are more 
severe than 
healthy 
individuals) 
(Rausch et al., 
2016) 
SF-36 social 
functioning 
subscale, 42.87 
(4.06) [this is the 
least square mean 
(SE)] 
85.66 (19.83) 
(among male 
norms aged 25-
44); 88.54 
(18.09) (among 
male norms aged 
35-55); numerous 
other norms are 
available as well 
(Ware et al., 
1993). 
- Include both 
NSC and DR 
data 
SMDT - 1.62 (0.12) [this 
is the least square 
mean (SE)] 
37.45 (4.29) [this 
is the least square 
mean (SE)] 
          
Ghafoori 2017 PE - - - - SDS social 
subscale, 7 (2.6) 
- A score of 7 or 
above on this 
Include 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
PCT - - 7.3 (2.5) subscale 
indicates a 
marked 
impairment. 
Moreover, it 
has been 
suggested that 
clinicians 
should pay 
special 
attention to 
patients who 
score 5 or 
greater on this 
subscale (Rush 
et al., 2000). 
 
          
Harned 2014 DBT - - TRGI guilt 
cognitions 
subscale, 2.4 
(0.9) 
1 (0.5) (among 
participants 
with a history 
of potentially 
traumatic 
CSA/CPA 
without any 
axis-I disorder; 
these are more 
severe than 
healthy 
individuals) 
(Rausch et al., 
2016)  
- - - Include 
DBT -PE - 2.4 (0.8) - 
          
Hinton 2009 IT-CBT ERS, 0.9 (0.6)  - - - - - Include 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
DT-CBT 0.8 (0.5) - - Normative data 
for this scale 
were not 
available. This 
scale is rated on 
a 0-4 Likert-
type scale, 
rating the 
ability to 
distance from 
affects, ranging 
from “not at 
all” to “very 
much so.” 
These scores 
appear to 
indicate that 
participants are 
only edging 
towards 
somewhat 
being able to 
distance from 
affects. 
          
Hinton 2011 CA-CBT ERS, 0.7 (0.5) - - - - - Include 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
AMR 0.9 (0.4) - - As above with 
Hinton, 2009, 
these scores 
appear to 
indicate that 
participants are 
only edging 
towards 
somewhat 
being able to 
distance from 
affects. 
          
          
Hogberg 2007 EMDR - - - - SDI, 4.5 (2.3) 1.53 (1.13) 
(among subjects 
who had 
experienced 
traumatic events 
but who had 
never developed 
PTSD) (Nardo et 
al., 2011)  
- Include 
WL - - 5.9 (4.5) 
          
Hollified 2007 CBT - - - - SDS global rating 
scale, 4.09 (0.81) 
- Normative data 
for this scale 
Include 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
WL - - 4 (1.02) were not 
available. 
Participants’ 
scores on this 
scale appear to 
be impaired as 
possible scores 
on this scale 
appear to range 
from 0 to 5, 
with higher 
scores 
indicating 
greater 
impairment.  
          
Jung 2013 CRIM - - RSES, 22.1 (7.8) 49.2 (8.2) (non-
clinical) (Roth 
et al., 2008)  
- - This version of 
the RSES 
appears to 
range from 1-
60.  
Include 
WL - 20.6 (5.7) - 
          
Keane 1989 Implosive 
(flooding) 
- - - - Social subscale 
of the Social 
Adjustment 
Measures, 4 (1.9)  
- Normative data 
for this scale 
were not 
available. The 
Include 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
WL - - 2.6 (1.7) weighted mean 
of participants’ 
scores on this 
scale indicate 
that participants 
are closer to 
being extremely 
dissatisfied 
than extremely 
satisfied with 
their social life.  
          
Kip 2013 ART - - TRGI guilt 
cognitions 
subscale, 26.7 
(no SD reported) 
21 (10.5) 
(among 
participants 
with a history 
of potentially 
traumatic 
CSA/CPA 
without any 
axis-I disorder; 
these are more 
severe than 
healthy 
individuals) 
(the mean and 
SD were 
rescaled in light 
of the scoring 
method of Kip, 
2013) (Rausch 
et al., 2016)  
Relating to others 
subscale of the 
PTGI, 11.6 (7.92; 
SD imputed from 
Nijdam, 2018) 
23.04 (no SD 
reported) (non-
clinical) 
(Tedeschi & 
Calhoun, 1996)  
- Include DR 
data but not 
NSC data. 
AC - 20.2 (no SD 
reported) 
13 (7.92; SD 
imputed from 
Nijdam, 2018) 
          
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
Krakow 2001 CIT - - - - SDS social 
life/leisure 
activities index 
(no baseline 
scores were 
reported) 
- Inferential 
statistics 
including effect 
sizes showing 
changes in the 
SDS social 
life/leisure 
activities index 
in the groups 
were reported 
(no baseline 
scores). 
Include – 
although 
exclude in 
sensitivity 
analysis. 
WL - - 
          
Krupnick 2008 IPT - - - - IIP - Patients with a 
score of 3 or 
higher on any 
item of the IIP 
(indicating 
significant 
interpersonal 
distress) 
qualified for 
participation in 
the study. 
Include 
WL 
 
- -  
  
 
        
Kubany 2003 Immediate 
CTT-BW 
- - RSES, 13.6 (5.2) 22.62 (5.80) 
(non-clinical) 
- - It is also worth 
noting that an 
Include 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
Delayed CTT-
BW 
- 12.7 (6.7) (Sinclair et al., 
2010) 
  inclusion 
criterion in this 
study was a 
score on the 
TRGI global 
guilt scale 
reflecting at 
least moderate 
abuse-related 
guilt. 
          
Kubany 2004 Immediate 
CTT-BW 
- - RSES, 14.8 (5.4) 22.62 (5.80) 
(non-clinical) 
(Sinclair et al., 
2010)  
- - It is also worth 
noting that an 
inclusion 
criterion in this 
study was a 
score on the 
TRGI global 
guilt scale 
reflecting at 
least moderate 
abuse-related 
guilt. 
Include 
Delayed CTT-
BW 
- 14.5 (4.5) - 
          
Lindauer 2005 BEP - - - - Relationships 
Questionnaire, 
- At least 50% of 
the sample had 
Include 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
WL - - 50% of 
participants 
across groups had 
problems with 
relationships 
(binary measure, 
not a continuous 
measure; 
therefore no 
means or SDs 
were reported) 
problems with 
relationships.  
          
Marks 1998 Exposure - - - - WSAS, 21.5 
(8.9) 
- Baseline scores 
above 20 on the 
WSAS suggest 
moderately 
severe or worse 
psychopatholo-
gy (Mundt et 
al., 2002). 
Include 
Cognitive - - 26.9 (8.8) 
E+C - - 29.4 (7.9) 
Relaxation - - 22.1 (9.5) 
          
McDonagh 
2005 
CBT - - TSI, 3.1 (0.6)  1.83 (0.34) 
(non-clinical) 
(the mean and 
SD were 
rescaled in light 
of the scoring 
method of 
McDonagh, 
2014) 
(Kadambi & 
Truscott, 2004) 
- - - Include 
PCT - 2.9 (0.5) - 
WL - 3.2 (0.6) - 
          
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
Monson 2006 CPT ACS - TRGI guilt 
cognitions 
subscale 
- SAS-SR, 2.48 
(0.39) 
1.59 (0.33) (non-
clinical) 
(Weissman et al., 
1978) 
- Include 
(exclude AD 
and NSC data 
in sensitivity 
analysis, as 
baseline AD 
and NC data 
were not 
available) 
WL   2.68 (0.54) 
          
Mueser 2008 CBT - - PTCI-self, 3.89 
(1.11) 
Median (SD) 
among people 
with no trauma: 
1.08 (0.76) 
(Foa et al., 
1999) 
- - - Include 
TAU - 3.64 (1.14) - 
          
Mueser 2015 CBT - - PTCI-self, 4.10 
(1.36) 
Median (SD) 
among people 
with no trauma: 
1.08 (0.76) 
CAPS social 
functioning 
subscale, 2.35 
(0.79) 
- Using the "1, 2" 
rule (i.e., a 
frequency score 
of 1 and an 
Include NSC 
data but not 
DR data. 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
BT - 4.15 (1.31) (Foa et al., 
1999) 
2.36 (0.81) intensity score 
of 2) for the 
CAPS social 
functioning 
subscale to 
determine 
symptom 
severity, scores 
above 3 meet 
the clinical 
threshold 
(Weathers et 
al., 1999) 
          
Nijdam 2012 BEP - - - - Relating to others 
subscale of the 
PTGI, 14.38 
(7.92) [this is the 
mean (SD) across 
both groups] 
23.04 (no SD 
reported) (non-
clinical) 
(Tedeschi & 
Calhoun, 1996)   
- - 
EMDR - -  
          
Pacella 2012 PE - - PTCI-self, 3.23 
(1.19) 
Median (SD) 
among people 
with no trauma: 
1.08 (0.76) 
(Foa et al., 
1999) 
- - - Include 
WL - 3.04 (1.38) - 
          
Power 2002 EMDR - - - - SDS, 21.3 (5.4) - Each of the 
baseline mean 
Include 
 E+CR - - 22.8 (6.3) 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
 WL - - 23.3 (4.7) SDS scores 
need to be 
divided by 3 so 
they are 
comparable to 
those of Ehlers, 
2003 and 2005 
above (e.g., 
21.3/3 = 7.1).   
          
 
Resick 2002 
 
CPT 
-  TRGI global guilt 
subscale, 2.34 
(1.13) 
0.6 (0.8) 
(among 
participants 
with a history 
of potentially 
traumatic 
CSA/CPA 
without any 
axis-I disorder; 
these are more 
severe than 
healthy 
individuals) 
(Rausch et al., 
2016) 
- - - Include 
PE - 2.53 (1.11) - 
MA - 2.60 (1.03) - 
          
Scheck 1998 EMDR - - TSCS, 284.57 
(40.94) 
345.75 (38.72) 
(non-clinical) 
(Caplan, 
Henderson, 
Henderson, & 
Fleming, 2002)   
- - - Include 
AL - 285.24 (38.23) - 
          
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
Steel 2017 CBT - - PTCI-self, 4.46 
(1.13) [this is the 
mean (SD) across 
both groups] 
Median (SD) 
among people 
with no trauma: 
1.08 (0.76) 
(Foa et al., 
1999) 
- - - Include 
TAU - - 
          
Suris 2013 CPT - - PTCI-self, 4.80 
(1.12) 
Median (SD) 
among people 
with no trauma: 
1.08 (0.76) 
(Foa et al., 
1999) 
- - - Include 
PCT - 4.82 (1.25) - 
          
Talbot 2014 CBT-I - - - - WSAS, mean of 
>24 for both 
groups (as 
depicted in a 
graph) 
- Baseline scores 
above 20 on the 
WSAS suggest 
moderately 
severe or worse 
psychopatholo-
gy (Mundt et 
al., 2002). 
Include 
WL - - 
          
ter Heide 2011 EMDR - - - - Social subscale 
of the WHO-
QOL Bref, 2.4 
(0.86) 
- Normative data 
for this 
subscale were 
not available. A 
Include 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
Stabilisation - - 3.07 (0.49) weighted mean 
of less than 3 
represents 
being between 
dissatisfied (2) 
and neither 
satisfied nor 
dissatisfied (3; 
which is in the 
middle) on the 
different items 
of this subscale. 
Therefore, 
participants are 
closer to being 
impaired than 
intact.    
          
ter Heide 2016 EMDR - - - - Social subscale 
of the WHO-
QOL Bref, 2.71 
(0.80) 
- Normative data 
for this 
subscale were 
not available. A 
Include 
Study Ref Groups 
included 
 
Name of AD 
assessment, 
baseline mean 
(SD) 
Normative AD 
data for 
interpretation, 
mean (SD) 
 
Name of NSC 
assessment, 
baseline mean 
(SD) 
Normative 
NSC data for 
interpretation, 
mean (SD) 
 
Name of DR 
assessment, 
baseline mean 
(SD) 
Normative DR 
data for 
interpretation, 
mean (SD) 
Other 
information 
for 
interpretation 
Decision 
 Stabilisation - - 2.55 (0.98) weighted mean 
of less than 3 
represents 
being between 
dissatisfied (2) 
and neither 
satisfied nor 
dissatisfied (3; 
which is in the 
middle) on the 
different items 
of this subscale. 
Therefore, 
participants are 
closer to being 
impaired than 
intact.    
          
van den Berg 
2015 
PE - - PTCI-self, 4.52 
(1.22) 
Median (SD) 
among people 
with no trauma: 
1.08 (0.76) 
(Foa et al., 
1999) 
- - - Include 
EMDR - 4.4 (1.12) - 
WL - 4.26 (0.96) - 
          
Abbreviations: AC, Attention Control; ACF, Affect Control Scale; AL, Active Listening Control; AMR, Applied Muscle Relaxation; ART, Accelerated Resolution Therapy; 
BEP, Brief Eclectic Psychotherapy; BPS, Borderline Personality disorder; BT, Brief Treatment; CA-CBT, Culturally Adapted Cognitive Behaviour Therapy; CAPS, Clinician-
Administered PTSD Scale; CBT, Cognitive Behaviour Therapy; CBT-I, Cognitive Behavioral Therapy for Insomnia; CIT, Cognitive Imagery Treatment; CPT, Cognitive 
Processing Therapy; CRIM, Cognitive Restructuring and Imagery Modification; CSA, Childhood Sexual Abuse; CT, Cognitive Therapy; CTT-BW, Cognitive Trauma Therapy 
for Battered Women; DBT, Dialectical Behavior Therapy; DBT PE, Dialectical Behavior Therapy Prolonged Exposure; DET, Dialogical Exposure Therapy; DT –CBT, Delayed 
Treatment Cognitive Behaviour Therapy;E+C, Exposure and Cognitive; E+CR, Exposure plus Cognitive Restructuring; EMDR, Eye Movement Desensitization and 
Reprocessing Therapy; ERS, Emotion Regulation Scale; EXP, Experimental Treatment; EXP, Exposure Therapy Only; Intensive CT, Intensive Cognitive Therapy; IIP, 
Inventory of Interpersonal Problems; IIP-C, Inventory of Interpersonal Problems – Circumplex Version; IPT, Interpersonal Psychotherapy; MA, Minimal Attention; MA WL, 
Minimal Attention Wait List; MCPT, Modified Cognitive Processing Therapy Intervention; MVA, Motor Vehicle Accident; NMR, General Expectancy for Negative Mood 
Regulation Scale; PCT, Present Centred Therapy; PE, Prolonged exposure; PE-CR, Prolonged Exposure plus Cognitive Restructuring; PE-SIT, Prolonged Exposure + Stress 
Inoculation Training; PGT, Psychoeducational Group Therapy; PTCI, Posttraumatic Cognitions Inventory; PTGI, Post-Traumatic Growth Inventory; PTSD, Post-traumatic 
Stress Disorder; RA, Repeated Assessments; REM, Rapid Eye Movement; RSES, Rosenberg Self-Esteem Scale; SAS, Social Adjustment Scale; SAS-SR, Social Adjustment 
Scale-Self-Report; SCQD, Self-Control Questionnaire for Depression; SDI, Social Disability Index; SDS, Sheehan Disability Scale; SF-36, Short Form-36 Health Survey; 
SHB, Self-help booklet; SIDES, Structured Interview for Disorders of Extreme Stress; SIT, Stress inoculation training; SMDT, Symptom –Monitoring Delayed Treatment; 
SMT, Self- Management Therapy; SSBT, Single Session of Behavioural Treatment; STAIRS + MPE, Skills Training in Affective and Interpersonal Regulation with modified 
Prolonged Exposure; TARGET, Trauma Affect Regulation: Guide for Education and Therapy; TAU, Treatment as usual; TFCBT, Trauma-Focused Cognitive-Behavioural 
Therapy; TMT, Trauma Management Therapy; TRGI, Trauma Related Guilt Inventory; TSCS, Tennessee Self-Concept Scale; TSI, Traumatic Stress Institute Beliefs Scale; 
Weekly CT, Weekly Cognitive Therapy; Weekly ST, Weekly Supportive Therapy ;WL, Waitlist; WHOQOL-26, World Health Organization Quality of Life Questionnaire; 
WHO-QOL Bref, The short form of the World Health Organization Quality of Life scale; WSAS, Work and Social Adjustment Scale. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References for comparator samples or scoring guidelines referred to in Table E.1 above 
 
Bäckström, M., & Holmes, B. M. (2001). Measuring adult attachment: a construct validation 
of two self-report instruments. Scandinavian Journal of Psychology, 42(1), 79–86. 
https://doi.org/10.1111/1467-9450.00216 
Brahler, E., Horowitz, L. M., Kordy, H., Schumacher, J., & Strauss, B. (1999). Validation of 
the Inventory of Interpersonal Problems (IIP)--Results of a representative study in 
East and West Germany. Psychotherapie Psychosomatik Medizinische Psychologie, 
49(11), 422–431. 
Caplan, S. M., Henderson, C. E., Henderson, J., & Fleming, D. L. (2002). Socioemotional 
Factors Contributing to Adjustment Among Early-Entrance College Students. Gifted 
Child Quarterly, 46(2), 124–134. https://doi.org/10.1177/001698620204600205 
Catarizaro, S. J., & Mearns, J. (1990). Measuring Generalized Expectancies for Negative 
Mood Regulation: Initial Scale Development and Implications. Journal of Personality 
Assessment, 54(3–4), 546–563. https://doi.org/10.1080/00223891.1990.9674019 
Foa, E. B., Tolin, D. F., Ehlers, A., Clark, D. M., & Orsillo, S. M. (1999). The Posttraumatic 
Cognitions Inventory (PTCI): Development and validation. Psychological 
Assessment, 11(3), 303–314. https://doi.org/10.1037/1040-3590.11.3.303 
Hodgekins, J., French, P., Birchwood, M., Mugford, M., Christopher, R., Marshall, M., … 
Fowler, D. (2015). Comparing time use in individuals at different stages of psychosis 
and a non-clinical comparison group. Schizophrenia Research, 161(2–3), 188–193. 
https://doi.org/10.1016/j.schres.2014.12.011 
Kadambi, M. a, & Truscott, D. (2004). Vicarious Trauma Among Therapists Working with 
Sexual Violence, Cancer, and General Practice. Canadian Journal of Counselling, 38, 
260–276. 
Mezo, P. G., & Heiby, E. M. (2004). A comparison of four measures of self-control skills. 
Assessment, 11(3), 238–250. https://doi.org/10.1177/1073191104268199 
Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. M. (2002). The Work and Social 
Adjustment Scale: a simple measure of impairment in functioning. The British 
Journal of Psychiatry, 180(5), 461–464.  
Nardo, D., Högberg, G., Flumeri, F., Jacobsson, H., Larsson, S. A., Hällström, T., & Pagani, 
M. (2011). Self-rating scales assessing subjective well-being and distress correlate 
with rCBF in PTSD-sensitive regions. Psychological Medicine, 41(12), 2549–2561. 
https://doi.org/10.1017/S0033291711000912 
Rausch, S., Herzog, J., Thome, J., Ludï¿½scher, P., Mï¿½ller-Engelmann, M., Steil, R., … 
Kleindienst, N. (2016). Women with exposure to childhood interpersonal violence 
without psychiatric diagnoses show no signs of impairment in general functioning, 
quality of life and sexuality. Borderline Personality Disorder and Emotion 
Dysregulation, 3(1). https://doi.org/10.1186/s40479-016-0048-y 
Roth, M., Decker, O., Herzberg, P. Y., & Brähler, E. (2008). Dimensionality and norms of 
the Rosenberg self-esteem scale in a German general population sample. European 
Journal of Psychological Assessment, 24(3), 190–197. https://doi.org/10.1027/1015-
5759.24.3.190 
 
Rush, J.A. (2000). American Psychiatric Association: Handbook of Psychiatric Measures. 
Washington, DC, American Psychiatric Press. 
Sinclair, S. J., Blais, M. A., Gansler, D. A., Sandberg, E., Bistis, K., & LoCicero, A. (2010). 
Psychometric properties of the Rosenberg Self-Esteem Scale: Overall and across 
demographic groups living within the United States. Evaluation and the Health 
Professions, 33(1), 56–80. https://doi.org/10.1177/0163278709356187 
Tedeschi, R. G., & Calhoun, L. G. (1996). The posttraumatic growth inventory: Measuring 
the positive legacy of trauma. Journal of Traumatic Stress, 9(3), 455–471. 
https://doi.org/10.1002/jts.2490090305 
Ware, J. E., Snow, K. K., Kosinski, M., & Grandek, B. (1993). SF-36 health survey : manual 
and interpretation guide. Boston, MA: The Health Institute 
Weathers, F. W., Ruscio, A. M., & Keane, T. M. (1999). Psychometric properties of nine 
scoring rules for the Clinician-Administered Posttraumatic Stress Disorder Scale. 
Psychological Assessment, 11(2), 124–133. https://doi.org/10.1037/1040-
3590.11.2.124 
Weissman, M. M., Prusoff, B. A., Douglas Thompson, W., Harding, P. S., & Myers, J. K. 
(1978). Social adjustment by self-report in a community sample and in psychiatric 
outpatients. Journal of Nervous and Mental Disease, 166(5), 317–326. 
https://doi.org/10.1097/00005053-197805000-0000
F.        Risk of Bias Criteria 
 
 
Selection Bias: random sequence generation 
A judgement of unclear risk of bias was made where randomisation was referred to but 
described in insufficient detail to determine independent random sequence generation. There 
was judged to be low risk of bias where this procedure was explicitly reported.  
 
Selection Bias: allocation concealment 
A judgement of unclear risk of bias was made where randomisation was referred to but 
described in insufficient detail to determine allocation concealment. There was judged to be 
low risk of bias where this procedure was explicitly reported.  
 
Performance Bias: blinding of participants and personnel 
Blinding of participants and personnel was not possible due to the nature of the interventions, 
as is the case with trials of psychosocial interventions in general. This resulted in a judgement 
of high risk of performance bias across studies.  
 
Detection Bias: blinding of assessments 
Detection bias was judged to be high where non-blinding of assessors was stated or where no 
information was given, and low if blinding was explicitly reported.  
 
Attrition Bias: incomplete outcome data 
A judgement of high risk of attrition bias was made where data for ≥ 25% of those randomised 
was missing (Xia et al., 2009) or if attrition was not reported (or clearly reported) and a 
completer analysis was carried out. If attrition was low (<25%) and completer analysis was 
used risk of attrition bias was rated as low.  
 
Reporting Bias: selective outcome reporting 
If outcomes are pre-specified and reported a low risk of reporting bias rating was given. 
However, if no protocol is reported a high risk of reporting bias rating was given. If subgroup 
analysis is reported but not pre-specified a high risk of reporting bias rating was given.  
 
Overall Quality 
An overall quality rating for each study was also produced. Performance bias was not taken 
into consideration when producing this rating, as blinding of participants was not possible due 
to the nature of the interventions. All of the other criteria above were considered (i.e., selection 
bias: random sequence generation and allocation concealment, detection bias, attrition bias, 
and reporting bias). A high overall quality rating was given if a study received a low risk of 
bias rating for detection bias, at least another low risk of bias rating, and ≤2 high risk of bias 
ratings. A low overall quality rating was given if a study did not meet these criteria.   
 
 
 
 
 
 
G.        Table F.1. Risk of Bias in Included Studies – Summary 
 
Study Selection Bias: 
random 
sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: 
selective outcome 
reporting 
Overall Quality 
Ahmadi 2015 Unclear Unclear High risk High risk High risk High risk Low quality 
Azad marzabadi 
2014 
Unclear Unclear High risk High risk Low risk High risk Low quality 
Basoglu 2007 Low risk Unclear High risk Low risk Low risk High risk High quality 
Beidel 2011 Unclear Unclear High risk High risk High risk High risk Low quality 
Beidel 2019 Unclear Unclear High risk High risk High risk High risk Low quality 
Bryant 2013 Low risk Low risk High risk Low risk High risk High risk High quality 
Butollo 2016 Unclear Unclear High risk High risk Low risk High risk Low quality 
Cloitre 2002 Unclear Unclear High risk Low risk Low risk High risk High quality 
Difede 2007 Unclear Unclear High risk High risk High risk High risk Low quality 
Dorrepaal 2012 Unclear Low risk High risk Low risk Low risk High risk High quality 
Duffy 2007 Unclear Unclear High risk High risk Low risk High risk Low quality 
Dunn 2007 Low risk High risk High risk Low risk High risk High risk High quality 
Dunne 2012 Unclear Unclear High risk High risk Low risk High risk Low quality 
Ehlers 2003 Low risk Low risk High risk Low risk Low risk High risk High quality 
Ehlers 2005 Unclear Unclear High risk Low risk Low risk High risk High quality 
Ehlers 2014 Low risk Low risk High risk Low risk Low risk High risk High quality 
Foa 1999 Unclear Unclear High risk Low risk Low risk High risk High quality 
Foa 2005 Unclear Unclear High risk Low risk High risk High risk Low quality 
Forbes 2012 Low risk Low risk High risk Low risk Low risk High risk High quality 
Ford 2011 Low risk Low risk High risk High risk High risk High risk Low quality 
Galovski 2012 Low risk Unclear High risk Low risk High risk High risk High quality 
Ghafoori 2017 Low risk Unclear High risk High risk High risk High risk Low quality 
Harned 2014 Low risk Unclear High risk Low risk High risk High risk High quality 
Hinton 2009 Low risk Unclear High risk Low risk Low risk High risk High quality 
Hinton 2011 Unclear Unclear High risk High risk Low risk High risk Low quality 
Hogberg 2007 Unclear Low risk High risk High risk Low risk High risk Low quality 
Hollified 2007 Low risk Low risk High risk High risk High risk High risk Low quality 
Jung 2013 Unclear Unclear High risk High risk Low risk High risk Low quality 
Keane 1989 Unclear Unclear High risk High risk Low risk High risk Low quality 
Study Selection Bias: 
random 
sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: 
selective outcome 
reporting 
Overall Quality 
Kip 2013 Low risk Unclear High risk High risk Low risk Low risk Low quality 
Krakow 2001 Low risk Unclear High risk Low risk Low risk High risk High quality 
Krupnick 2008 Unclear Unclear High risk High risk High risk High risk Low quality 
Kubany 2003 Unclear Unclear High risk Low risk Low risk High risk High quality 
Kubany 2004 Unclear Unclear High risk Low risk High risk High risk Low quality 
Lindauer 2005 Low risk Unclear High risk Low risk High risk High risk High quality 
Marks 1998 Unclear Unclear High risk Low risk Low risk High risk High quality 
McDonagh 2005 Unclear Unclear High risk Low risk Low risk High risk High quality 
Monson 2006 Unclear Unclear High risk Low risk Low risk High risk High quality 
Mueser 2008 Low risk Low risk High risk Low risk High risk High risk High quality 
Mueser 2015 Low risk Low risk High risk Low risk Low risk Low risk High quality 
Nijdam 2012 Low risk Low risk High risk Low risk High risk Low risk High quality 
Pacella 2012 Low risk Unclear High risk Low risk Low risk High risk High quality 
Power 2002 Low risk Low risk High risk Low risk High risk High risk High quality 
Resick 2002 Unclear Unclear High risk High risk High risk High risk Low quality 
Scheck 1998 Low risk Low risk High risk Low risk High risk High risk High quality 
Steel 2017 Low risk Low risk High risk Low risk Low risk Low risk High quality 
Suris 2013 Low risk Low risk High risk Low risk High risk High risk High quality 
Talbot 2014 Low risk Low risk High risk Low risk Low risk High risk Low quality 
ter Heide 2011 Low risk Unclear High risk High risk High risk High risk High quality 
ter Heide 2016 Low risk Unclear High risk Low risk Low risk Low risk High quality 
van den Berg 
2015 
Low risk Low risk High risk Low risk Low risk Low risk High quality 
 
 
 
 
 
 
 
 
 
 
H.        Table H.1. Risk of Bias in Included Studies – Detailed 
 
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
Ahmadi 2015  Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Not reported. “The drop-out rate 
from the study was 
also high 
comprising over 
31% of the initial 
participants.” No 
follow-up data – 
beyond post-
intervention data. 
Protocol not available. 
Unclear Unclear High risk High risk High risk High risk 
Azad 
marzabadi 
2014 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Not reported. “Two participants 
dropped out in 
each group as the 
study continued 
(due to reasons like 
being discharged 
from the hospital or 
stopping 
participation in the 
study).” 
Protocol not available. 
Unclear Unclear High risk High risk Low risk High risk 
Basoglu 2007 “A computer-
generated sequence 
of random numbers 
that ensured equal 
cell sizes and did not 
lead to allocation of 
more than two 
consecutive cases to 
the same 
experimental 
Not reported.  Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“The assessors were 
blind as to the 
participants’ 
experimental 
condition at the week 
4 and week 8 
assessments.” 
Only four non-
completer cases, 
and ITT was used. 
Protocol not available. 
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
condition was used in 
the randomization.” 
Low risk Unclear High risk Low risk Low risk High risk 
Beidel 2011 Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Not reported (for the 
relevant assessments). 
5 of the 35 
participant did not 
complete the 
intervention and 
then another 5 did 
not complete the 
relevant post-
intervention 
assessments. ITT 
was used. 10/35 = 
29%. No follow-up 
data – beyond post-
intervention data. 
Protocol not available.  
Unclear Unclear High risk High risk High risk High risk 
Beidel 2019 Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
“Participants were 
randomized to either 
TMT or EXP prior to 
initiating treatment. 
However, clinicians 
and participants were 
blinded to group 
assignment until VRET 
and the mid-treatment 
assessment were 
completed.” 
Not reported. “The overall 
dropout rate was 
39%, consistent 
with other clinical 
trials examining 
treatment for 
combat-related 
PTSD (Reger et al., 
2016; Resick et al., 
2015). The dropout 
rate was 28% for 
TMT and 50% for 
EXP, which was 
not signiﬁcantly 
diﬀerent (χ2 = 
2.14, df = 91, p < 
0.14).” 
Protocol not available.  
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
Unclear Unclear High risk High risk High risk High risk 
Bryant 2013 “Randomization was 
conducted by a 
process of 
minimization 
stratiﬁed on gender, 
trauma type and 
Clinician 
Administered PTSD 
Scale-2 (CAPS-2; 
Blake et al. 1995) 
total score. 
Participants were 
randomly assigned 
according to a 
random numbers 
system administered 
by an individual who 
was independent of 
the study and who 
worked at a site that 
was distant from the 
treatment centre.” 
Distance randomisation 
– “Participants were 
randomly assigned 
according to a random 
numbers system 
administered by an 
individual who was 
independent of the 
study and who worked 
at a site that was 
distant from the 
treatment centre.” 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“Post-treatment and 
6-month follow-up 
assessments were 
conducted by 
independent clinicians 
who were unaware of 
the treatment 
condition of 
participants. Blindness 
was maintained by 
ensuring that 
clinicians who 
conducted assessments 
did not have access to 
(a) participant notes 
or (b) condition 
allocation of 
participants.” 
“Of the 
participants, 51 
(73%) completed 
treatment and 32 
(46%) completed 
the 6-month follow-
up assessment.” 
Protocol not available.  
Low risk Low risk High risk Low risk High risk High risk 
Butollo 2016 
 
 
 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“The IES-R  [36] , a 
self-report instrument 
that measures the 
intensity of PTSD 
symptoms, was our 
primary outcome 
measure. It was 
administered by the 
therapist before each 
session as a process 
“Drop-out rates at 
the posttreatment 
assessment were 
12.2% for DET 
(4.1% of those 
allocated to DET 
did not start 
treatment, 8.1% 
dropped out of 
treatment) and 
Protocol not available.  
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
measure, as well as 
before and after 
treatment and at the 
follow-up.” 
14.9% for CPT 
(6.0% declined 
treatment after 
allocation, 9.0% 
dropped out of 
treatment). At the 
6-month follow-up, 
study drop-out 
rates were 
markedly higher, 
increasing the 
overall study 
dropout to 47.3% 
in the DET and 
37.3% in the CPT 
condition.” 
Unclear Unclear High risk High risk Low risk High risk 
Cloitre 2002 Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Clinician raters of the 
CAPS (PTSD 
measure) were blind to 
treatment condition at 
pre- and 
posttreatment. No 
reference to any 
blinding (e.g., re 
scoring) the NMR and 
IIP.  
“Of the 58 women 
who entered 
treatment, 12 
dropped out: 9 
from the active 
treatment (29%) 
and 3 from the wait 
list (11%).” This is 
<25% overall.  
Protocol not available.  
Unclear Unclear High risk Low risk Low risk High risk 
Difede 2007 Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Not reported. “Our dropout rate 
of 40% was higher 
than the typical 
exposure therapy 
study for PTSD, 
where dropouts are 
Protocol not available.  
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
reported in the 
20% to 30% 
percent range 
(Bradley et al., 
2005).” Also, 
>30% dropped out 
of the allocated 
intervention.  
Unclear Unclear High risk High risk High risk High risk 
Dorrepaal 
2012 
“The randomization 
was performed 
independently on a 1:   
1 basis, stratified per 
site, by a 
methodologist not 
involved in the study. 
Condition 
assignments were e-
mailed to the group 
leader, who then 
informed the patient 
without informing the 
researchers or 
assessors.” No more 
relevant information.  
“The randomization 
was performed 
independently on a 1:   
1 basis, stratified per 
site, by a methodologist 
not involved in the 
study. Condition 
assignments were e-
mailed to the group 
leader, who then 
informed the patient 
without informing the 
researchers or 
assessors.” 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“The interviews were 
conducted by trained 
independent assessors, 
who were blind to the 
treatment condition 
and were audiotaped 
for use in 
supervision.” 
Attrition was 16%.  Protocol not available.  
Unclear Low risk High risk Low risk Low risk High risk 
Duffy 2007 Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Not reported. 21% dropped out.  Protocol not available.  
Unclear Unclear High risk High risk Low risk High risk 
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
Dunn 2007 “The study 
statistician (J. 
Souchek [J.So.]) 
provided 
randomization 
numbers and group 
assignments from a 
list generated by the 
PLAN procedure in 
SAS, version 6.11. We 
randomized in blocks 
of two, in the order of 
participants’ 
enrollment, to 
facilitate equal 
participant numbers 
in each group.” 
The list of random 
numbers provided 
could suggest that 
investigators could 
possibly foresee 
assignments.  
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“Interviewers were 
blind to participants’ 
therapy group 
assignments 
throughout the study.” 
30% of those 
allocated to the 
interventions did 
not complete them, 
and 41% of those 
allocated to the 
interventions were 
lost to follow-up at 
12 months.  
Protocol not available.  
Low risk High risk High risk Low risk High risk High risk 
Dunne 2012 Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
“Participants in this 
study were also not 
blinded to condition.” 
“Although the use of 
the same assessor for 
the diagnostic 
interview for all 
participants at all 3 
time points is a 
methodological 
strength, this also 
meant the assessor 
was not blinded to the 
treatment condition 
representing a 
potential bias in 
postassessment and 
follow-up 
assessment.” 
“A further strength 
of the study was the 
use of the intent-to-
treat sample for 
data analyses, 
despite the 
relatively low 
attrition in this 
study (9% at 6-mo 
follow-up).” 
Protocol not available.  
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
Unclear Unclear High risk High risk Low risk High risk 
Ehlers 2003 Reference to using 
the random permuted 
blocks within strata 
algorithm.  
Investigators enrolling 
participants could not 
possibly foresee 
assignments as the 
allocation list was kept 
locked in a central 
office and the patient’s 
allocation was only 
revealed three weeks 
later – following the 
self-monitoring 
assessment.  
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Independent assessors, 
blind to treatment 
condition, 
administered the 
CAPS. No reference to 
how the SDS (which is 
a self-report measure) 
was scored.  
Attrition was < 
25%.  
Protocol not available.  
Low risk Low risk High risk Low risk Low risk High risk 
Ehlers 2005 Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Independent assessors, 
blind to treatment 
condition, 
administered the 
CAPS. No reference to 
how the SDS (which is 
a self-report measure) 
was scored.  
No patient dropped 
out.  
Protocol not available.  
Unclear Unclear High risk Low risk Low risk High risk 
Ehlers 2014 “The participants 
were then randomly 
allocated to one of 
the four trial 
conditions by an 
independent 
researcher who was 
not involved in 
assessing patients 
using the 
minimization 
“The participants were 
then randomly 
allocated to one of the 
four trial conditions by 
an independent 
researcher who was 
not involved in 
assessing patients 
using the minimization 
procedure (15) to 
stratify for sex and 
“Participants were not 
blind to the nature of 
the treatment, but care 
was taken to create 
similarly positive 
expectations in each 
treatment group by 
informing them that 
several psychological 
treatments were 
effective in PTSD and it 
“The assessments of 
treatment outcome 
were conducted by 
independent 
evaluators without 
knowledge of the 
patient’s treatment 
condition. Patients 
were asked not to 
reveal their group 
Attrition was < 
25%.  
Protocol not available.  
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
procedure (15) to 
stratify for sex and 
severity of PTSD 
symptoms. The 
assessors 
determining the 
suitability of a patient 
for inclusion were not 
informed about the 
stratiﬁcation 
variables and 
algorithm.” 
severity of PTSD 
symptoms. The 
assessors determining 
the suitability of a 
patient for inclusion 
were not informed 
about the stratiﬁcation 
variables and 
algorithm.” 
was unknown which 
worked best, and by 
giving a detailed 
rationale for the 
treatment condition to 
which the patient was 
allocated.” 
assignment to the 
evaluators.” 
Low risk Low risk High risk Low risk Low risk High risk 
Foa 1999 Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Assessors were 
unaware of treatment 
assignment.  
17.7 dropped out 
altogether; 
although drop-out 
were not spread 
evenly throughout 
the groups – 8% 
dropped out of the 
PE group, 27% of 
the SIT group, 27% 
of the PE-SIT 
group, 0% of the 
WL group. ITT 
was used. 
Protocol not available.  
Unclear Unclear High risk Low risk Low risk High risk 
Foa 2005 Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“Independent 
evaluations were 
conducted at 
pretreatment and 
posttreatment and 3-, 
6-, and 12-month 
posttreatment. All 
“The overall 
dropout rate was 
32.4% and was 
lower for WL 
(3.8%) than PE/CR 
(40.5%)… and PE 
(34.2%)” These 
Protocol not available.  
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
evaluations were 
conducted by trained 
doctoral or master’s 
level CTSA clinicians 
who were blind to 
study condition.” 
were not available 
for post-
intervention 
assessment.  
Unclear Unclear High risk Low risk High risk High risk 
Forbes 2012 A random number 
ordered list was used.  
After full assessment 
by an independent 
clinical assessor, 
participants were 
randomised by the 
project manager at an 
independent research 
centre.  
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Assessors were blind 
to allocation and 
treatment.  
20% did not 
complete the post-
intervention 
assessment and 
31% did not 
complete the 3 
month follow-up 
(which is a short-
term follow-up. 
Protocol not available.  
Low risk Low risk High risk Low risk Low risk High risk 
Ford 2011 “One hundred forty 
six women (ages 18–
45; M=30.7, SD=6.9) 
completed the 
screening and 
baseline assessment 
and then were 
randomized (by a 
study assessor using 
numbers concealed in 
sealed envelopes 
previously prepared 
by a different study 
staff member using 
the Excel random 
number generator) to 
WL (N=45), TARGET 
“One hundred forty six 
women (ages 18–45; 
M=30.7, SD=6.9) 
completed the 
screening and baseline 
assessment and then 
were randomized (by a 
study assessor using 
numbers concealed in 
sealed envelopes 
previously prepared by 
a different study staff 
member using the 
Excel random number 
generator) to WL 
(N=45), TARGET 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“All interviewers were 
blind to the 
experimental 
condition in baseline 
interviews, but due to 
technical difficulties 
they were not blind to 
experimental 
condition at 
posttherapy or follow-
up interviews.” 
32% of those 
allocated to 
treatment did not 
complete the post-
intervention 
assessment.  
Protocol not available.  
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
(N=48), or PCT 
(N=53).” 
(N=48), or PCT 
(N=53).” 
Low risk Low risk High risk High risk High risk High risk 
Galovski 2012 “If eligible, 
participants were 
randomly assigned in 
a 1:1 ratio using 
computer generated 
simple randomization 
to MCPT or to SMDT 
following the pre-
treatment 
assessment.” 
No more relevant 
information other than 
what is in the previous 
column.  
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“Finally, because it is 
technically possible to 
remain PTSD positive 
with a score of 20 on 
the PDS and reporting 
bias can exist in the 
therapy situation (e.g., 
patient wants to please 
therapist), a blind 
rater conducted the 
CAPS to ensure that 
the participant no 
longer met criteria for 
PTSD.” The other 
relevant measures 
were self-report, and 
no reference to any 
blind scoring of these. 
27% of those 
randomised did not 
complete an 
assessment at the 
time of the 
completion of the 
CBT intervention.  
Protocol not available.  
Low risk Unclear High risk Low risk High risk High risk 
Ghafoori 2017 A pre-determined, 
computer-generated, 
randomised list was 
used.  
No more relevant 
information other than 
what is in the previous 
column.  
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Outcome assessors 
were not blind to 
participant 
assignments.  
More than half of 
the sample 
terminated 
prematurely before 
completion of the 
treatment, and 
follow-up 
assessment time 
points were 
included.  
Protocol not available.  
Low risk Unclear High risk High risk High risk High risk 
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
Harned 2014 “A minimization 
randomization 
procedure was used.” 
No more relevant 
information other than 
what is in the previous 
column.  
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“All assessments were 
conducted by 
independent clinical 
assessors who were 
blind to treatment 
condition.” 
“Completion rates 
for the one year of 
treatment did not 
differ between 
conditions 
(DBT=55.6%, DBT 
+ DBT 
PE=58.8%).” 
Protocol not available.  
Low risk Unclear High risk Low risk High risk High risk 
Hinton 2009 Coin was tossed.  No more relevant 
information other than 
what is in the previous 
column.  
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Outcome assessor was 
blind to treatment 
condition.  
“All 24 randomized 
patients completed 
the study, and there 
were no missing 
data.” 
Protocol not available.  
Low risk Unclear High risk Low risk Low risk High risk 
Hinton 2011 Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
All assessments were 
self-report, although it 
does not clarify 
whether or not these 
were scored blind.  
“There was no 
missing data.” 
Protocol not available.  
Unclear Unclear High risk High risk Low risk High risk 
Hogberg 2007 No more relevant 
information other 
than what is in the 
next column. 
“The randomization 
was done by picking a 
sealed ballot in the 
presence of a research 
nurse who coordinated 
the study and followed 
the participants 
through all phases.” 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Not reported. “Three subjects 
dropped out after 
randomization but 
before 
treatment/WL. One 
of them had a 
strong aversive 
reaction to the 
SPECT 
examination and 
decided to interrupt 
Protocol not available.  
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
the examination. 
Two other subjects 
left the study 
because of 
difficulty with 
finding time for the 
study.” 5/24 = 
21%. 
Unclear Low risk High risk High risk Low risk High risk 
Hollified 2007 “Before enrolling 
participants, 90 study 
ID numbers were 
prerandomized to 
study group 
(acupuncture, CBT or 
WLC) by the research 
coordinator (RC) 
using a computerized 
random numbers 
procedure without 
restrictions.” 
“When a participant 
was enrolled, the RC 
opened the assignment 
program to reveal the 
participant’s group 
assignment. This 
allocation procedure 
was concealed from 
clinicians.” 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“The research 
coordinator collected, 
entered, and helped 
analyze the data. 
Although he was 
aware of participant 
group allocation at the 
time he collected data, 
he did not assist 
participants in 
completing the self-
rated assessments. It is 
possible, yet we think 
quite unlikely, that he 
could have 
systematically 
inﬂuenced participant 
reports.” 
“Eighty-four 
participants were 
randomized, 73 
began the protocol, 
and 61 (73% of 
those randomized 
and 84% of those 
who began the 
protocol 
(acupuncture 79% 
vs. CBT 84% vs. 
WLC 88%) 
completed 
treatment or wait-
list assessments. 
End treatment and 
3-month follow-up 
assessments were 
obtained for 60 and 
58 participants, 
respectively.” 
24/84 = 29%.  
Protocol not available.  
Low risk Low risk High risk High risk High risk High risk 
Jung 2013 Randomisation was 
referred to, but there 
Randomisation was 
referred to, but there 
Blinding of participants 
is generally not possible 
The PDS and RSES 
(the relevant 
“34 participants 
were randomly 
Protocol not available.  
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
was no more relevant 
information. 
was no more relevant 
information. 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
measures) were self-
report, but there is no 
reference to these 
being blindly scored.  
assigned to either 
the CRIM group (n 
= 17) or WL group 
(n = 17). Two 
patients in each 
condition decided 
against treatment 
after randomization 
and were defined 
as nonstarters. 
Further, 2 patients 
(1 in each 
condition) were 
excluded from the 
study due to 
protocol violations, 
specifically, 
because they had 
received further 
psychological 
treatment while 
participating in the 
study. No patient 
dropped out of 
treatment.” 6/34 = 
18%.  
Unclear Unclear High risk High risk Low risk High risk 
Keane 1989 Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“Post-test assessments 
for the Wait-list 
Control were 
conducted either by 
the therapist who 
would then treat the 
patient or, in the case 
of patients to be 
No reference to any 
missing data at 
post-assessment.  
“The original design of 
this study involved random 
assignment of subjects to 
the implosive therapy 
group, a stress 
management group 
wherein subjects were 
taught behavioral skills to 
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
treated elsewhere, by 
an unsystematically 
assigned therapist 
from the four in- 
volved in the study.” 
re- duce anxiety but 
exposure to traumatic 
memories was limited, and 
the waiting list control. 
Only 5 subjects completed 
the stress management 
condition, and thus, these 
data are not included in 
the present manuscript.” 
Unclear Unclear High risk High risk Low risk High risk 
Kip 2013 “Eligible service 
members/veterans 
were randomly 
assigned to the ART 
or AC regimen in a 
1:1 ratio using a 
random number 
generator and 
variable blocking 
scheme (blocks of 4, 
6, and 8).” 
No more relevant 
information other than 
what is in the previous 
column.  
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“Random assignment 
was unblinded; hence, 
the potential existed 
for over-reporting of 
reductions in pain 
with the ART 
intervention.” 
Attrition was 
<25%.  
“The trial was registered 
with ClinicalTrials.gov 
(NCT01559688).” The 
relevant PTSD measure 
was reported as the 
primary outcome in this 
protocol.  
Low risk Unclear High risk High risk Low risk Low risk 
Krakow 2001 “To mask treatment 
assignment, patients 
mailed back a 
postcard after intake 
to complete entry into 
the protocol. The 
postcard’s time and 
date were logged into 
a computer and 
entered into a 
previously generated 
list of numbers that 
No more relevant 
information other than 
what is in the previous 
column.  
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“To limit external 
bias, blinding 
occurred at 3 points of 
data collection: (1) at 
intake, group 
assignment had not 
been established; (2) 
at 3-month follow-up, 
questionnaires were 
completed through the 
mail; and (3) at 6-
month follow-up, 
“Of the 168 
randomized 
participants, 96 
completed 3-month 
follow-ups by mail, 
and 99 completed 
the 6-month follow-
ups in person. In 
total, 114 
individuals 
completed at least 
1 follow-up, and 77 
Protocol not available.  
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
randomly assigned 
participants to 
treatment and control 
groups. All numbers 
and group 
assignments were 
generated at the start 
of the protocol.” 
interviewers were 
unaware of group 
status.” 
participants 
completed both 
follow-ups.” 
Low risk Unclear High risk Low risk Low risk High risk 
Krupnick 
2008 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Not reported. “At termination, we 
obtained 
assessments for 
only 20 (out of 32) 
treatment and 7 
(out of 16) control 
participants. These 
figures increased to 
26 treatment and 
10 control 
participants for the 
4-month follow-up 
interview.” 
Therefore, attrition 
at termination was 
>25%.  
Protocol not available.  
Unclear Unclear High risk High risk High risk High risk 
Kubany 2003 Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
The assessors (of the 
CAPS; the PTSD 
measure) were blind to 
participants’ condition 
assignments. The 
RSES was also used, 
but this is a self-report 
measure and there is 
“Eighteen of 19 
women assigned to 
the Immediate 
CTT-BW condition 
completed CTT-
BW. Fourteen of 18 
women assigned to 
the Delayed CTT-
Protocol not available.  
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
no reference to this 
being blindly scored.  
BW condition 
completed CTT-
BW. Overall, 86% 
of the 37 women 
who started CTT-
BW (n = 32) 
completed 
treatment.” It 
appears these 
participants also 
completed the 
assessment at the 
time of the 
completion of 
Immediate CTT-
BW condition; 
therefore there was 
<25% attrition. Re 
follow-ups, “three-
month follow-up 
data was obtained 
for 78% of the 
women who 
completed 
Immediate CTT-
BW (n = 14) and 
for 79% of the 
women who 
completed Delayed 
CTT- BW (n = 
11).” 
Unclear Unclear High risk Low risk Low risk High risk 
Kubany 2004 Randomisation was 
referred to, but there 
Randomisation was 
referred to, but there 
Blinding of participants 
is generally not possible 
due to the nature of 
The assessors (of the 
CAPS; the PTSD 
measure) were blind to 
Posttreatment 
assessment data 
were only available 
Protocol not available.  
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
was no more relevant 
information. 
was no more relevant 
information. 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
participants’ condition 
assignments. The 
RSES was also used, 
but this is a self-report 
measure and there is 
no reference to this 
being blindly scored.  
for 84 of 125 
randomised 
participants; there 
attrition was >25%.  
Unclear Unclear High risk Low risk High risk High risk 
Lindauer 2005 “A colleague who 
had done no 
assessments used a 
computer program to 
randomly assign 12 
patients to each 
condition in a block 
design.” 
No more relevant 
information other than 
what is in the previous 
column.  
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“Each patient was 
assessed by a 
researcher (R.J.L.L. or 
E.P.M.M.), who were 
blind to all patients’ 
condition.” 
“In the per-
protocol analysis 
(patients who 
completed the 
treatment), the 
sample sizes were 7 
(58%) for the 
treatment group 
and 11 (92%) for 
the waitlist group”. 
Attrition = 25%. 
Protocol not available.  
Low risk Unclear High risk Low risk High risk High risk 
Marks 1998 
 
 
 
 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“Assessors were kept 
unaware of the 
treatment condition.” 
“Ten subjects 
(11%) dropped out 
but they did not 
differ signiﬁcantly 
by group.” 
Protocol not available.  
Unclear Unclear High risk Low risk Low risk High risk 
McDonagh 
2005 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“A separate group of 
female clinicians, who 
were blind to 
treatment condition 
and who had no other 
role in the study 
“The dropout rate 
for the study was 
23%, with a rate of 
41% (12 of 29) for 
CBT, 9% (2 of 22) 
for PCT, and 13% 
(3 of 23) for WL.” 
Protocol not available. 
Moreover, the following 
suggests a deviation from 
the protocol: “When it 
became clear that the 
dropout rate was greater 
for CBT, we changed the 
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
conducted the four 
CAPS interviews.” 
random assignment 
process to increase the 
chance of assignment to 
CBT.” 
Unclear Unclear High risk Low risk Low risk High risk 
Monson 2006 Randomisation was 
referred to, but there 
was no more relevant 
information. 
“The study 
biostatistician provided 
the participants’ 
condition assignment 
to the study 
coordinator.” This 
does not necessarily 
suggest allocation 
concealment.  
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“The independent 
clinician assessors 
were blinded to 
condition assignment 
and participants were 
instructed to not 
disclose their 
condition assignment 
to them.” 
“The overall drop-
out rate was 16.6% 
(20% from CPT, 
13% from the wait-
list condition).” 
Protocol not available.  
Unclear Unclear High risk Low risk Low risk High risk 
Mueser 2008 “Randomization was 
conducted at a 
central location in 
the research center 
by a computer based 
randomization 
program with 
assignments not 
known in advance by 
either clinical or 
research staff…” 
“Randomization was 
conducted at a central 
location in the research 
center by a computer 
based randomization 
program with 
assignments not known 
in advance by either 
clinical or research 
staff…” 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“Assessments were 
conducted by blinded 
interviewers at 
baseline, following the 
4-6 months treatment 
period for the CBT 
program, and 3- and 
6-months later.” 
Only 59/108 were 
analysed at post-
treatment.  
Protocol not available.  
Low risk Low risk High risk Low risk High risk High risk 
Mueser 2015 “Participants were 
randomised to the 
CBT or brief groups 
via a computer 
program operated by 
an off-site data 
manager, with no 
“Participants were 
randomised to the CBT 
or brief groups via a 
computer program 
operated by an off-site 
data manager, with no 
study personnel aware 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“All interviewers were 
masked to treatment 
assignment.” 
20% of randomised 
participants were 
not analysed at 
post-treatment. 
“All study procedures 
were approved by the 
Rutgers and Dartmouth 
Institutional Review 
Boards (trial registration: 
clinicaltrials.gov 
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
study personnel 
aware of assignments 
in advance.” 
of assignments in 
advance.” 
identifier: 
NCT00494650).” 
Low risk Low risk High risk Low risk Low risk Low risk 
Nijdam 2012 “Random assignment 
was done on a 1:1 
basis by a computer 
program, with a 
weighted maximum of 
subscribing four 
times the same 
treatment in a row.” 
“To ensure masking of 
assessors, one 
psychologist who had 
no other engagement in 
the study, had access to 
the computer program, 
kept a log file of all 
random assignments 
and assigned the 
patients to the 
therapists.” 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“Assessments were 
conducted by trained, 
independent, masked 
assessors who were 
master’s level clinical 
psychologists or 
master’s level 
psychology students 
supervised by an 
experienced clinical 
psychologist.” 
32% of randomised 
participants were 
lost to the first 
post-assessment.  
“Trial registration: Dutch 
Trial Register, number 
NTR46 and 
ISRCTN64872147.” 
Low risk Low risk High risk Low risk High risk Low risk 
Pacella 2012 “The principal 
investigator (DLD) 
generated the 
allocation sequence 
using blocked 
randomization (4:3 
ratio of 
experimental:control 
participants).” 
No more relevant 
information other than 
what is in the previous 
column.  
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“The graduate student 
conducting the 
assessments remained 
blind to group 
membership.” 
“At the post-
intervention 
assessment, 23 
participants were 
retained in the PE 
group (32% drop-
out rate) and 24 
participants were 
retained in the 
control group (0% 
drop-out rate).” It 
also says: 
“Unequal numbers 
of participants 
were assigned to 
each group, as it 
was anticipated 
that the PE group 
Protocol not available.  
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
would have a 
higher dropout 
rate.” 
Low risk Unclear High risk Low risk Low risk High risk 
Power 2002 “Randomization was 
by means of a 
predetermined 
schedule unbeknown 
to the assessors, 
therapists or 
patients.” 
“Following completion 
of the entire initial 
assessment, for those 
patients who met entry 
criteria, the blind 
assessor then opened a 
sealed envelope that 
informed as to which 
group patients were to 
be allocated.” 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“Assessments pre- and 
post-treatment were 
conducted by two 
independent assessors 
respectively, who were 
blind to treatment 
conditions.” 
“A total of 105 
patients met entry 
criteria and were 
randomized to 
groups as follows: 
39 to EMDR, 37 to 
ECCR and 29 to 
WL. Drop-out rates 
between these three 
groups were as 
follows, 12 (31%) 
from EMDR, 16 
(43%) from E+CR 
and ﬁve (17%) 
from WL.” 
Protocol not available.  
Low risk Low risk High risk Low risk High risk High risk 
Resick 2002 Randomisation was 
referred to, but there 
was no more relevant 
information. 
Randomisation was 
referred to, but there 
was no more relevant 
information. 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Not reported. Attrition was > 
25%.  
Protocol not available.  
Unclear Unclear High risk High risk High risk High risk 
Scheck 1998 “Envelopes filled 
with papers labeled 
either EMDR or AL 
were shuffled and 
numbered 1 though 
100.” 
“During each 
interview, envelopes 
were opened 
consecutively to 
identify which therapy 
was to be assigned to 
the participant.” 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“During the post-test 
assessment, a trained 
volunteer who was 
blind to group 
assignment 
administered the 
29% dropped out.  Protocol not available.  
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
standardized instru- 
ments”. 
Low risk Low risk High risk Low risk High risk High risk 
Steel 2017 “Block 
randomization was 
conducted 
independently of the 
research team 
through the 
OpenCDMS database 
speciﬁcally developed 
for the study.” 
“Block randomization 
was conducted 
independently of the 
research team through 
the OpenCDMS 
database speciﬁcally 
developed for the 
study.” 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“Robust procedures 
were adopted to 
minimize the risk of 
interviewers being 
able to identify the 
group allocation of 
participants…” 
50/61 were 
analysed at post-
treatment.  
“The trial was given 
ethical approval by 
Berkshire Research Ethics 
Committee (SC/09/ 
H0505/85) and was 
registered as ISTCRN 
67096137.” 
Low risk Low risk High risk Low risk Low risk Low risk 
Suris 2013 “For the purpose of 
randomization, 
participants were 
assigned sequential 
PIN numbers as they 
entered the study. 
Blocks of random 
numbers were 
generated for each 
therapist, and were 
allocated to either 
CPT or PCT using a 
conditional 
statement.”  
“The random number 
sequence was 
maintained on an Excel 
spreadsheet, and as 
subjects’ PINs were 
entered into the 
spreadsheet, the 
preassigned condition 
was revealed.” 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Assessors were blind 
to treatment condition. 
“Excluding data 
from this therapist 
reduced the ﬁnal 
sample to 86 
participants from 
the original 129.” 
This study has a high risk 
of reporting bias as lots of 
participants were removed 
from the analysis due to 
low treatment fidelity of a 
certain clinician. 
Low risk Low risk High risk Low risk High risk High risk 
Talbot 2014 “Blind assignment 
was determined by a 
computer generated 
random allocation 
schedule operated by 
“Group allocation was 
provided to the study 
coordinator in opaque, 
sealed envelopes that 
were opened by the 
study coordinator with 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“Clinical interviewers 
and the 
polysomnography 
technician were blind 
to participants’ 
treatment conditions 
Only 16% in total 
were lost to follow-
up. 
Protocol not available.  
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
the study 
statistician.” 
the participant 
following the 
completion of baseline 
measures.” 
during both 
pretreatment and 
posttreatment 
administration and 
scoring.” 
Low risk Low risk High risk Low risk Low risk High risk 
ter Heide 2011 Coin was tossed.  No more relevant 
information.  
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
The relevant measures 
were self-report and 
there is no reference to 
these being blindly 
scored. Re the 
clinician administered 
measure – “blindness 
was maintained only 
in 70% of SCID 
interviews, thus 
threatening the 
reliability of clinician 
rated outcomes.”  
10/20 (50%) 
dropped out.  
Protocol not available.  
Low risk Unclear High risk High risk High risk High risk 
ter Heide 2016 Coin was tossed.  No more relevant 
information.  
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
“Interviews were 
administered by 
trained Master’s 
students in psychology 
who were kept masked 
to treatment condition 
by having limited 
access to participant 
data and by asking 
participants not to 
reveal treatment 
content.” 
Attrition was 
<25%. 
“Trial registration: 
NARCIS (Dutch National 
Academic Research and 
Collaborations 
Information System) 
OND1324839; 
ISRCTN20310201.” 
Low risk Unclear High risk Low risk Low risk Low risk 
Study Selection Bias: 
random sequence 
generation 
Selection Bias: 
allocation 
concealment 
Performance Bias: 
blinding of 
participants and 
personnel 
Detection Bias: 
blinding of 
assessments 
 
Attrition Bias: 
incomplete 
outcome data 
Reporting Bias: selective 
outcome reporting 
van den Berg 
2015 
“An independent 
randomization 
bureau randomized 
the treatment 
condition using 
stratified 
randomization blocks 
per therapist with 
equal strata sizes.” 
“An independent 
randomization bureau 
randomized the 
treatment condition 
using stratified 
randomization blocks 
per therapist with 
equal strata sizes.” 
Blinding of participants 
is generally not possible 
due to the nature of 
psychological trials. 
Nothing in this trial to 
suggest otherwise. 
Assessors were blind 
to treatment 
allocation.  
Attrition was 
<25%. 
“The trial design was 
approved by the medical 
ethics committee of the VU 
University Medical Center 
and was registered at 
isrctn.com 
(ISRCTN79584912).” 
Low risk Low risk High risk Low risk Low risk Low risk 
 
I.        GRADE Assessment Criteria 
 
We applied the following criteria for downgrading to each outcome.  
 
Risk of Bias 
If >50% of studies had a low overall quality rating, the quality of the outcome was downgraded by 1. If >75% of studies had a low overall quality 
rating, the quality of the outcome was downgraded by 2. 
 
Imprecision 
We downgraded an outcome for imprecision by 1 point if “a recommendation or clinical course of action would differ if the upper versus the 
lower boundary of the CI represented the truth” and/or the number of events and sample size meant the optimal information size was not reached 
(Guyatt et al., 2011). We downgraded by 2 points if an analysis was based on only 1-2 studies. 
 
Inconsistency  
We downgraded an outcome for inconsistency by 1 point if the I2 statistic was ≥40% in the context of an unclear direction of effect or ≥75% in 
the context of a clear direction of effect. We downgraded by 2 points if the I2 statistic was ≥75% in the context of an unclear direction of effect.  
 
Publication Bias 
We downgraded an outcome for publication bias by 1 point when, for outcomes with at least 10 studies (Higgins & Green, 2011), the funnel-plots 
showed asymmetry and this was not better explained by selective reporting bias or some other factor. However, if the ‘trim and fill’ method 
indicated that any publication bias was not likely to affect the overall magnitude of the effect size, we did not downgrade. 
 
Indirectness 
Indirectness was assessed by considering the relevance of the outcome data to the construct of interest for each outcome, together with that of the 
study population, nature of the intervention under investigation and the control condition.  
 
 
 
 
 
 
 
J.        Table J.1. Other Comparisons 
 
Studies Outcome Comparison 
(A vs B) 
k 
included 
studies 
Group A 
N 
Group B 
N 
Hedges’ g (95% 
CI), p-value 
Heterogeneity, 
I2, p-value 
Quality 
(GRADE) 
Versus TAU/WL 
Krupnick 2008 PTSD + DR IPT vs WL 1 32 16 -1.02 (-1.65, -
0.39), 0.002 
- Very low 
-2 RoB 
-2 
imprecision 
Azad 
marzabadi 
2014 
DR Mindfulness vs 
TAU 
1 14 14 -1.60 (-2.43, -
0.77), <0.001 
- Very low 
-2 RoB 
-2 
imprecision 
Head-to-head comparisons 
Beidel 2011 PTSD, DR & 
AD 
TMT vs 
exposure 
1 14 16 -0.09 (-0.79, 
0.61), 0.801 
- Very low 
-2 RoB 
-2 
imprecision 
Beidel 2019 PTSD & DR TMT vs 
exposure 
1 43 49 -0.05 (-0.46, 
0.36), 0.815 
- Very low 
-2 RoB 
-2 
imprecision 
Butollo 2016 PTSD & NSC DET vs CBT 1 66 72 0.27 (-0.07, 0.60), 
0.118 
- -Very low 
-2 RoB 
-2 
imprecision 
Bryant 2013 PTSD & NSC CBT + ERT vs 
CBT + SC 
1 36 34 -0.04 (-0.51, 
0.43), 0.866 
- Low 
-2 
imprecision 
Studies Outcome Comparison 
(A vs B) 
k 
included 
studies 
Group A 
N 
Group B 
N 
Hedges’ g (95% 
CI), p-value 
Heterogeneity, 
I2, p-value 
Quality 
(GRADE) 
Harned 2014 PTSD & NSC DBT + 
Exposure vs 
DBT 
1 12 6 0.51 (-0.43, 1.45), 
0.291  
- Low 
-2 
imprecision 
ter Heide 
2011,  
ter Heide 2016 
PTSD & DR EMDR vs 
STBT 
2 36 34 -0.16 (-0.61, 
0.29), 0.486 
0%, 0.360 Low 
-2 
imprecision 
Abbreviations: AD=affect dysregulation; CBT=cognitive behavioural therapy; DBT=dialectical behaviour therapy; DET=dialogical exposure therapy; DR=disturbances in 
relationships; EMDR=eye-movement and desensitisation and reprocessing therapy; ERT=emotion regulation training; IPT=interpersonal psychotherapy; NSC=negative self-
concept; PTSD=posttraumatic stress disorder; SC=supportive counselling; STBT=stabilisation treatment; TAU=treatment as usual; TMT=trauma management therapy; 
WL=waiting list.  
  
K.        Table K.1. Clinically Significant Response (number needed to treat per control group event rate) 
 
Treatment 
 
 
 
Comparator Outcome 
 
 
g (95% CI), p-value 10% CER* 22% CER* 50% CER* 
CBT vs TAU/WL DR -0.66 (-0.84, -0.48), <0.001 6B (4B, 9B) 4B (3B, 6B) 4B (3B, 5B) 
CBT vs control DR -0.32 (-0.60, -0.03), 0.029 15B (7B, 186B) 9B (5B, 111B) 8B (4B, 84B) 
CBT vs TAU/WL AD -1.42 (-2.20, -0.65), <0.001 2B (1B, 6B) 2B (1B, 4B) 2B (2B, 4B) 
CBT vs control AD -0.82 (-2.91, 1.26), 0.440  5B (1B, 3H) 3B (1B, 2H) 3B (2B, 3H) 
CBT vs TAU/WL NSC -0.82 (-1.19, -0.44), <0.001 5B (3B,10B) 3B (2B, 7B) 3B (3B, 6B) 
CBT vs control NSC -0.24 (-0.69, 0.21), 0.295 20B (6B, 24H) 13B (4B, 15H) 11B (4B, 12H) 
CBT vs TAU/WL PTSD -0.90 (-1.11, -0.68), <0.001 4B (3B, 6B) 3B (2B, 4B) 3B (3B, 4B) 
CBT vs control PTSD -0.37 (-0.66, -0.09), 0.011 12B (6B 60B) 8B (4B, 36B) 7B (4B, 28B) 
CBT vs TAU/WL PTSD + 1, 2 or 3 -0.81 (-1.00, -0.62), <0.001 5B (3B, 6B ) 3B (3B, 5B) 3B (3B, 4B) 
CBT vs TAU/WL PTSD + 2 or 3 -0.78 (-1.31, -0.24), 0.005 5B (2B, 20B) 4B (2B, 13B) 4B (2B, 11B) 
CBT vs TAU/WL PTSD + 3 -0.53 (-0.96, -0.09), 0.017 8B (4B, 60B) 5B (3B, 36B) 5B (3B, 28B) 
CBT vs control PTSD + 1, 2 or 3 -0.34 (-0.62, -0.06), 0.019 14B (6B, 91B) 9B (5B, 55B) 8B (4B, 42B) 
CBT vs control PTSD + 2 or 3 -    
CBT vs control PTSD + 3 -    
Exposure vs TAU/WL DR -0.59 (-1.12, -0.07), 0.028 7B (3B, 78B) 5B (2B, 47B) 5B (3B, 36B)  
Exposure vs control DR -0.12 (-0.60, 0.37), 0.642 44B (7B, 12H) 27B (5B, 8H) 21B (4B, 7H) 
Exposure vs TAU/WL AD -    
Exposure vs control AD -    
Exposure vs TAU/WL NSC -0.73 (-1.03, -0.43), <0.001 5B (3B, 10B) 4B (3B, 7B) 4B (3B, 6B) 
Exposure vs control NSC -    
Exposure vs TAU/WL PTSD -1.05 (-1.52, -0.58), <0.001 3B (2B, 7B ) 3B (2B, 5B) 3B (2B, 5B) 
Exposure vs control PTSD -0.08 (-0.47, 0.30), 0.675 68B (9B, 16H) 41B (6B 10H) 31B (6B, 8H) 
Exposure vs TAU/WL PTSD + 1, 2 or 3 -0.86 (-1.25, -0.47), <0.001 4B (3B, 9B) 3B (2B, 6B) 3B (3B, 6B) 
Exposure vs TAU/WL PTSD + 2 or 3 -0.56 (-0.99, -0.14), 0.009 7B (4B, 37B) 5B (3B, 23B) 5B (3B, 18B) 
Exposure vs TAU/WL PTSD + 3 -    
Treatment 
 
 
 
Comparator Outcome 
 
 
g (95% CI), p-value 10% CER* 22% CER* 50% CER* 
Exposure vs control PTSD + 1, 2 or 3 -0.19 (-0.57, 0.20), 0.336 27B (7B, 25H) 17B (5B, 16H) 13B (5B, 13H) 
Exposure vs control PTSD + 2 or 3 -    
Exposure vs control PTSD + 3 -    
EMDR vs TAU/WL DR -0.76 (-1.35, -0.16), 0.012 5B (2B, 32B) 4B (2B, 20B) 4B (2B , 16B) 
EMDR vs control DR -0.35 (-1.01, 0.31), 0.312 13B (3B, 15H), 9B (3B, 10H ) 7B (3B, 8H) 
EMDR vs TAU/WL AD -1.64 (-2.56, -0.72), 0.000 2B (1B, 5B ) 2B (1B, 4B) 2B (2B, 4B) 
EMDR vs control AD 0.25 (-0.57, 1.08), 0.548 20H (5B, 3H ) 12H (5B, 2H) 10H (5B, 3H) 
EMDR vs TAU/WL NSC -0.61 (-1.04, -0.17), 0.006 7B (3B , 30B) 5B (3B, 19B) 4B (3B, 15B) 
EMDR vs control NSC -0.78 (-1.56, -0.01), 0.049 4B (2B, 566B) 4B (2B, 336B) 4B (2B, 251B) 
EMDR vs TAU/WL PTSD -1.26 (-2.01, -0.51), 0.001 3B (2B, 8B) 2B (1B, 6B) 3B (2B, 5B) 
EMDR vs control PTSD -0.69 (-1.35, -0.03), 0.041 6B (2B, 186B) 4B (2B, 111B) 4B (2B , 84B) 
EMDR vs TAU/WL PTSD + 1, 2 or 3 -1.15 (-1.92, -0.37), 0.004 3B (2B, 12B) 2B (2B, 8B) 3B (2B, 7B) 
EMDR vs TAU/WL PTSD + 2 or 3 -1.36 (-3.13, 0.42), 0.134 2B (1B, 11H) 2B (1B, 7H) 2 (2B , 6H) 
EMDR vs TAU/WL PTSD + 3 -    
EMDR vs control PTSD + 1, 2 or 3 -0.52 (-0.97, -0.08), 0.020 8B (4B, 68B) 6B (3B, 41B)  5B (3B, 31B) 
EMDR vs control PTSD + 2 or 3 -0.44 (-1.31, 0.43), 0.321 10B (2B, 10H) 7B (2B, 7H)  6B (2B, 6H) 
EMDR vs control PTSD + 3 -    
CBT (T) vs exposure (C) DR 0.07 (-0.26, 0.39), 0.689 78C (19T, 12C)   47C (12T, 8C) 36C (10T, 7C) 
CBT (T) vs exposure (C) AD -    
CBT (T) vs exposure (C) NSC -0.31 (-0.67, 0.04), 0.082 15T (6T, 139C) 10T (4T, 83C) 8T (4T, 63C) 
CBT (T) vs exposure (C) PTSD -0.03 (-0.23, 0.17), 0.784 186T (22T, 
30C) 
111T (14T, 
19C) 
84T (11T, 15C) 
CBT (T) vs exposure (C) PTSD + 1, 2, or 3 -0.04 (-0.27, 0.19), 0.719 139T (18T, 
27C) 
83T (11T, 
17C) 
63T (9T, 13C) 
CBT (T) vs exposure (C) PTSD + 2 or 3 -    
CBT (T) vs exposure (C) PTSD + 3 -    
CBT (T) EMDR (C) DR 0.28 (-0.29, 0.34), 0.338 17C (16T, 14C) 11C (11T, 9C) 9C (9T, 8C) 
Treatment 
 
 
 
Comparator Outcome 
 
 
g (95% CI), p-value 10% CER* 22% CER* 50% CER* 
CBT (T) EMDR (C) AD -    
CBT (T) EMDR (C) NSC -    
CBT (T) EMDR (C) PTSD 0.37 (0.03, 0.71), 0.031 12C (186C, 5C) 8C (111C, 4C) 7C (84C, 4C) 
CBT (T) EMDR (C) PTSD + 1, 2, or 3 0.31 (-0.07, 0.68), 0.111 15C (78T, 6C) 10C (47T, 4C) 8C (36T, 4C) 
CBT (T) EMDR (C) PTSD + 2 or 3 -    
CBT (T) EMDR (C) PTSD + 3 -    
EMDR (T) Exposure (C) DR -0.10 (-0.51, 0.31), 0.640 54T (8T, 15C) 33T (6T, 10C) 25T (5T, 8C) 
EMDR (T) Exposure (C) AD -    
EMDR (T) Exposure (C) NSC 0.16 (-0.25, 0.57), 0.444 32C (20T, 7C) 20C (12T, 
47C) 
16C (10T, 5C) 
EMDR (T) Exposure (C) PTSD 0.10 (-0.28, 0.49), 0.604 54C (17T, 9C) 33C (11T, 6C) 25C (9T, 5C) 
EMDR (T) Exposure (C) PTSD + 1, 2, or 3 0.06 (-0.35, 0.46), 0.789 91C (35T, 9C) 55C (9T, 6C) 42C (7T, 6C) 
EMDR (T) Exposure (C) PTSD + 2 or 3 0.06 (-0.35, 0.46), 0.789 91C (35T, 9C) 55C (9T, 6C) 42C (7T, 6C) 
EMDR (T) Exposure (C) PTSD + 3 -    
IPT vs TAU/WL PTSD + DR -1.02 (-1.65, -0.39), 0.002 3B (2B, 12B) 3B (2B, 8B) 3B (2B, 7B) 
Mindfulness vs TAU/WL DR -1.60 (-2.43, -0.77), <0.001 2B (1B, 5B) 2B (1B, 4B) 2B (2B, 4B) 
TMT (T) Exposure (C) PTSD + DR + AD -0.09 (-0.79, 0.61), 0.801 60T (5T, 7C) 36T (3T, 5C) 28T (4T, 4C) 
TMT (T) Exposure (C) PTSD + DR -0.05 (-0.46, 0.36), 0.815 110T (9T, 13C) 66T (6T, 8C) 50T (6T, 7C) 
DET (T) CBT (C) PTSD + NSC 0.27 (-0.07, 0.60), 0.118 18C (78T, 7C) 11C (47T, 5C) 9C (36T, 4C) 
CBT + ERT (T) CBT + SC (C) PTSD + NSC -0.04 (-0.51, 0.43), 0.866 139T (8T, 10C) 83T (6T, 7C) 63T (5T, 6C) 
DBT + Exp (T) CBT (C) PTSD + NSC 0.51 (-0.43, 1.45), 0.291  8C (10T, 2C) 7C (7T, 2C) 5C (6T, 2C) 
EMDR (T) STBT (C) PTSD + DR -0.16 (-0.61, 0.29), 0.486 32T (7T, 16C) 20T (5T, 11C) 16T (4T, 9C) 
       
Abbreviations: AD=affect dysregulation; CBT=cognitive behavioural therapy; CPTSD=complex posttraumatic stress disorder; CER=control event rate; DBT=dialectical 
behaviour therapy; DET=dialogical exposure therapy; DR=disturbances in relationships; DSO=disturbances in self-organisation; EMDR=eye-movement and desensitisation 
and reprocessing therapy; ERT=emotion regulation training; IPT=interpersonal psychotherapy; NSC=negative self-concept; PTSD=posttraumatic stress disorder; PTSD + 1, 
2 or 3=PTSD + 1, 2 or 3 CPTSD (DSO) outcomes; PTSD + 2 or 3=PTSD + 2 or 3 CPTSD (DSO) outcomes; PTSD + 3=PTSD + all 3 CPTSD (DSO) outcomes; 
SC=supportive counselling; STBT=stabilisation treatment; TAU=treatment as usual; TMT=trauma management therapy; WL=waiting list. *Note: B = benefit; H = harm; T = 
favours T; C = favours C 
  
L.        Table L.1. Meta-regression Moderators (univariate) 
 
Moderator 
(univariate) 
Coefficients (95% CI) R2 or ∆R2 p-value Effects per group Quality 
      
Random sequence 
generation (low vs 
unclear or high risk of 
bias, k=52) 
Unclear risk of bias 
-0.14 (-0.43, +0.16) 
2% 0.358 Low (k=26)  
-0.64 (-0.84, -0.45) 
Unclear (k=26) 
-0.78 (-0.99, -0.56) 
High (k=0) 
Low 
-1 missing 
information 
-1 imprecise 
Allocation 
concealment (low vs 
unclear or high risk of 
bias, k=52) 
Unclear risk of bias 
-0.24 (-0.53, +0.06) 
5% 0.112 Low (k=20) 
-0.57 (-0.79, -0.35) 
Unclear (k=32) 
-0.80 (-0.99, -0.61) 
High (k=0) 
Low 
-1 missing 
information 
-1 imprecise 
Detection bias (low vs 
unclear or high risk of 
bias, k=52) 
High risk of bias 
-0.04 (-0.35, +0.28) 
1% 0.820 Low (k=35) 
-0.69 (-0.87, -0.52) 
Unclear (k=0) 
High (k=17) 
-0.72 (-0.99, -0.47) 
Moderate 
-1 imprecise 
Selective reporting 
bias (low vs unclear or 
high risk of bias, 
k=52) 
High risk of bias 
-0.35 (-0.81, +0.11) 
7% 0.131 Low (k=5) 
-0.39 (-0.82, 0.04) 
Unclear (k=0) 
High (k=47) 
-0.74 (-0.89, -0.59) 
Moderate 
-1 imprecise 
Moderator 
(univariate) 
Coefficients (95% CI) R2 or ∆R2 p-value Effects per group Quality 
      
Attrition bias (low vs 
unclear or high risk of 
bias, k=52) 
High risk of bias 
+0.10 (-0.20, +0.39) 
1% 0.524 Low (k=31) 
-0.65 (-0.87, -0.42) 
Unclear (k=0) 
High (k=21) 
-0.74 (-0.93, -0.55) 
Moderate 
-1 imprecise 
Quality (high quality 
vs low quality, k=52) 
Low quality 
+0.05 (-0.26, +0.35) 
0% 0.754 Low quality (k=20) 
-0.67 (-0.91, -0.44) 
High quality (k=32) 
-0.72 (-0.91, -0.54) 
Moderate 
-1 imprecise 
CPTSD symptoms 
(PTSD alone vs 
various CPTSD, 
k=52) 
PTSD + ER 
-0.57 (-1.44, +0.32) 
PTSD + NC + ID + ER 
-0.03 (-1.01, +0.50) 
PTSD + ID 
-0.20 (-0.92, 0.53) 
PTSD + NC 
-0.11 (-0.85, 0.63) 
PTSD + NC + ID 
-0.26 (-1.11, +0.59) 
 
PTSD + AD 
1% 
PTSD + NSC + DR 
+ AD 
2% 
PTSD + DR 
3% 
PTSD + NSC 
3% 
PTSD + NSC + DR 
7% 
Overall 
7% 
PTSD + AD 
0.215 
PTSD + NSC + DR 
+ AD 
0.955 
PTSD + DR 
0.593 
PTSD + NSC 
0.778 
PTSD + NSC + DR 
0.548 
Overall 
0.741 
PTSD (k=3) 
-0.53 (-1.25, 0.18) 
PTSD + AD (k=4) 
-1.09 (-1.66, -0.53) 
PTSD + NSC + DR + AD 
(k=2) 
-0.55 (-1.27, 0.17) 
PTSD + DR (k=24) 
-0.72 (-0.94, -0.50) 
PTSD + NSC (k=15) 
-0.63 (-0.90, -0.36) 
PTSD + NSC + DR (k=4) 
-0.78 (-1.29, -0.27) 
Moderate 
-1 imprecise 
Comparator 
(TAU/WL vs control, 
k=52) 
Control  
+0.48 (+0.18, +0.77) 
28% 0.001 TAU/WL (k=38) 
-0.83 (-0.99, -0.67) 
Control (k=14) 
-0.35 (-0.60, -0.10) 
Moderate 
-1 imprecise 
Moderator 
(univariate) 
Coefficients (95% CI) R2 or ∆R2 p-value Effects per group Quality 
      
Treatments (individual 
CBT vs others, k=52) 
EMDR  
-0.08 (-0.53, +0.38) 
Exposure  
+0.04 (-0.53, +0.38) 
Group CBT  
+0.42 (-0.15, +0.99) 
Group IPT 
-0.29 (-1.34, +0.75) 
EMDR 1% 
Exposure 0% 
Group CBT 7% 
Group IPT 2% 
Overall 10% 
EMDR 0.736 
Exposure 0.834 
Group CBT 0.150 
Group IPT 0.581 
Overall 0.608 
CBT (k=33) 
-0.73 (-0.91, -0.54) 
EMDR (k=7) 
-0.80 (-1.23, -0.38) 
Exposure (k=8) 
-0.68 (-1.06, -0.31) 
Group CBT (k=3) 
-0.30 (-0.86, 0.25) 
Group IPT (k=1) 
-1.02 (-2.07, 0.04) 
Moderate 
-1 imprecise 
Therapy format 
(individual vs group, 
k=52) 
Group only or in addition 
+0.27 (-0.25, +0.78) 
4% 0.309 Individual (k=48) 
-0.73 (-0.88, -0.58) 
Group only or in addition 
(k=4) 
-0.46 (-0.95, 0.03) 
Moderate 
-1 imprecise 
Trauma onset (Adult 
vs child, k=48) 
Child  
+0.18 (-0.16, +0.52) 
2% 0.308 Adult (k=37) 
-0.76 (-0.93, -0.59) 
Child (k=11) 
-0.58 (-0.88, -0.29) 
 
Moderate 
-1 imprecise 
      
Abbreviations: AD=affect dysregulation; CBT=cognitive behavioural therapy; DR=disturbances in relationships; EMDR=eye-movement and desensitisation and reprocessing 
therapy; k= number of included comparisons; NSC=negative self-concept; PTSD=posttraumatic stress disorder; CPTSD=complex posttraumatic stress disorder; 
TAU=treatment as usual; WL=waiting list.  
 
 
 
M.        Table M.1. Meta-regression Moderators (multivariate) 
 
Moderator (k=48, 
multivariate) 
Coefficients (95% CI) ∆R2 p-value Narrative summary Quality 
      
Quality (high vs low) Low  
+0.30 (+0.00, +0.61)  
Low 
1% 
Low 
0.048 
The effect for low quality 
studies is 0.30 lower than 
high quality studies 
Moderate 
-1 imprecise 
CPTSD symptoms 
(PTSD alone vs 
various CPTSD) 
PTSD + AD 
-0.13 (-1.06, +0.80) 
PTSD + NSC + DR + 
AD 
+0.39 (-0.62, +1.40) 
PTSD + DR 
+0.28 (-0.43, +1.00) 
PTSD + NSC 
+0.06 (-0.63, +0.75) 
PTSD + NSC + DR 
+0.25 (-0.52, +1.02) 
 
PTSD + AD 
-1% 
PTSD + NSC + DR 
+ ER 
1% 
PTSD + DR 
0% 
PTSD + NSC 
0% 
PTSD + NSC + DR 
2% 
Overall 
2% 
PTSD + AD 
0.783 
PTSD + NSC + DR 
+ ER 
0.447 
PTSD + DR 
0.437 
PTSD + NSC 
0.860 
PTSD + NSC + DR 
0.518 
Overall 
0.504 
No association between 
number or type of CPTSD 
symptoms reported and 
effect size was observed 
(direction of effect favoured 
smaller effects with more 
CPTSD symptoms). 
Moderate 
-1 imprecise 
Comparator 
(TAU/WL vs control) 
Control  
+0.69 (+0.38, +1.00) 
Control 
34% 
Control  
<0.0001 
Use of a control condition is 
associated with a moderate 
to large reduction in effect 
size. 
High 
Moderator (k=48, 
multivariate) 
Coefficients (95% CI) ∆R2 p-value Narrative summary Quality 
      
Treatments (individual 
CBT vs others) 
EMDR  
-0.25 (-0.69, +0.18) 
Exposure  
+0.07 (-0.30, +0.44) 
Group CBT  
+0.23 (-0.36, 0.82) 
Group IPT 
-0.70 (-1.66, 0.25) 
EMDR  
3% 
Exposure  
0% 
Group CBT  
7% 
Group IPT 
1% 
Overall 
11% 
EMDR  
0.254 
Exposure  
0.697 
Group CBT  
0.441 
Group IPT 
0.147 
Overall 
0.282 
No association between 
overall effect size and type 
of intervention was 
observed. 
Moderate 
-1 imprecise 
Trauma onset (adult 
vs child) 
Child  
+0.35 (+0.02, +0.69) 
Child 
5% 
Child  
0.038 
Inclusion of participants 
with predominantly 
childhood-onset trauma is 
associated with a small-
moderate reduction in effect 
size, compared to trials 
where participants have 
mainly adult-onset trauma 
Low 
-1 imprecise 
-1 
ecological 
bias 
      
Abbreviations: AD=affect dysregulation; CBT=cognitive behavioural therapy; DR=disturbances in relationships; EMDR=eye-movement and desensitisation and reprocessing 
therapy; k= number of included comparisons; NSC=negative self-concept; PTSD=posttraumatic stress disorder; CPTSD=complex posttraumatic stress disorder; 
TAU=treatment as usual; WL=waiting list.  
 
 
 
 
 
N.        Forest Plots – Cognitive/imagery modification with or without exposure vs 
TAU/WL or non-specific control 
 
Fig. N.1. Disturbances in relationships (DR): Cognitive/imagery modification with or 
without exposure vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Difede 2007 vs TAU ID -0.578 0.453 -1.467 0.310 0.202 7 14
Ehlers 2005 vs WL ID -1.534 0.420 -2.358 -0.711 0.000 14 14
Dunne 2012 vs WL ID -0.657 0.414 -1.468 0.154 0.112 12 11
Talbot 2014 vs WL ID -0.887 0.320 -1.514 -0.260 0.006 29 16
Foa 1999 vs WL ID -0.769 0.306 -1.370 -0.169 0.012 41 15
Monson 2006 vs WL ID -0.712 0.304 -1.308 -0.116 0.019 20 25
Power 2002 vs WL ID -0.689 0.302 -1.282 -0.096 0.023 21 24
Hollifield 2007 vs WL ID -0.572 0.287 -1.135 -0.009 0.046 25 24
Duffy 2007 vs WL ID -0.764 0.279 -1.310 -0.217 0.006 29 25
Galovski 2012 vs WL ID -1.265 0.267 -1.788 -0.741 0.000 34 32
Basoglu 2007 vs WL ID -0.144 0.258 -0.649 0.361 0.577 31 28
Ehlers 2003 vs SH + WL ID -0.798 0.241 -1.270 -0.327 0.001 28 52
Foa 2005 vs WL ID -0.422 0.231 -0.876 0.032 0.068 74 25
Ehlers 2014 vs WL ID -0.910 0.231 -1.363 -0.457 0.000 61 30
Krakow 2001 vs WL ID -0.415 0.206 -0.818 -0.011 0.044 47 48
Lindauer 2005 vs WL ID -0.259 0.118 -0.490 -0.028 0.028 12 12
-0.659 0.091 -0.837 -0.481 0.000 485 395
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
Difede 2007 vs TAU DR 
Ehlers 2005 vs WL DR 
Dunne 2012 vs WL DR 
Talbot 2014 vs WL DR 
Foa 1999 vs WL DR 
Monson 2006 vs WL DR 
Power 2002 vs WL DR 
Hollifield 2007 vs WL DR 
Duffy 2007 vs WL DR 
Galovski 201  vs WL DR 
Basoglu 2007 vs WL DR 
Ehlers 2003 vs SH + WL DR 
Foa 2005 vs WL DR 
Ehlers 2014 vs WL DR 
Krakow 2001 vs WL DR 
Lindauer 2005 vs WL DR 
 
Fig. N.2. Disturbances in relationships (DR): Cognitive/imagery modification with or 
without exposure vs non-specific control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Ehlers 2014 vs ST ID -0.508 0.224 -0.948 -0.069 0.023 61 30
Marks 1998 vs relax ID -0.331 0.275 -0.871 0.209 0.229 37 20
Forbes 2012 vs range ID -0.048 0.257 -0.552 0.455 0.850 30 29
-0.315 0.144 -0.598 -0.033 0.029 128 79
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
lers 2014 vs ST R 
arks 998 vs relax R 
Forbes 2012 vs range DR 
 
Fig. N.3. Affect dysregulation (AD): Cognitive/imagery modification with or without 
exposure vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Hinton 2009 vs WL ER -2.443 0.529 -3.479 -1.406 0.000 12 12
Cloitre 2002 vs WL ER -1.291 0.320 -1.918 -0.664 0.000 22 24
Monson 2006 vs WL ER -0.847 0.308 -1.451 -0.244 0.006 20 25
-1.424 0.397 -2.202 -0.647 0.000 54 61
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Hinton 2009 vs WL AD 
Cloitre 2002 vs WL AD 
Mons  2006 vs WL AD 
Fig. N.4. Affect dysregulation (AD): Cognitive/imagery modification with or without 
exposure vs non-specific control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Dunn 2007 vs PsyEd ER 0.198 0.198 -0.190 0.586 0.316 51 50
Hinton 2011 vs PMR ER -1.931 0.483 -2.877 -0.985 0.000 12 12
-0.821 1.064 -2.906 1.264 0.440 63 62
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Du n 2 07 PsyEd AD 
Hinton 2011 vs PMR AD 
Fig. N.5. Negative self-concept (NSC): Cognitive/imagery modification with or without 
exposure vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Kubany 2003 vs WL NC -2.994 0.511 -3.995 -1.993 0.000 18 14
Jung 2013 vs WL NC -0.740 0.380 -1.485 0.005 0.052 14 14
Monson 2006 vs WL NC -0.452 0.301 -1.042 0.138 0.133 20 25
McDonagh 2005 vs WL NC -0.548 0.280 -1.097 0.001 0.050 29 23
Mueser 2008 vs TAU, NC -0.257 0.259 -0.764 0.251 0.322 32 27
Galovski 2012 vs WL NC -0.935 0.257 -1.438 -0.432 0.000 34 32
Ford 2011 vs WL NC -1.149 0.222 -1.585 -0.714 0.000 48 45
Resick 2002 vs WL NC -0.888 0.212 -1.304 -0.472 0.000 62 39
Kubany 2004 vs WL NC -0.209 0.178 -0.558 0.141 0.242 63 62
-0.816 0.191 -1.190 -0.441 0.000 320 281
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
u     SC 
J     SC 
onson 2006 vs L SC 
cDonagh 2005 vs L NSC 
Mueser 2008 vs TAU NSC 
Galovski 2012 vs WL NSC 
Ford 2011 vs WL NSC 
Resick 2002 vs WL NSC 
Kubany 2004 vs WL NSC 
Fig. N.6. Negative self-concept (NSC): Cognitive/imagery modification with or without 
exposure vs non-specific control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Suris 2013 vs PCT NC -0.915 0.322 -1.547 -0.284 0.004 45 13
McDonagh 2005 vs PCT NC 0.410 0.281 -0.142 0.961 0.145 29 22
Ford 2011 vs control NC -0.453 0.200 -0.846 -0.060 0.024 48 53
Mueser 2015 vs control NC -0.071 0.158 -0.380 0.238 0.653 85 75
-0.239 0.228 -0.686 0.208 0.295 207 163
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
Suris 2013 v   SC 
McDonag     SC 
Ford 2   tr l SC 
Mueser 201  v  tr l SC 
Fig. N.7. PTSD: Cognitive/imagery modification with or without exposure vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Kubany 2003 vs WL PTSD -2.92 0.50 -3.90 -1.93 0.00 18 14
Hinton 2009 vs WL PTSD -1.91 0.48 -2.85 -0.97 0.00 12 12
Ehlers 2005 vs WL PTSD -2.19 0.47 -3.11 -1.27 0.00 14 14
Dunne 2012 vs WL PTSD -0.92 0.42 -1.75 -0.09 0.03 12 11
Lindauer 2005 vs WL PTSD -0.90 0.42 -1.72 -0.09 0.03 12 12
Jung 2013 vs WL PTSD -0.81 0.38 -1.56 -0.06 0.03 14 14
Difede 2007 vs TAU PTSD -0.34 0.35 -1.03 0.35 0.33 15 16
Foa 1999 vs WL PTSD -1.51 0.33 -2.16 -0.87 0.00 41 15
Cloitre 2002 vs WL PTSD -1.27 0.32 -1.90 -0.65 0.00 22 24
Power 2002 vs WL PTSD -1.14 0.32 -1.76 -0.51 0.00 21 24
Talbot 2014 vs WL PTSD -0.64 0.31 -1.26 -0.03 0.04 29 16
Hollifield 2007 vs WL PTSD -0.68 0.29 -1.25 -0.11 0.02 25 24
McDonagh 2005 vs WL PTSD -0.49 0.28 -1.04 0.06 0.08 29 23
Steel 2017 vs TAU PTSD 0.16 0.28 -0.39 0.70 0.57 25 25
Galovski 2012 vs WL PTSD -1.50 0.28 -2.04 -0.96 0.00 34 32
Monson 2006 vs WL PTSD -1.13 0.28 -1.67 -0.59 0.00 30 30
Duffy 2007 vs WL PTSD -0.88 0.27 -1.41 -0.34 0.00 29 29
Mueser 2008 vs TAU PTSD -0.44 0.26 -0.95 0.07 0.09 32 27
Basoglu 2007 vs WL PTSD -0.44 0.26 -0.95 0.08 0.09 31 28
Ehlers 2003 vs SH + WL PTSD -1.08 0.25 -1.56 -0.59 0.00 28 52
Ehlers 2014 vs WL PTSD -1.38 0.24 -1.85 -0.90 0.00 61 30
Dorrepaal 2012 vs TAU PTSD -0.29 0.24 -0.75 0.17 0.22 38 33
Foa 2005 vs WL PTSD -0.80 0.23 -1.26 -0.34 0.00 74 26
Ford 2011 vs WL PTSD -0.96 0.22 -1.39 -0.54 0.00 48 45
Resick 2002 vs WL PTSD -1.13 0.21 -1.54 -0.73 0.00 62 47
Kubany 2004 vs WL PTSD -0.28 0.18 -0.63 0.07 0.12 63 62
Krakow 2001 vs WL PTSD -0.13 0.15 -0.43 0.17 0.39 80 88
-0.90 0.11 -1.11 -0.68 0.00 899 773
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Fig. N.8. PTSD: Cognitive/imagery modification with or without exposure vs non-
specific control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Hinton 2011 vs PMR PTSD -1.532 0.452 -2.418 -0.646 0.001 12 12
Marks 1998 vs relax  PTSD 0.084 0.281 -0.467 0.635 0.765 39 18
McDonagh 2005 vs PCT PTSD 0.221 0.279 -0.326 0.769 0.428 29 22
Forbes 2012 vs range PTSD -0.393 0.260 -0.902 0.115 0.130 30 29
Suris 2013 vs PCT PTSD -1.067 0.233 -1.524 -0.610 0.000 52 34
Ehlers 2014 vs ST PTSD -0.623 0.226 -1.065 -0.180 0.006 61 30
Dunn 2007 vs PsyEd PTSD -0.207 0.198 -0.595 0.181 0.297 51 50
Ford 2011 vs control PTSD -0.042 0.198 -0.430 0.345 0.831 48 53
Mueser 2015 vs control PTSD -0.260 0.158 -0.569 0.050 0.100 86 75
-0.373 0.146 -0.660 -0.087 0.011 408 323
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
Fig. N.9. PTSD plus 1, 2 or 3 CPTSD outcomes: Cognitive/imagery modification with or 
without exposure vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Kubany 2003 vs WL PTSD + NC -2.956 0.508 -3.951 -1.961 0.000 18 14
Hinton 2009 vs WL PTSD + ER -2.177 0.505 -3.167 -1.187 0.000 12 12
Ehlers 2005 vs WL PTSD + ID -1.861 0.445 -2.732 -0.990 0.000 14 14
Dunne 2012 vs WL PTSD + ID -0.788 0.420 -1.610 0.034 0.060 12 11
Difede 2007 vs TAU PTSD + ID -0.460 0.403 -1.250 0.330 0.254 7 14
Jung 2013 vs WL PTSD + NC -0.774 0.381 -1.520 -0.027 0.042 14 14
Cloitre 2002 vs WL PTSD + ER -1.282 0.319 -1.908 -0.656 0.000 22 24
Foa 1999 vs WL PTSD + ID -1.142 0.318 -1.765 -0.518 0.000 41 15
Talbot 2014 vs WL PTSD + ID -0.766 0.317 -1.387 -0.144 0.016 29 16
Power 2002 vs WL PTSD + ID -0.912 0.310 -1.519 -0.305 0.003 21 24
Steel 2017 vs TAU, PTSD + NC 0.076 0.303 -0.517 0.669 0.802 18 18
Monson 2006 vs WL PTSD + ER + ID + NC -0.786 0.297 -1.368 -0.204 0.008 20 25
Hollifield 2007 vs WL PTSD + ID -0.625 0.288 -1.189 -0.061 0.030 25 24
McDonagh 2005 vs WL PTSD + NC -0.520 0.280 -1.068 0.028 0.063 29 22
Duffy 2007 vs WL PTSD + ID -0.820 0.278 -1.365 -0.275 0.003 29 25
Lindauer 2005 vs WL PTSD + ID -0.581 0.267 -1.104 -0.058 0.029 12 12
Galovski 2012 vs WL PTSD + NC + ID -1.233 0.267 -1.755 -0.710 0.000 34 32
Mueser 2008 vs TAU, PTSD + NC -0.349 0.260 -0.859 0.161 0.179 32 27
Basoglu 2007 vs WL PTSD + ID -0.290 0.259 -0.798 0.218 0.263 31 28
Ehlers 2003 vs SH + WL PTSD + ID -0.939 0.244 -1.417 -0.461 0.000 28 52
Dorrepaal 2012 vs TAU PTSD + ER + ID + NC -0.338 0.238 -0.803 0.127 0.155 38 33
Ehlers 2014 vs WL PTSD + ID -1.144 0.235 -1.605 -0.683 0.000 61 30
Foa 2005 vs WL PTSD + ID -0.620 0.232 -1.075 -0.165 0.008 74 25
Ford 2011 vs WL PTSD + NC -1.060 0.220 -1.491 -0.629 0.000 48 45
Resick 2002 vs WL PTSD + NC -1.011 0.210 -1.421 -0.600 0.000 62 39
Krakow 2001 vs WL PTSD + ID -0.274 0.180 -0.626 0.079 0.129 47 48
Kubany 2004 vs WL PTSD + NC -0.245 0.179 -0.595 0.105 0.170 63 62
-0.808 0.095 -0.995 -0.622 0.000 841 705
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Kubany 2003 vs WL PTSD + NSC 
Hinton 2009 vs WL PTSD + AD 
Ehlers 2005 vs WL PTSD + R 
Dunne 2012 vs WL PTSD + DR 
Difede 2007 vs TAU + DR 
Jung 2013 vs WL PTSD + NSC 
Cloitre 2002 vs WL PTSD + AD 
Foa 1999 vs WL PTSD + DR 
Talbot 2014 vs WL PTSD + DR 
Power 2002 vs WL PTSD + R 
Steel 2017 vs TAU PTSD + NSC 
Monson 2006 vs WL PTSD + AD + DR + NSC 
Hollifield 2007 vs WL PTSD + DR 
McDonagh 2005 vs WL PTSD + NSC 
Duffy 2007 vs WL PTSD + R 
Lindauer 2005 vs WL PTSD + DR 
Galovski 2012 vs WL PTSD + NSC + DR 
Mueser 2008 vs TAU PTSD + NSC 
Basoglu 2007 vs WL PTSD + DR 
Ehlers 2003 vs SH + WL PTSD + DR 
Dorrepaal 2012 vs TAU PTSD + AD + DR + NSC 
Ehlers 2014 vs WL PTSD + DR 
Foa 2005 vs WL PTSD + DR 
Ford 2011 vs WL PTSD + NSC 
Resick 2002 vs WL PTSD + NSC 
Krakow 2001 vs WL PTSD + DR 
Kubany 2004 vs WL PTSD + NSC 
 
 
 
 
 
Fig. N.10. PTSD plus 2 or 3 CPTSD outcomes: Cognitive/imagery modification with or 
without exposure vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Monson 2006 vs WL PTSD + ER + ID + NC -0.786 0.297 -1.368 -0.204 0.008 20 25
Galovski 2012 vs WL PTSD + NC + ID -1.233 0.267 -1.755 -0.710 0.000 34 32
Dorrepaal 2012 vs TAU PTSD + ER + ID + NC -0.338 0.238 -0.803 0.127 0.155 38 33
-0.775 0.273 -1.310 -0.240 0.005 92 90
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
Monson 2006 vs WL PTSD + AD  D   NSC 
Galovski 2012 vs WL PTSD + NSC + DR 
Dorrepaal 2012 vs TAU PTSD + AD + DR + NSC 
Fig. N.11. PTSD plus all 3 CPTSD outcomes: Cognitive/imagery modification with or 
without exposure vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Monson 2006 vs WL PTSD + ER + ID + NC -0.786 0.297 -1.368 -0.204 0.008 20 25
Dorrepaal 2012 vs TAU PTSD + ER + ID + NC -0.338 0.238 -0.803 0.127 0.155 38 33
-0.526 0.221 -0.960 -0.093 0.017 58 58
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
Monson 2006 vs WL PTSD + AD + DR + SC 
Dorrepaal 2012 vs TAU PTSD + AD + DR + NSC 
Fig. N.12. PTSD plus 1, 2 or 3 CPTSD outcomes: Cognitive/imagery modification with 
or without exposure vs non-specific control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Hinton 2011 vs PMR PTSD + ER -1.732 0.468 -2.648 -0.815 0.000 12 12
McDonagh 2005 vs PCT PTSD + NC 0.315 0.280 -0.234 0.865 0.260 29 22
Marks 1998 vs relax PTSD + ID -0.124 0.278 -0.668 0.421 0.657 37 20
Suris 2013 vs PCT PTSD + NC -0.991 0.278 -1.536 -0.446 0.000 45 13
Forbes 2012 vs range PTSD + ID -0.221 0.259 -0.727 0.286 0.394 30 29
Ehlers 2014 vs ST PTSD + ID -0.566 0.225 -1.007 -0.125 0.012 61 30
Ford 2011 vs control PTSD + NC -0.248 0.199 -0.638 0.142 0.213 48 53
Dunn 2007 vs PsyEd PTSD + ER -0.005 0.198 -0.393 0.384 0.982 51 50
Mueser 2015 vs control PTSD + NC -0.166 0.158 -0.475 0.144 0.295 85 85
-0.336 0.143 -0.615 -0.056 0.019 398 314
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
Hinton 201  v  R PTSD + AD 
McDonagh 20  PCT + NSC 
Marks 19 8 vs r  TSD + DR 
Suris 2013 vs P  PTSD + NSC 
Forbes 2012 vs r  PTSD + DR 
Ehlers 2014 vs  TSD + DR 
Ford 2011 vs co tr l TSD + NSC 
Dunn 2007 vs P d PTSD + AD 
Mueser 2015 control PTSD + SC 
O.        Forest Plots – Exposure only vs TAU/WL or non-specific control 
 
Fig. O.1. Disturbances in relationships (DR): Exposure only vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Foa 1999 vs WL ID -1.497 0.371 -2.224 -0.770 0.000 22 15
Keane 1989 vs WL ID -0.730 0.353 -1.422 -0.037 0.039 11 31
Foa 2005 vs WL ID -0.237 0.229 -0.685 0.211 0.300 78 25
van den Berg 2015 vs WL ID -0.177 0.215 -0.599 0.244 0.410 47 39
-0.594 0.270 -1.123 -0.066 0.028 158 110
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Foa 19 9 v  R 
Keane 1989 v  R 
Foa 20 5 v   R 
van den Berg 2015 vs L DR 
Fig. O.2. Disturbances in relationships (DR): Exposure only vs non-specific control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Ghafoori 2017 vs PCT ID -0.116 0.248 -0.602 0.371 0.642 47 24
-0.116 0.248 -0.602 0.371 0.642 47 24
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Ghafoori 2017 vs PCT DR 
Fig. O.3. Negative self-concept (NSC): Exposure only vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
van den Berg 2015 vs WL NC -0.739 0.222 -1.174 -0.304 0.001 47 39
Resick 2002 vs WL NC -0.519 0.207 -0.924 -0.114 0.012 61 39
Pacella 2012 vs WL NC -1.107 0.309 -1.712 -0.501 0.000 23 24
-0.728 0.155 -1.031 -0.425 0.000 131 102
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
van den Berg 2015 vs  SC 
Resick 2002 vs WL NSC 
Pacella 2012 vs WL NSC 
Fig. O.4. PTSD: Exposure only vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Foa 1999 vs WL PTSD -1.915 0.392 -2.683 -1.146 0.000 23 15
Pacella 2012 vs WL PTSD -2.146 0.364 -2.858 -1.434 0.000 23 24
Keane 1989 vs WL PTSD -0.237 0.345 -0.914 0.439 0.492 11 31
Foa 2005 vs WL PTSD -0.656 0.229 -1.104 -0.207 0.004 79 26
van den Berg 2015 vs WL PTSD -0.777 0.212 -1.191 -0.362 0.000 48 47
Resick 2002 vs WL PTSD -0.862 0.201 -1.255 -0.468 0.000 62 47
-1.048 0.241 -1.521 -0.575 0.000 246 190
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Fig. O.5. PTSD: Exposure only vs non-specific control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Marks 1998 vs relax  PTSD -0.145 0.319 -0.769 0.480 0.650 20 18
Ghafoori 2017 vs PCT PTSD -0.044 0.248 -0.530 0.442 0.859 47 24
-0.082 0.196 -0.466 0.302 0.675 67 42
-1.00 -0.50 0.00 0.50 1.00
Favours A Favours B
Meta Analysis
Fig. O.6. PTSD plus 1, 2 or 3 CPTSD outcomes: Exposure only vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Foa 1999 vs WL PTSD + ID -1.706 0.382 -2.455 -0.957 0.000 22 15
Keane 1989 vs WL PTSD + ID -0.484 0.349 -1.168 0.200 0.165 11 16
Pacella 2012 vs WL PTSD + NC -1.627 0.337 -2.286 -0.967 0.000 23 24
Foa 2005 vs WL PTSD + ID -0.447 0.229 -0.896 0.002 0.051 78 25
van den Berg 2015 vs WL PTSD + NC + ID -0.564 0.216 -0.988 -0.140 0.009 47 39
Resick 2002 vs WL PTSD + NC -0.690 0.204 -1.090 -0.291 0.001 61 39
-0.861 0.200 -1.252 -0.469 0.000 242 158
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Foa 1999 vs WL PTSD + DR 
Keane 1989 vs WL PTSD + DR 
Pacella 2012 vs WL PTSD + NSC 
Foa 2005 vs WL PTSD + DR 
van den Berg 2015 vs WL PTSD + NSC + DR 
Resick 2002 vs WL PTSD + NSC 
Fig. O.7. PTSD plus 2 or 3 CPTSD outcomes: Exposure only vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
van den Berg 2015 vs WL PTSD + NC + ID -0.564 0.216 -0.988 -0.140 0.009 47 39
-0.564 0.216 -0.988 -0.140 0.009 47 39
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
van den Berg 2015 vs WL PTSD + NSC + DR 
Fig. O.8. PTSD plus 1, 2 or 3 CPTSD outcomes: Exposure only vs non-specific control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Marks 1998 vs relax PTSD + ID -0.306 0.317 -0.927 0.315 0.334 20 18
Ghafoori 2017 vs PCT ID -0.116 0.248 -0.602 0.371 0.642 47 24
-0.188 0.195 -0.571 0.195 0.336 67 42
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Marks 1998 vs relax PTS  R 
Ghafoori 2017 vs PCT DR 
P.        Forest Plots – EMDR vs TAU/WL or non-specific control 
 
Fig. P.1. Disturbances in relationships (DR): EMDR vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Ahmadi 2015 vs TAU ID -1.126 0.435 -1.979 -0.273 0.010 11 12
Hogberg 2007 vs WL ID -0.345 0.427 -1.181 0.492 0.419 12 9
Power 2002 vs WL ID -1.357 0.307 -1.959 -0.755 0.000 27 24
van den Berg 2015 vs WL ID -0.276 0.219 -0.705 0.154 0.208 44 39
-0.758 0.303 -1.351 -0.164 0.012 94 84
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
Ahmadi 2015 v   R 
Hogberg 2007 v  R 
Power 2002 v  R 
van den r   s L R 
Fig. P.2. Disturbances in relationships (DR): EMDR vs non-specific control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Ahmadi 2015 vs REM ID -0.776 0.436 -1.631 0.079 0.075 11 10
Kip 2014 vs control ID -0.075 0.279 -0.621 0.472 0.789 26 24
-0.345 0.341 -1.014 0.324 0.312 37 34
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
Ah adi 2015 vs E  R 
Kip 2013 vs control DR 
Fig. P.3. Affect dysregulation (AD): EMDR vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Ahmadi 2015 vs TAU ER -1.636 0.469 -2.556 -0.717 0.000 11 12
-1.636 0.469 -2.556 -0.717 0.000 11 12
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
Ahmadi 2015 vs TAU AD 
Fig. P.4. Affect dysregulation (AD): EMDR vs non-specific control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Ahmadi 2015 vs REM ER 0.253 0.421 -0.572 1.079 0.548 11 10
0.253 0.421 -0.572 1.079 0.548 11 10
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
Ahmadi 5 vs REM AD 
Fig. P.5. Negative self-concept (NSC): EMDR vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
van den Berg 2015 vs WL NC -0.607 0.223 -1.044 -0.170 0.006 44 39
-0.607 0.223 -1.044 -0.170 0.006 44 39
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
van den Berg 2   L NSC 
Fig. P.6. Negative self-concept (NSC): EMDR vs non-specific control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Kip 2014 vs control NC -1.195 0.303 -1.789 -0.601 0.000 26 24
Scheck 1998 vs AL NC -0.401 0.260 -0.910 0.108 0.123 30 29
-0.782 0.397 -1.560 -0.005 0.049 56 53
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
i  2013 vs control NSC 
Scheck 1998 vs AL NSC 
Fig. P.7. PTSD: EMDR vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Ahmadi 2015 vs TAU PTSD -2.325 0.529 -3.361 -1.289 0.000 11 12
Hogberg 2007 vs WL PTSD -0.613 0.434 -1.463 0.237 0.157 12 9
Power 2002 vs WL PTSD -1.693 0.323 -2.326 -1.060 0.000 27 24
van den Berg 2015 vs WL PTSD -0.655 0.202 -1.052 -0.259 0.001 55 47
-1.259 0.383 -2.009 -0.509 0.001 105 92
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Fig. P.8. PTSD: EMDR vs non-specific control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Ahmadi 2015 vs REM PTSD 0.058 0.420 -0.764 0.880 0.890 11 10
Kip 2014 vs control PTSD -1.245 0.286 -1.806 -0.685 0.000 29 28
Scheck 1998 vs AL PTSD -0.710 0.270 -1.240 -0.181 0.009 30 27
-0.690 0.337 -1.350 -0.029 0.041 70 65
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Ahmadi 2015 vs REM PTSD 
Kip 2013 vs control PTSD 
Scheck 1998 vs AL PTSD 
Fig. P.9. PTSD plus 1, 2 or 3 CPTSD outcomes: EMDR vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Ahmadi 2015 vs TAU PTSD -2.325 0.529 -3.361 -1.289 0.000 11 12
Hogberg 2007 vs WL PTSD + ID -0.479 0.431 -1.323 0.365 0.266 12 9
Power 2002 vs WL PTSD + ID -1.525 0.315 -2.142 -0.908 0.000 27 24
van den Berg 2015 vs WL PTSD + NC + ID -0.513 0.215 -0.934 -0.092 0.017 44 39
-1.146 0.395 -1.920 -0.373 0.004 94 84
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Ahmadi 2015 vs TAU PTSD 
Hogberg 2007 vs WL PTSD + DR 
Power 2002 vs WL PTSD + DR 
van den Berg 2015 vs WL PTSD + NSC + DR 
Fig. P.10. PTSD plus 2 or 3 CPTSD outcomes: EMDR vs TAU/WL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Ahmadi 2015 vs TAU PTSD -2.325 0.529 -3.361 -1.289 0.000 11 12
van den Berg 2015 vs WL PTSD + NC + ID -0.513 0.215 -0.934 -0.092 0.017 44 39
-1.355 0.904 -3.126 0.417 0.134 55 51
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Ahmadi 2015 vs TAU PTSD 
van den Berg 2015 vs WL PTSD + NS   R  
Fig. P.11. PTSD plus 1, 2 or 3 CPTSD outcomes: EMDR vs non-specific control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Ahmadi 2015 vs REM PTSD 0.058 0.420 -0.764 0.880 0.890 11 10
Kip 2014 vs control PTSD + NC + ID -0.838 0.289 -1.405 -0.271 0.004 26 24
Scheck 1998 vs AL PTSD + NC -0.556 0.265 -1.075 -0.037 0.036 30 27
-0.524 0.226 -0.967 -0.081 0.020 67 61
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Ahmadi 2015 vs REM PTSD 
Kip 2013 vs control PTSD + NS   R 
Scheck 1998 vs AL PTSD + NS  
Fig. P.12. PTSD plus 2 or 3 CPTSD outcomes: EMDR vs non-specific control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Ahmadi 2015 vs REM PTSD 0.058 0.420 -0.764 0.880 0.890 11 10
Kip 2014 vs control PTSD + NC + ID -0.838 0.289 -1.405 -0.271 0.004 26 24
-0.442 0.445 -1.314 0.431 0.321 37 34
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Ahmadi 2015 vs REM PTSD 
Kip 2013 vs control PTSD + NS  + DR 
Q.        Forest Plots – Comparison of CBT, Exposure and EMDR 
 
Fig. Q.1. Disturbances in relationships (DR): CBT vs Exposure alone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Marks 1998 vs exp ID 0.167 0.274 -0.371 0.704 0.544 37 20
Foa 1999 vs exp ID 0.364 0.263 -0.152 0.879 0.167 41 22
Foa 2005 vs exp ID -0.159 0.162 -0.476 0.158 0.326 74 78
0.066 0.166 -0.259 0.391 0.689 152 120
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
rks  s Exp R 
Foa 1999 vs Exp DR 
Foa 2005 vs Exp DR 
Fig. Q.2. Negative self-concept (NSC): CBT vs Exposure alone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Resick 2002 vs Exp NC -0.314 0.180 -0.667 0.040 0.082 62 61
-0.314 0.180 -0.667 0.040 0.082 62 61
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
Resick 2002 vs Exp NSC 
Fig. Q.3. PTSD: CBT vs Exposure alone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Marks 1998 vs exp PTSD 0.237 0.272 -0.297 0.771 0.384 39 20
Foa 1999 vs exp PTSD 0.180 0.258 -0.326 0.685 0.486 41 23
Resick 2002 vs Exp PTSD -0.179 0.179 -0.529 0.172 0.318 62 62
Foa 2005 vs exp PTSD -0.079 0.161 -0.394 0.237 0.625 74 79
-0.028 0.101 -0.225 0.170 0.784 216 184
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
Fig. Q.4. PTSD plus 1, 2 or 3 CPTSD outcomes: CBT vs Exposure alone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Marks 1998 vs exp PTSD + ID 0.202 0.273 -0.333 0.737 0.459 37 20
Foa 1999 vs exp PTSD + ID 0.272 0.261 -0.240 0.784 0.297 41 22
Resick 2002 vs Exp PTSD + NC -0.246 0.180 -0.598 0.106 0.171 62 61
Foa 2005 vs exp PTSD + ID -0.119 0.162 -0.437 0.199 0.463 74 78
-0.042 0.116 -0.269 0.185 0.719 214 181
-4.00 -2.00 0.00 2.00 4.00
Favours A Favours B
Meta Analysis
Marks 19 8 vs Ex    R 
Foa 1999 vs Exp  R 
Resick 2002 vs Exp P   SC 
Foa 2005 vs Exp PTS  + R 
Fig. Q.5. Disturbances in relationships (DR): CBT vs EMDR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Power 2002 vs EMDR ID 0.596 0.293 0.023 1.169 0.042 21 27
Nijdam 2012 vs EMDR ID 0.018 0.221 -0.414 0.451 0.934 38 43
0.275 0.287 -0.287 0.838 0.338 59 70
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
Power 2002 vs EM R 
Nijdam 2012 vs EM  R 
Fig. Q.6. PTSD: CBT vs EMDR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Power 2002 vs EMDR PTSD 0.511 0.291 -0.059 1.081 0.079 21 27
Nijdam 2012 vs EMDR PTSD 0.295 0.212 -0.120 0.711 0.164 41 48
0.370 0.171 0.034 0.706 0.031 62 75
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
Fig. Q.7. PTSD plus 1, 2 or 3 CPTSD outcomes: CBT vs EMDR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
Power 2002 vs EMDR PTSD + ID 0.554 0.292 -0.019 1.126 0.058 21 27
Nijdam 2012 vs EMDR PTSD + ID 0.157 0.217 -0.268 0.581 0.470 38 43
0.307 0.193 -0.071 0.684 0.111 59 70
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
Power 20 2 vs E SD + DR 
Nijdam 2012 vs EM  + R 
Fig. Q.8. Disturbances in relationships (DR): EMDR vs Exposure alone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
van den Berg 2015 vs Exp ID -0.097 0.208 -0.505 0.311 0.640 44 47
-0.097 0.208 -0.505 0.311 0.640 44 47
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
van den Berg  xp R 
Fig. Q.9. Negative self-concept (NSC): EMDR vs Exposure alone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
van den Berg 2015 vs Exp NC 0.159 0.208 -0.249 0.568 0.444 44 47
0.159 0.208 -0.249 0.568 0.444 44 47
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
van den Berg 2015 vs Exp SC 
Fig. Q.10. PTSD: EMDR vs Exposure alone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
van den Berg 2015 vs Exp PTSD 0.102 0.197 -0.284 0.487 0.605 55 48
0.102 0.197 -0.284 0.487 0.605 55 48
-1.00 -0.50 0.00 0.50 1.00
Favours A Favours B
Meta Analysis
Fig. Q.11. PTSD plus 1, 2 or 3 CPTSD outcomes: EMDR vs Exposure alone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
van den Berg 2015 vs Exp PTSD + NC + ID 0.055 0.204 -0.346 0.455 0.789 44 47
0.055 0.204 -0.346 0.455 0.789 44 47
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
van den Berg 2015 vs Exp PTSD + NS  R 
Fig. Q.12. PTSD plus 2 or 3 CPTSD outcomes: EMDR vs Exposure alone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit p-Value Group-A Group-B
van den Berg 2015 vs Exp PTSD + NC + ID 0.055 0.204 -0.346 0.455 0.789 44 47
0.055 0.204 -0.346 0.455 0.789 44 47
-2.00 -1.00 0.00 1.00 2.00
Favours A Favours B
Meta Analysis
van den Berg 2015 vs Exp PTSD + NS  + DR 
R.        Bubble Plots – Meta-regression Moderators (univariate) 
 
Fig. R.1. Random sequence generation (low vs unclear or high risk of bias, k=52) 
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Fig. R.2. Allocation concealment (low vs unclear or high risk of bias, k=52) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regression of Hedges's g on Allocation concealment
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Fig. R.3. Detection bias (low vs unclear or high risk of bias, k=52) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regression of Hedges's g on Detection bias
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Fig. R.4. Selective reporting bias (low vs unclear or high risk of bias, k=52) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regression of Hedges's g on Reporting bias
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Fig. R.5. Attrition bias (low vs unclear or high risk of bias, k=52) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regression of Hedges's g on Attrition bias
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Fig. R.6. Overall quality (high quality vs low quality, k=52) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regression of Hedges's g on Quality overall
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Fig. R.7. CPTSD symptoms (PTSD alone vs various CPTSD, k=52) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regression of Hedges's g on N CPTSD symptoms
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Fig. R.8. Comparator (TAU/WL vs control, k=52) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regression of Hedges's g on Comparator
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Fig. R.9. Treatments (individual CBT vs others, k=52) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regression of Hedges's g on Treatment
Treatment
He
dg
es
's
 g
CBT EMDR Exp Group CBT Group IPT
3.00
2.00
1.00
0.00
-1.00
-2.00
-3.00
-4.00
-5.00
Fig. R.10. Therapy format (individual vs group, k=52) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regression of Hedges's g on Group only or in addition
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Fig. R.11. Trauma onset (Adult vs child, k=48) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regression of Hedges's g on Trauma onset
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S.        Bubble Plots – Meta-regression Moderators (multivariate) 
 
Fig. S.1. Overall quality (high vs low) 
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Fig. S.2. CPTSD symptoms (PTSD alone vs various CPTSD) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regression of Hedges's g on N CPTSD symptoms
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Fig. S.3. Comparator (TAU/WL vs control) 
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Fig. S.4. Treatments (individual CBT vs others) 
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Fig. S.5. Trauma onset (adult vs child) 
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T.        Funnel Plots for Meta-analyses (where publication bias is indicated)  
 
Fig. T.1. Disturbances in relationships (DR): Cognitive/imagery modification with or 
without exposure vs TAU/WL  
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Fig. T.2. PTSD: Cognitive/imagery modification with or without exposure vs TAU/WL 
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Fig. T.3. PTSD plus 1, 2 or 3 CPTSD outcomes: Cognitive/imagery modification with or 
without exposure vs TAU/WL 
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U.        PRISMA Checklist 
 
Section/topic  # Checklist item  Reported 
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  Yes 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; 
conclusions and implications of key findings; systematic review registration number.  
Yes 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  Yes 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
Yes 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
Yes 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
Yes 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to 
identify additional studies) in the search and date last searched.  
Yes 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could 
be repeated.  
Yes 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
Yes 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
Yes 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions 
and simplifications made.  
Yes 
Section/topic  # Checklist item  Reported 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this 
was done at the study or outcome level), and how this information is to be used in any data synthesis.  
Yes 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  Yes 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
Yes 
 
Section/topic  # Checklist item  Reported 
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, 
selective reporting within studies).  
Yes 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
Yes 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
Yes 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations.  
Yes 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  Yes 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
Yes 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  Yes 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  Yes 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 
16]).  
Yes 
DISCUSSION   
Section/topic  # Checklist item  Reported 
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
Yes 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete 
retrieval of identified research, reporting bias).  
Yes 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future 
research.  
Yes 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders 
for the systematic review.  
N/A 
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DR=disturbances in relationships; DSO=disturbances in self-organisation; EMDR=eye-movement and desensitisation and reprocessing therapy; ER=emotion regulation (training); IPT=interpersonal 
psychotherapy; NSC=negative self-concept; PTSD=posttraumatic stress disorder; PTSD + 1, 2 or 3=PTSD + 1, 2 or 3 CPTSD (DSO) outcomes; PTSD + 2 or 3=PTSD + 2 or 3 CPTSD (DSO) 
outcomes; PTSD + 3=PTSD + all 3 CPTSD (DSO) outcomes; STBT=stabilisation treatment; TAU=treatment as usual; TMT=trauma management therapy; WL=waiting list.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Bubble plot of trauma onset (adult vs child) by Hedges’ g, controlling for study quality, degree of CPTSD symptom severity, type of 
comparator, and type of treatment in multivariate meta-regression.  
 
 
 
 
 
 
 
 
Table 1. Cognitive behavioural therapy with or without exposure vs TAU/WL or non-specific control 
 
Outcome Comparator k 
included 
studies 
Treatment 
N 
Control 
N 
Hedges’ g 
(95% CI), p-
value 
Heterogeneity, 
I2, p-value 
Publication bias, 
p-value, 
adjusted g (95% 
CI), k imputed 
studies 
Quality 
(GRADE) 
DR vs TAU/WL 16 485 395 -0.66 (-0.84, 
-0.48), 
<0.001 
45%, 0.021 0.007, -0.39 (-
0.59, -0.20), 8  
Moderate 
-1 
publication 
bias 
DR vs control 3 128 79 -0.32 (-0.60, 
-0.03), 0.029 
0%, 0.402 - Moderate 
-1 
imprecision 
AD vs TAU/WL 3 54 61 -1.42 (-2.20, 
-0.65), 
<0.001 
71%, 0.033 - Moderate 
-1 
imprecision 
AD vs control 2 63 62 -0.82 (-2.91, 
1.26), 0.440  
94%, <0.001 - Very low 
-1 
inconsistency 
-2 
imprecision 
NSC vs TAU/WL 9 320 281 -0.82 (-1.19, 
-0.44), 
<0.001 
79%, <0.001 - Moderate 
-1 
inconsistency 
NSC vs control 4 207 163 -0.24 (-0.69, 
0.21), 0.295 
75%, 0.008 - Low 
-1 
inconsistency 
-1 
imprecision 
 
Abbreviations: AD=affect dysregulation; CPTSD=complex posttraumatic stress disorder; DR=disturbances in relationships; DSO=disturbances in self-organisation; 
NSC=negative self-concept; PTSD=posttraumatic stress disorder; PTSD + 1, 2 or 3=PTSD + 1, 2 or 3 CPTSD (DSO) outcomes; PTSD + 2 or 3=PTSD + 2 or 3 CPTSD 
(DSO) outcomes; PTSD + 3=PTSD + all 3 CPTSD (DSO) outcomes; TAU=treatment as usual; WL=waiting list.  
 
PTSD vs TAU/WL 27 899 773 -0.90 (-1.11, 
-0.68), 
<0.001 
76%, <0.001 0.002, -0.90 (-
1.11, -0.68), 0 
Moderate 
-1 
inconsistency 
 
PTSD vs control 9 408 323 -0.37 (-0.66, 
-0.09), 0.011 
71%, 0.001  Moderate 
-1 
inconsistency 
 
PTSD + 1, 2 or 
3 
vs TAU/WL 27 841 705 -0.81 (-1.00, 
-0.62), 
<0.001 
68%, <0.001 0.003, -0.81 (-
1.00, -0.62), 0 
High 
PTSD + 2 or 3 vs TAU/WL 3 92 90 -0.78 (-1.31, 
-0.24), 0.005 
68%, 0.043  Moderate 
-1 
imprecision 
 
PTSD + 3 vs TAU/WL 2 58 58 -0.53 (-0.96, 
-0.09), 0.017 
28%, 0.239  Low 
-2 
imprecision 
PTSD + 1, 2 or 
3 
vs control 9 398 314 -0.34 (-0.62, 
-0.06), 0.019 
68%, 0.001  Low 
-1 
imprecision 
-1 
inconsistency 
 
PTSD + 2 or 3 vs control 0 - - - -   
PTSD + 3 vs control 0 - - - -   
Table 2. Exposure only vs TAU/WL or non-specific control 
 
Outcome Comparator k 
included 
studies 
Treatment 
N 
Control 
N 
Hedges’ g 
(95% CI), p-
value 
Heterogeneity, 
I2, p-value 
Publication bias, 
p-value, 
adjusted g (95% 
CI), k imputed 
studies 
Quality 
(GRADE) 
DR vs TAU/WL 4 158 110 -0.59 (-1.12, 
-0.07), 0.028 
73%, 0.011 - Moderate 
-1 
imprecision 
DR vs control 1 47 24 -0.12 (-0.60, 
0.37), 0.642 
- - Very low 
-2 RoB 
-2 
imprecision 
AD vs TAU/WL 0 - - - - - - 
AD vs control 0 - - - - - - 
NSC vs TAU/WL 3 131 102 -0.73 (-1.03, 
-0.43), 
<0.001 
21%, 0.283 - Moderate 
-1 
imprecision 
 
NSC vs control 0 - - - - - - 
PTSD vs TAU/WL 6 246 190 -1.05 (-1.52, 
-0.58), 
<0.001 
79%, <0.001 - Low 
-2 
imprecision 
PTSD vs control 2 67 42 -0.08 (-0.47, 
0.30), 0.675 
0%, 0.803 - Low 
-2 
imprecision 
Outcome Comparator k 
included 
studies 
Treatment 
N 
Control 
N 
Hedges’ g 
(95% CI), p-
value 
Heterogeneity, 
I2, p-value 
Publication bias, 
p-value, 
adjusted g (95% 
CI), k imputed 
studies 
Quality 
(GRADE) 
PTSD + 1, 2 or 
3 
vs TAU/WL 6 242 158 -0.86 (-1.25, 
-0.47), 
<0.001 
69%, 0.006 - High 
PTSD + 2 or 3 vs TAU/WL 1 47 39 -0.56 (-0.99, 
-0.14), 0.009 
- - Low 
-2 
imprecision 
PTSD + 3 vs TAU/WL 0 - - - - - - 
PTSD + 1, 2 or 
3 
vs control 2 67 42 -0.19 (-0.57, 
0.20), 0.336 
0%, 0.636 - Low 
-2 
imprecision 
PTSD + 2 or 3 vs control 0 - - - - - - 
PTSD + 3 vs control - - - - - - - 
 
Abbreviations: AD=affect dysregulation; CPTSD=complex posttraumatic stress disorder; DSO=disturbances in self-organisation; DR=disturbances in relationships; 
NSC=negative self-concept; PTSD=posttraumatic stress disorder; PTSD + 1, 2 or 3=PTSD + 1, 2 or 3 CPTSD (DSO) outcomes; PTSD + 2 or 3=PTSD + 2 or 3 CPTSD 
(DSO) outcomes; PTSD + 3=PTSD + all 3 CPTSD (DSO) outcomes; TAU=treatment as usual; WL=waiting list.  
 
 
 
 
 
 
 
 
 
Table 3. EMDR vs TAU/WL or non-specific control 
 
Outcome Comparator k included 
studies 
Treatment 
N 
Control 
N 
Hedges’ g 
(95% CI), p-
value 
Heterogeneity, 
I2, p-value 
Publication 
bias, p-value, 
adjusted g 
(95% CI), k 
imputed 
studies 
Quality 
(GRADE) 
DR vs TAU/WL 4 94 84 -0.76 (-1.35, -
0.16), 0.012 
70%, 0.019 - Moderate 
-1 
imprecision 
DR vs control 2 37 34 -0.35 (-1.01, 
0.31), 0.312 
46%, 0.174 - Very low 
-2 RoB 
-2 
imprecision 
-1 
inconsistency 
AD vs TAU/WL 1 11 12 -1.64 (-2.56, -
0.72), 0.000 
- - Very low 
-2 RoB 
-2 
imprecision 
AD vs control 1 11 10 0.25 (-0.57, 
1.08), 0.548 
- - Very low 
-2 RoB 
-2 
imprecision 
NSC vs TAU/WL 1 44 39 -0.61 (-1.04, -
0.17), 0.006 
- - Low 
-2 
imprecision 
NSC vs control 2 56 53 -0.78 (-1.56, -
0.01), 0.049 
75%, 0.047 - Very low 
-1 
inconsistency 
Outcome Comparator k included 
studies 
Treatment 
N 
Control 
N 
Hedges’ g 
(95% CI), p-
value 
Heterogeneity, 
I2, p-value 
Publication 
bias, p-value, 
adjusted g 
(95% CI), k 
imputed 
studies 
Quality 
(GRADE) 
-2 
imprecision 
PTSD vs TAU/WL 4 105 92 -1.26 (-2.01, -
0.51), 0.001 
79%, 0.002 - Low 
-1 
inconsistency 
-1 
imprecision 
PTSD vs control 3 70 65 -0.69 (-1.35, -
0.03), 0.041 
70%, 0.035 - Very low 
-1 RoB 
-1 
inconsistency 
-1 
imprecision 
PTSD + 1, 2 or 
3 
vs TAU/WL 4 94 84 -1.15 (-1.92, -
0.37), 0.004 
81%, 0.002 - Low 
-1 
inconsistency 
-1 
imprecision 
PTSD + 2 or 3 vs TAU/WL 2 55 51 -1.36 (-3.13, 
0.42), 0.134 
90%, 0.001 - Very low 
-1 
inconsistency 
-2 
imprecision 
PTSD + 3 vs TAU/WL 0 - - - - - - 
Outcome Comparator k included 
studies 
Treatment 
N 
Control 
N 
Hedges’ g 
(95% CI), p-
value 
Heterogeneity, 
I2, p-value 
Publication 
bias, p-value, 
adjusted g 
(95% CI), k 
imputed 
studies 
Quality 
(GRADE) 
PTSD + 1, 2 or 
3 
vs control 3 67 61 -0.52 (-0.97, -
0.08), 0.020 
35%, 0.213 - Low 
-1 RoB 
-1 
imprecision 
PTSD + 2 or 3 vs control 2 37 34 -0.44 (-1.31, 
0.43), 0.321 
68%, 0.079 - Very low 
-2 RoB 
-1 
inconsistency 
-2 
imprecision 
PTSD + 3 vs control 0 - - - - - - 
 
Abbreviations: AD=affect dysregulation; CPTSD=complex posttraumatic stress disorder; DR=disturbances in relationships; DSO=disturbances in self-organisation; 
EMDR=eye-movement and desensitisation and reprocessing therapy; NSC=negative self-concept; PTSD=posttraumatic stress disorder; PTSD + 1, 2 or 3=PTSD + 1, 2 or 3 
CPTSD (DSO) outcomes; PTSD + 2 or 3=PTSD + 2 or 3 CPTSD (DSO) outcomes; PTSD + 3=PTSD + all 3 CPTSD (DSO) outcomes; TAU=treatment as usual; 
WL=waiting list.  
 
 
 
  
Table 4. Comparison of CBT, Exposure and EMDR 
 
Outcome Comparison 
(A vs B) 
k 
included 
studies 
Group A N Group 
B N 
Hedges’ g 
(95% CI), p-
value 
Heterogeneity, 
I2, p-value 
Publication 
bias, p-value, 
adjusted g 
(95% CI), k 
imputed studies 
Quality 
(GRADE) 
DR CBT vs 
exposure 
alone 
3 152 120 0.07 (-0.26, 
0.39), 0.689 
38%, 0.200 - Moderate 
-1 
imprecision 
AD CBT vs 
exposure 
alone 
0 - - - - - - 
NSC CBT vs 
exposure 
alone 
1 62 61 -0.31 (-0.67, 
0.04), 0.082  
- - Very low 
-2 RoB 
-2 
imprecision 
PTSD CBT vs 
exposure 
alone 
4 216 184 -0.03 (-0.23, 
0.17), 0.784 
0%, 0.493 - Moderate 
-1 
imprecision 
PTSD + 1, 2 or 
3 
CBT vs 
exposure 
alone 
4 214 181 -0.04 (-0.27, 
0.19), 0.719 
20%, 0.291 - Moderate 
-1 
imprecision 
PTSD + 2 or 3 CBT vs 
exposure 
alone 
0 - - - - - - 
PTSD + 3 CBT vs 
exposure 
alone 
0 - - - - - - 
Outcome Comparison 
(A vs B) 
k 
included 
studies 
Group A N Group 
B N 
Hedges’ g 
(95% CI), p-
value 
Heterogeneity, 
I2, p-value 
Publication 
bias, p-value, 
adjusted g 
(95% CI), k 
imputed studies 
Quality 
(GRADE) 
DR CBT vs 
EMDR 
2 59 70 0.28 (-0.29, 
0.34), 0.338 
60%, 0.115 - Very low 
-2 
imprecision 
-1 
inconsistency 
AD CBT vs 
EMDR 
0 - - - - - - 
NSC CBT vs 
EMDR 
0 - - - - - - 
PTSD CBT vs 
EMDR 
2 62 75 0.37 (0.03, 
0.71), 0.031 
0%, 0.548 - Low 
-2 
imprecision 
PTSD + 1, 2 or 
3 
CBT vs 
EMDR 
2 59 70 0.31 (-0.07, 
0.68), 0.111 
16%, 0.275 - Low 
-2 
imprecision 
PTSD + 2 or 3 CBT vs 
EMDR 
0 - - - - - - 
PTSD + 3 CBT vs 
EMDR 
0 - - - - - - 
DR EMDR vs 
exposure 
alone 
1 44 47 -0.10 (-0.51, 
0.31), 0.640 
- - Low 
-2 
imprecision 
AD EMDR vs 
exposure 
alone 
0 - - - - - - 
Outcome Comparison 
(A vs B) 
k 
included 
studies 
Group A N Group 
B N 
Hedges’ g 
(95% CI), p-
value 
Heterogeneity, 
I2, p-value 
Publication 
bias, p-value, 
adjusted g 
(95% CI), k 
imputed studies 
Quality 
(GRADE) 
NSC EMDR vs 
exposure 
alone 
1 44 47 0.16 (-0.25, 
0.57), 0.444 
- - Low 
-2 
imprecision 
PTSD EMDR vs 
exposure 
alone 
1 55 48 0.10 (-0.28, 
0.49), 0.604 
- - Low 
-2 
imprecision 
PTSD + 1, 2 or 
3 
EMDR vs 
exposure 
alone 
1 44 47 0.06 (-0.35, 
0.46), 0.789 
- - Low 
-2 
imprecision 
PTSD + 2 or 3 EMDR vs 
exposure 
alone 
1 44 47 0.06 (-0.35, 
0.46), 0.789 
- - Low 
-2 
imprecision 
PTSD + 3 EMDR vs 
exposure 
alone 
0 - - - - - - 
 
Abbreviations: AD=affect dysregulation; CPTSD=complex posttraumatic stress disorder; DR=disturbances in relationships; DSO=disturbances in self-organisation; 
EMDR=eye-movement and desensitisation and reprocessing therapy; NSC=negative self-concept; PTSD=posttraumatic stress disorder; PTSD + 1, 2 or 3=PTSD + 1, 2 or 3 
CPTSD (DSO) outcomes; PTSD + 2 or 3=PTSD + 2 or 3 CPTSD (DSO) outcomes; PTSD + 3=PTSD + all 3 CPTSD (DSO) outcomes.   
 
 
